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Apoptosis, or programmed cell death, is a process of crucial importance for maintaining a 
homeostatic balance between cell proliferation and death.  In the present study a new 
mathematical model is presented that draws attention to the possible occurrence of bistability in 
mitochondria-dependent apoptotic pathways, as well as a transition from bistable to monostable 
behavior -either apoptotic or cytoprotective, under well-defined conditions. Bistability is 
proposed to be conferred by positive feedback loops that enhance caspase-3 activation pathways 
through mitochondria and by kinetic cooperativity in the formation of an apoptosome complex. It 
essentially ensures that cells will not die in the presence of relatively small pro-apoptotic effects, 
but will undergo apoptosis when perturbing conditions or levels of pro-apoptotic agents exceed 
certain threshold values. The passage from bistable to monostable cytoprotective behavior i.e., 
resistance to apoptosis, may be induced by decreasing the levels of Bax, a pro-apoptotic enzyme, 
in agreement with experimental observations; while the opposite passage to a pro-apoptotic 
monostable state may be triggered by a change in the levels of mitochondrial permeability 
transition pore complexes (PTPCs). Further computations shed light on the origins of the 
experimentally observed dichotomous effects of nitric oxide (NO), demonstrating that the 
MATHEMATICAL MODELING AND SIMULATION OF APOPTOSIS  
AND NITRIC OXIDE EFFECTS 
Elife Zerrin Bagci, PhD 
University of Pittsburgh, 2007
 iv 
relative concentrations of anti- and pro-apoptotic reactive NO species, and the interplay of 
glutathione, dominate the cell fate at long times (of the order of hours). Transient apoptotic 
effects may be observed in the presence of high levels of intracellular non-heme iron, the 
duration of which may reach up to hours, despite the eventual convergence to an anti-apoptotic 
state. The computational results thus point to the importance of the precise timing of NO 
production and external stimulation in determining the eventual pro- or anti-apoptotic role of 
NO. The same mathematical model (network of interactions) applied with different model 
parameters to different cell types demonstrates that cells with high levels of intracellular non-
heme iron are resistant to apoptosis while those subjected to high levels of superoxide undergo 
pathological death, consistent with experimental observations. 
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1.0  INTRODUCTION 
1.1 COMPUTATIONAL CELLULAR DYNAMICS 
1.1.1 Quantitative modeling as a tool for improving our understanding of the 
dynamics of cellular processes 
Mathematical models of biochemical processes and computer simulations of molecular events at 
the cellular scale can increase our insight into the molecular basis of microphysiological 
processes in cellular systems. The models constructed using available biological data can, not 
only reproduce experiments, but also give insights into the spatial and temporal dynamics of 
cellular processes. This type of modeling is described as computational cellular dynamics 
(Kitano, 2006; Kholodenko, 2006). The other important use of computational models is their 
efficient generation of data compared to experiments. Experiments usually require time 
consuming treatments whereas computational models can be readily modified and simulated. 
Also, the measurement of the concentration and activities of the components in the biochemical 
system may require difficult techniques whereas a range of quantities can be easily screened to 
search for optimal parameters. Therefore, realistic models that incorporate experimental data are 
expected to become increasingly important for rapid generation of testable hypotheses and 
predicting the effects of various experimental settings such as the depletion or supply of one or 
 1 
more of components in the system. The predictions of the models that are of interest in the 
healthy and pathological functioning of organisms can then be validated by experiments, and 
experiments can provide, in return, insights for model improvement and parameter optimization 
(Kitano, 2002). 
1.1.2 Focus of the present thesis: Modeling apoptosis and its regulation by 
mitochondria-dependent pathways: 
Apoptosis is a highly regulated form of cell death. There have been considerable efforts for 
mathematical modeling of apoptotic regulation in response to various stimuli (Aldridge et al., 
2006; Bagci et al., 2006; Bentele et al., 2004; Eissing et al., 2004; Legewie et al., 2006; Rehm et 
al., 2006; Siehs et al., 2002; Stucki and Simon, 2005). In particular, NO has been widely 
recognized to be an important modulator of apoptosis although the origin and mechanisms of its 
proapoptotic and antiapoptotic effects are still to be clarified.  
The first aim in the present thesis is to construct a new model and perform a quantitative 
analysis of the corresponding reaction kinetics for improving our understanding of the regulation 
of apoptotic response, with particular focus on mitochondria-dependent apoptosis. In the present 
thesis, the term ‘reaction’ is used in a broad sense, to refer to both chemical reactions and 
physical interactions (e.g. binding, multimerization, dissociation or disassembly). The second 
aim is to construct a mathematical model for describing the dynamics of NO pathways. Finally, 
the third aim will be the integration of the two models, so as to explain the dichotomous effects 
of NO with the help of a deterministic model that couples NO chemistry to apoptotic pathways. 
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1.2 APOPTOSIS 
1.2.1 Apoptosis is important for healthy functioning of the organism 
The biochemical mechanism of apoptosis, a form of programmed cell death (PCD), is an area of 
extensive study because of the importance of maintaining the homeostatic balance in response to 
pro- or anti-apoptotic stimuli (Sanfilippo and Blaho, 2003). The balance between cell 
proliferation and apoptosis is crucial for the healthy functioning of organisms. About 1010 cells 
die in a day in each individual, which counters the number of new cells that are generated 
through mitosis. This corresponds to the whole body weight in one year (Reed, 2002). 
Apoptosis is a highly regulated form of cell death, unlike necrosis that is an uncontrolled 
and undesirable cell death. During development, apoptosis is involved in sculpting the body, 
shaping the organs, and carving out the fingers and the toes. Apoptosis is also necessary for 
eliminating pathogen-invaded cells and cells with severely damaged DNA. In apoptosis, the cells 
die individually (Tyas et al., 2000); however in necrosis, groups of cells are simultaneously 
affected (King, 2000; Weinberg, 2006). During apoptosis, the volume of the cells decrease and 
they are packaged into small apoptotic bodies that are consumed by neighboring cells. During 
necrosis, on the other hand, the volume of the cells increases and cells die by lysis without 
clearance of the remains of the cells as in apoptosis. Hence, necrosis usually gives rise to 
inflammation while apoptosis does not. Mitochondria functions are normal at the initiation of 
apoptosis, whereas they are aberrant in necrosis (King, 2000). 
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1.2.2 Caspases are enzymes playing a major role in initiating and executing 
apoptotic responses 
Caspases are a structurally related group of cysteine proteases, essential for apoptosis. They 
possess a crucial cysteine residue that specifically cleaves peptide bonds after aspartate residues, 
hence their nomenclature: cysteine-dependent aspartate-specific protease. They are normally 
inactive (as pro-caspases) and require proteolytic processing for activity, which can be achieved 
by other activated caspases, or by the formation of large protein complexes known as the DISC 
(death inducing signalling complex) and the apoptosome (see below). Pro-apoptotic stimuli 
usually activate initiator caspases, e.g., caspases-8 and -9. These caspases in turn activate the 
executioner caspases e.g, caspases-3 and -7. Executioner caspases cause morphological changes 
in the cells by cleaving many proteins. These changes indicate that the cell is undergoing 
apoptosis. 
1.2.3 Apoptotic pathways 
Apoptotic responses are triggered and propagated by two different mechanisms, referred to as 
extrinsic and intrinsic apoptotic pathways.  
In the case of extrinsic pathways, apoptosis is initiated by extracellular signals. Death 
ligands such as Fas ligand (FasL), tumor necrosis factor (TNF) or tumor necrosis-related 
apoptosis-inducing ligand (TRAIL), usually induce the oligomerization of the associated TNF-
Receptors (TNF-Rs), followed by the recruitment of adaptor proteins - Fas-Associated Death 
Domain proteins (FADD), to the cytoplasmic portions of the receptors (Nagata, 1997). The 
resulting Death Inducing Signaling Complex (DISC) recruits multiple procaspases-8 molecules 
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that mutually cleave and activate one another through induced proximity (Figure 1). In Type I 
cells, activation of caspase-8 (casp8) in large quantities leads to the activation of other caspases, 
including the executioner caspase-3 (casp3) that ultimately leads to apoptosis. In Type II cells, 
the amount of casp8 generated at the DISC is small, and the activation cascade does not 
propagate directly, but is, instead, amplified via the mitochondria (Figure 1). The biochemical 
pathways presented in Figure 1 will be discussed in more detail in Chapter 3 and used in Model 3 
for our computational study of apoptosis. 
Apoptosis can also be triggered intracellularly. This pathway is called intrinsic or 
mitochondrial apoptotic pathway. Intrinsic apoptotic pathways can be activated by excessive 
amounts of calcium within the cell, excessive amounts of oxidants, DNA-damaging agents, and 
other agents that disrupt the microtubules that are key components of the cytoskeleton and the 
mitotic spindle (Weinberg, 2006). 
 
1.2.3.1. Bcl-2 family members in mitochondrial apoptotic pathways 
The mitochondrial apoptotic pathway observed in Type II cells is largely mediated through Bcl-2 
family proteins. This family includes both pro-apoptotic proteins such as Bid, Bax, Bak, and 
BNIP3 that promote mitochondrial permeability, and anti-apoptotic members such as Bcl-2 and 
Bcl-xL that inhibit their effects, or inhibit the mitochondrial release of cytochrome c (cyt c) 
(Antonsson et al., 1997). The pro-apoptotic and anti-apoptotic Bcl-2 family member proteins 
inhibit a number of proteins. Anti-apoptotic Bcl-2, Bcl-xL, Bcl-w, Mcl-1 and A1 inhibit pro-
apoptotic Bax and Bak. As another layer of regulation, pro-apoptotic Bad inhibits Bcl-2, Bcl-xL 
and Bcl-w and pro-apoptotic Noxa inhibits Mcl-1 and A1. Bim, Puma and tBid inhibits Bcl-2, 
Bcl-xL, Bcl-w, Mcl-1 and A1 (Weinberg, 2006). 
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The mitochondrial apoptotic pathway is initiated by the cleavage of Bid by casp8. The 
translocation of the truncated Bid (tBid) to the mitochondria induces the oligomerization of Bax 
along with the formation of a channel on the mitochondria membrane. Pro-apoptotic molecules 
such as cyt c and Smac/DIABLO are released to the cytoplasm through these channels (Yin et 
al., 1999). The relative levels of pro- and anti-apoptotic Bcl-2 family proteins determine whether 
the cyt c in mitochondria will be released or not (Weinberg, 2006). The balance between them is 
delicate. The experiments presented by Bouillet et al (2001) demonstrate that the kidney tissue 
from a Bcl-2 double knockout mouse exhibits excessive apoptosis as opposed to the tissue from 
a wild type mouse which is healthy. However, this deleterious effect is abolished in a Bcl-2 -/- 
and Bim+/- (Bim is a pro-apoptotic Bcl-2 family protein) mouse. 
 
1.2.3.2. Mechanism of cytochrome c release from the mitochondria 
The mechanisms of cyt c release from mitochondria are highly diverse and controversial 
(Newmeyer and Ferguson-Miller, 2003; Nakagawa et al., 2005). We assume here that cyt c is 
released by two independent mechanisms:  
(i) formation of Bax channels as described above  
(ii) formation/activation of mitochondrial permeability transition pores (MPTPs) (Green 
and Kroemer, 2004; Halestrap and Brenner, 2003) irrespective of Bax channel formation.  
An enzyme known as adenine nucleotide translocase (ANT) forms the inner membrane 
channel of MPTP. Binding of cyclophilin-D (CyP-D) to ANT facilitates a conformational change 
converting the ANT from a specific transporter to a non-specific pore that releases cyt c and 
Smac/DIABLO to the cytoplasm. A voltage-dependent anion channel (VDAC) binds to the outer 
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face of the ANT, and together VDAC, ANT and CyP-D represent the minimal set of proteins that 
assemble to form the MPTP (Halestrap and Brenner, 2003). 
Another important component of apoptosis regulation network is the tumor suppressor 
protein p53. This protein simultaneously suppresses transcriptional level of Bcl-2 and activates 
Bax. Cyt c leakage supports the formation of an apoptosome complex by binding to apoptotic 
protease activating factor-1 (Apaf-1) that activates the caspase-9 (casp9) molecules (upon 
cleavage of the bound zymogen procaspases-9). The activated casp9 molecules in turn activate 
casp3 molecules (Vodovotz et al., 2004). Caspase-3 cleaves ICAD (inhibitor of caspase activated 
DNAse), leading to DNA degradation or fragmentation (Enari et al., 1998), while the inhibitor of 
apoptosis (IAP) inhibits both casp3 and casp9 activities (Figure 1). Smac/DIABLO released from 
mitochondria together with cyt c binds to IAPs and dissociates them from caspases, abolishing 
their inhibitory effect on caspases. Hence, mitochondria have two pro-apoptotic effects, 
activation of casp9 and casp3 molecules, along with inhibition of the caspase inhibitors IAPs. 
Apoptosis is followed by packaging of cell fragments and their removal by phagocytosis. 
Hence, apoptosis is a “silent” form of cell death as opposed to necrosis that causes inflammation 
(Salvesen, 2002). 
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Figure 1. Mitochondria-dependent apoptotic pathways. The dotted box includes the interactions considered in 
Model 3 ((Bagci et al., 2006) and chapter 3 of this thesis). Solid arrows indicate chemical reactions or upregulation; 
those terminated by a bar indicate inhibition or downregulation; and dashed arrows indicate subcellular 
translocation. The components of the model are procaspase-8 (pro8), procaspase-3 (pro3), procaspase-9 (pro9), 
caspase-8 (casp8), caspase-9 (casp9), , caspase-3 (casp3), IAP (inhibitor of apoptosis), cytochrome c (cyt c), 
apoptotic protease activating factor 1 (Apaf-1), the heptameric apoptosome complex (apop), the mitochondrial 
permeability transition pore complex (PTPC), p53, Bcl-2, Bax, Bid, truncated Bid (tBid).  
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All caspases are synthesized as inactive enzymes (zymogens), which are activated by 
proteolysis. The initiator caspases-8 and -9 are suggested to be activating themselves after being 
recruited to protein complexes where they exist in high concentrations. This is called induced 
proximity hypothesis (Salvesen and Dixit, 1999). The executioner procaspases, on the other 
hand, are activated through their cleavage by initiator caspases. Executioner caspases cleave 
“death substrates” that cause morphological transformations of cells into small apoptotic bodies. 
Examples of death substrates are lamins, inhibitor of caspase-activated DNase (ICAD) and 
cytoskeletal proteins such as actin and plectin. Lamins are at the inner surface of the nuclear 
membrane and their cleavage is involved in chromatin condensation and nuclear shrinkage seen 
in apoptosis. The cleavage of ICAD results in the dissociation of caspase-activated DNase that 
fragments the chromosomal DNA. Cleavage of cytoskelatal proteins results in the dissociation of 
the cytoskeleton, the formation of blebs that protrude from the cell membrane and the formation 
of apoptotic bodies that are cleared by the neighboring cells (Weinberg, 2006). 
1.2.4 Experimental studies point to mechanisms of regulating apoptosis 
A recent study by Nair and co-workers (Nair et al., 2004) invites attention to the occurrence of a 
bifurcation into two states, favoring either cell death or cell survival, upon examination of a 
population of cells undergoing oxidative stress. Essentially, each cell is observed to activate 
either homeostatic or apoptotic signals early after hydrogen peroxide (H2O2) exposure; 
eventually, the stimuli that activate pro-apoptotic signals cause a given cell to succumb to PCD 
in accord with an all-or-none activation of the caspase cascade (Rehm et al., 2002). The 
remaining cells, which undergo activation of the ERK signaling pathway at an early stage of 
oxidative stress, exhibit cytoprotective responses. The observed bistable behavior, or the choice 
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of individual cells between these two competing and mutually exclusive responses is suggested 
to be a stochastic process (Nair et al., 2004), the origin and mechanism of which is still to be 
elucidated. A recent study (Bentele et al., 2004), on the other hand, points to the occurrence of a 
transition from cell survival to cell death provided that the stimuli exceed some threshold values. 
In this case, the cells exhibit essentially a transition between two monostable regimes, rather than 
two states possibly coexisting under certain combination of stimuli as observed by Nair et al. 
(2004). 
In view of these different viewpoints, and knowing that bistability is a functional feature 
in many cellular networks (Angeli et al., 2004; Ferrell and Xiong, 2001; Ferrell, 2002; Ozbudak 
et al., 2004; Xiong and Ferrell, 2003), we aim here at exploring if and how a mathematical model 
of apoptosis can explain the occurrence of a bistable response. Of particular interest is also to 
assess the conditions necessary for a transition from bistable to monostable behavior that may be 
related to dysregulation of apoptosis.  
1.2.5 Regulation of apoptosis 
Apoptosis is highly regulated and should occur only in cells of which death will benefit the 
organism. So cell survival state should be resistant to apoptotic signals. For example only the 
cells infected should be killed by cytotoxic T lymphocytes or natural killer (NK) cells that induce 
death receptor Fas (Weinberg, 2006). A few death ligands from the killer cells can diffuse to the 
cells that are healthy and close to the target cell. These cells should be resistant to small 
apoptotic stimulus they receive. Additionally, the cells do not apoptose with a small DNA 
damage. If the DNA damage is not severe, it is repaired by DNA repair mechanisms and the cell 
does not apoptose. On the other hand, the cell should not be very resistant to apoptotic stimuli 
 10 
because, in this case, apoptosis would be impossible. This would suggest two possibilities for 
regulation of apoptosis: bistability (Bagci et al., 2006; Eissing et al., 2004; Legewie et al., 2006) 
and monostable cell survival with transient executioner caspase activation (Bagci et al., 2007). 
1.2.6 Positive feedback loops in apoptotic pathways 
Positive feedback loops amplify a weak signal to a strong response. The positive feedback loops 
in mitochondria-dependent apoptotic pathways amplify the weak pro-apoptotic signal to an 
apoptotic response. Positive feedback loops can also play a role for emergence of bistability in 
systems that have ultrasensitivities such as kinetic cooperativity (Bagci et al., 2006) and 
inhibition (Eissing et al., 2004). The effect of positive feedback loops in bistability has recently 
been demonstrated by Craciun et al. (2006). The following positive feedback loops are 
considered in mathematical models that are bistable (Bagci et al., 2006; Eissing et al., 2004; 
Legewie et al. 2006) and those included in the models that have a switch-like behavior (Aldridge 
et al., 2006; Bentele et al.; 2004): 
• Activation of casp3 by casp8 that, in return, activates casp3. This feedback loop is 
considered in the models of Aldridge et al. (2006) and Eissing et al. (2004). 
•  Caspase-3 upregulates itself through two positive feedback loops involving cleavage of 
Bid and Bcl-2 (Bagci et al., 2006). These feedback loops are illustrated in Figure 1. 
• Caspase-3 activates caspase-2 that in return activates more casp3 by cleaving Bid. This 
feedback loop is considered in the model of Bentele et al. (2004). 
• Activation of casp3 by casp9 that, itself, activates casp3. This feedback is considered in 
the model of Legewie at al. (2006). 
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1.2.7 Dysregulation of apoptosis and associated pathological conditions 
Dysregulation of apoptotic signalling may play a primary or secondary role in various diseases: 
insufficient apoptosis leads to cancer (cell accumulation, resistance to therapy), autoimmunity 
(failure to eliminate autoreactive lymphocytes), persistent infections (failure to remove infected 
cells), etc., whereas excessive apoptosis contributes to neurodegeneration (Alzheimers’ disease, 
Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis), autoimmunity 
(uncontrolled apoptosis induction in specific organs), AIDS (depletion of T lymphocytes),  and 
ischaemia (stroke, myocardial infarction) (Reed, 2002). 
Most or possibly all kinds of cancer cells inactivate key components of the apoptosis-
inducing machinery. They inhibit apoptosis by decreasing levels or activities of important pro-
apoptotic proteins, e.g., FADD, casp8, p53, casp9, and Bax. Conversely, they upregulate certain 
anti-apoptotic proteins, e.g., IAPs and Bcl-2 (Weinberg, 2006). 
Pathologies such as ischemia and neurodegenerative diseases involve excessive 
apoptosis. After ischemia, increased intracellular calcium and reactive oxygen species trigger 
mitochondrial permeability, which causes cell loss in cardiac infarction and cerebral stroke. 
Mitochondrial permeability transition and death of neurons are observed in neurodegenerative 
diseases (Green and Kroemer, 2004). 
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1.3 NITRIC OXIDE EFFECTS ON APOPTOSIS 
1.3.1 Nitric oxide dependent pathways 
Nitric oxide (NO) is a lipophilic and highly diffusible molecule whose effects on cell survival 
and death are highly complex. The effect of NO depends on its concentration and its form within 
the cell. The complexity of NO effects arises from the ability of NO to react with many 
molecules such as reactive oxygen species, metal ions and proteins. These reactions may 
promote apoptosis in one cell type while having an anti-apoptotic effect in another cell type 
(Kim et al., 2001). Furthermore, the concentration of NO can determine the fate of a specific 
type of cell; NO can protect against apoptosis in physiological concentrations, but can be toxic at 
higher concentrations (Kim et al., 1999). Those observations can be explained by direct and 
indirect effects of NO. The direct effects of NO are exerted by NO itself. The indirect effects are 
mediated through reactive nitric oxide species formed by the reactions of NO with reactive 
oxygen species metal ions and proteins (Kim et al., 2001; Wink et al., 1999; Wink et al., 1994). 
 
1.3.1.1. Direct effects of NO on apoptotic responses 
One important direct effect of NO is its reaction with soluble guanylate cyclase (sGC) to 
produce anti-apoptotic cyclic guanosine monophosphate (cGMP) (Kim et al., 2001b; Kim et al., 
1997) using GTP (Cary et al., 2005), following the reaction scheme 
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 sGC + NO  → sGC⋅NO (1-I) 
sGC⋅NO + GTP ↔ sGC⋅NO⋅GTP (1-II) 
sGC⋅NO⋅GTP → sGC⋅NO + cGMP (1-III) 
 
 
 
 
 
Synthesis of cGMP has several regulatory/anti-inflammatory effects like regulation of 
vascular tone, inhibition of platelet aggregation, and leukocyte-endothelial cell interactions 
(Grisham et al., 1999). cGMP can have both pro- and anti-apoptotic effects depending on which 
chemical reactions it will go through in the cell .  
NO can also react with non-heme iron (FeLn) to form iron-nitrosyl complexes (FeLnNO) 
(Kim et al., 2000).  
 
FeLn + NO → FeLnNO (1-IV) 
 
Here L denotes any ligand other than heme. Iron-nitrosyl complexes (FeLnNO) inhibit caspases 
by nitrosation of these enzymes, and thus they have anti-apoptotic effect (see reaction (1-VII)) 
The third direct effect of NO is its oxygenation reaction. The end product of NO reaction 
with oxygen is N2O3  
4NO + O2 → 4NO2 + 4H (1-V) 
NO2 + NO ↔ N2O3 (1-VI) 
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N2O3 has both nitrosative and oxidative effects (Czapski and Goldstein, 1995). Therefore, NO 
oxygenation can induce both anti- and pro-apoptotic effects. The anti-apoptotic effect is through 
its S-nitrosation of caspases (See reaction 1-XIII). The pro-apoptotic effect, on the other hand, is 
through oxidative damaging reactions described below that are triggered upon production of 
peroxynitrite (reactions VIII-XII).    
 
1.3.1.2. Indirect effects of NO on apoptotic responses 
 
Indirect effects of NO include the following reactions:  
(i) nitrosation of thiol groups in proteins  (e.g. caspases) or in glutathione (GSH) by iron 
nitrosyl complexes – an anti-apoptotic effect (Afshar et al., 2004; Kim et al., 2001), 
RSH + FeLnNO → RSNO + FeLn (1-VII) 
 
(ii) oxidative damaging of DNA via production of peroxinitrite ONOO- (Huie and 
Padmaja, 1993; Spencer et al., 1996). DNA damage can induce p53 and apoptosis (Messmer & 
Brune, 1996).  
                      NO + O2- → ONOO- (1-VIII) 
                      ONOO- + H+ → ONOOH (1-IX) 
N N
N N
O
N N N
N N
O
N
H
H2
dR
H
deoxyguanosine (dG)
+ ONOOH + NO2 + H
8-hydroxy-deoxyguanosine (8-OH-dG)
65
4 3 2
17
8
9
H
H2
dR
65
4 3 2
17
8
9
HO
 
(1-X) 
Here dR is deoxyribose. 
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(iii) nitration of tyrosine to form nitrotyrosine succeeding the formation of ONOO- 
through the reaction of NO with the superoxide (O2-), (Beckman and Koppenol, 1996; Huie and 
Padmaja, 1993) 
                           NO + O2- → ONOO- (1-XI) 
O O
ONOO- +
NHR1
COR2
NHR1
COR2
NO2
tyrosine nitrotyrosine  
(1-XII) 
 
(iv) nitrosation of thiol groups in caspases by N2O3 (Wink et al., 1994), 
RSH + N2O3  → RSNO + NO2- + H+ (1-XIII) 
leading again to inactivation of caspases, i.e. an anti-apoptotic effect. 
1.3.2 Coupling NO-dependent pathways to apoptotic pathways 
As can be clearly seen from the set of effects summarized above, NO has dichotomous effects on 
apoptosis. Whether it acts as a cytoprotective or a cytotoxic agent is most likely to be determined 
by NO and O2- levels, GSH and non-heme iron content (Hon et al., 2002) of the particular cell. 
For example S-nitrosation of caspases is an important anti-apoptotic effect of NO (Li et al., 
1997) especially in cells with high non-heme iron content (Kim et al., 2000). This cytoprotective 
effect involves the above listed reactions 1-IV, 1-VII and 1-XIII). On the other hand, another 
important effect of NO is mediated by its reaction with O2- to form peroxynitrite (ONOO-), as 
described above. Peroxynitrite is implicated in apoptosis (Vodovotz et al., 2004). These suggest 
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that the effects of NO are largely determined by the different pathways or series of reactions it 
can trigger, and a sensitive balance, or competition between these counter effects. Our aim is to 
understand the conditions leading to the dominance of one or the other effect, first, and then to 
couple those pathways/reactions to apoptotic pathways so as to improve our understanding of the 
modulation of apoptosis by NO. The network for NO related reactions are presented in Figure 2. 
More details on the particular reactions and parameters shown in the figure will be presented in 
Chapter 4. 
1.4 APOPTOSIS MODELS 
Fussenegger et al. (2000) pioneered the mathematical modeling of apoptotic pathways that 
include both receptor-induced (extrinsic) and mitochondria-dependent (intrinsic) pathways. 
However, their model invariably progresses towards apoptosis, containing no anti-apoptotic 
mechanisms for cells. More recent models (Bentele et al., 2004; Eissing et al., 2004; Siehs et al., 
2002; Stucki and Simon, 2005)  point to the requirement of a homeostatic balance between the 
two responses, manifested by a bistable behavior (cell survival and cell death as two stable 
states) or a switch from one response (cell survival) to another (cell death) under well-defined 
conditions. 
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Figure 2.  NO-related reactions used in Model 4-A. The following compounds are included: ONOO- (peroxynitrite), 
GPX (glutathione peroxidase), O2- (superoxide), GSH (glutathione), GSNO (nitrosoglutathione), GSSG (glutathione 
disulfide), CcOX (cytochrome c oxidase), SOD (superoxide dismutase), FeLn (non-heme iron compounds), FeLnNO 
(non-heme iron nitrosyl compounds), NADPH (reduced form of nicotinamide adenine dinucleotide phosphate), 
NADP+ (oxidized form of nicotinamide adenine dinucleotide phosphate). The references for the reactions and their 
rate constants are presented in Table 3. The orange colored compounds interfere with apoptotic pathways (See Table 
6). The purple colored compounds comprise the GSH module that modulates the concentrations of orange colored 
compounds. Green color is used for NO, the key molecule in the reaction network. 
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1.4.1 Bistable models 
An insightful first study has been performed by Eissing et al. (2004) for receptor-induced 
apoptosis of Type I cells. Bistability was shown therein to result from the interplay between 
caspase-3 activation and the inhibitors of apoptosis (IAP and bifunctional apoptosis regulator 
(BAR)). In the basic model that includes only IAP, bistability was possible for a narrow range of 
parameters that are far from the values reported in the literature due to a balance between 
caspase-3 activation and inhibition solely due to IAP. However, the bistability was shown therein 
to be possible for a wider range of parameters close to the values reported in literature by further 
inhibition by BAR. Eissing et al. (2004) also showed computationally that apoptosis which takes 
about 10 minutes in single cells (Tyas et al., 2000; Rehm et al., 2002) seems to take longer in a 
culture of cells. .  
Legewie et al. (2006) showed that inhibition of casp3 and casp9 by inhibitors results in an 
implicit feedback loop and bistability. They also showed how cell-specific protein expression 
determines qualitative features of casp3 activation, such as gradual versus all-or-none apoptosis 
and reversible versus irreversible response. 
1.4.2 Models with a switch from cell survival to cell death 
The switch model proposed by Bentele et al. (2004) is not bistable and suggests a transition from 
cell survival to cell death provided that the stimuli exceed some threshold values. With regard to 
apoptotic pathways, Bentele et al. (2004) included both extrinsic and intrinsic pathways. They 
have performed a systematical analysis not only to determine the parameters from experiments, 
but also to assess the most important interactions by a rigorous sensitivity analysis.  
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The model proposed by Stucki and Simon (2005) focuses on the regulation of caspase-3 
activation and degradation only. Their model predicts an allosteric activation of the caspase-3 
degradation by the IAP–caspase-3 complex, which is represented by a Hill function with a Hill 
coefficient greater than unity. They predict that a caspase-3 concentration greater than a 
threshold value triggers downstream apoptotic events and eventually cell death.  
1.4.3 Stochastic simulations 
Siehs et al. (2002) focused on the interactions of Bcl-2 family members and consequent cyt c 
release. In terms of the method of approach, Siehs et al. (2002) simulated the time evolution of 
Bcl-2 family molecules using discrete time and space variables in a lattice molecular automaton. 
Their model predicts that the Bcl-2 family proteins such as Bcl-2, Bax and Bak form a diffusion-
driven molecular switch that dampens apoptosis induction. This controls the apoptosis cascade 
under noisy, apoptosis inducing conditions. This study thus differs from those described above, 
in that the stochastic character of cell cycle regulation has been incorporated by discrete time and 
space variables. 
1.4.4 What is missing in existing models, and what is our goal? 
The model by Eissing et al (2004) addresses an important issue that model by Fussenegger et al. 
(2000) did not include. The cell survival state is bistable in model by Eissing et al. (2004) 
However, their model does not refer to mitochondrial apoptotic pathways. The model by 
Legewie et al. also has a stable cell survival state, however the authors concentrate on only a 
portion of the mitochondrial apoptotic pathways. Bentele et al. (2004), incorporated a switch into 
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their model, however it seems more appropriate to have a switch mechanism that is not defined 
a-priori but emerges as an output. Again, the models by Stucki and Simon (2005) and Siehs et al. 
(2002) concentrated only on a particular portion of the mitochondrial apoptotic pathways.   
 
Our first goal is to study mitochondria-dependent apoptotic pathways that incorporate 
mitochondrial activation (through Bid truncation and permeability pore (PTPC) opening at the 
mitochondria), mitochondrial cyt c release, apoptosome complex formation, and caspase-9 and 
caspase-3 activations. Our second goal is to ensure that the model predicts cell survival in the 
presence of minimal pro-apoptotic signals, while a robust bistable response occurs under a broad 
range of conditions. Our final goal is to shed light into the origins of the experimentally observed 
dichotomous effects of NO on apoptosis in different types of cells. 
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2.0  EMERGENCE OF BISTABILITY IN MATHEMATICAL MODELS FOR 
APOPTOSIS 
In this chapter, we show how bistability emerges as a natural consequence of the competition 
between counter effects and how kinetic cooperativity may play a crucial role in imparting 
bistability. We present the results from several mathematical models for apoptosis in literature 
(Bagci et al., 2006; Eissing et al., 2004; Legewie et al., 2006) to provide an overview of different 
hypotheses and perspectives, how they deviate, and in which ways they complement each other. 
2.1 SIMPLIFIED MODEL FOR MITOCHONDRIA-DEPENDENT APOPTOSIS 
WITH KINETIC COOPERATIVITY (MODEL 2-A) 
First, we consider a simplified model (Figure 3A) for apoptosis with three components that have 
essentially the same network features as the detailed model (Model 3 in Chapter 3 and (Bagci et 
al., 2006)). This model has been shown to yield a number of qualitative results comparable to 
those obtained with the more detailed model shown in Figure 1. The common features of the 
detailed and simplified models are 1) positive feedback loop for casp3, 2) kinetic cooperativity 
(Bagci et al., 2006) in one of the steps in the positive feedback loop, 3) formation of cyt c in 
mitochondria, and 4) degradation of all components (Bagci et al., 2006). 
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The kinetic scheme adopted for the simplified mitochondria-dependent (intrinsic) 
apoptotic pathways with kinetic cooperativity is presented in Figure 3A. The diagram notations 
proposed by Kitano et al. (2005) are used in Figure 3. According to these notations, mRNAs are 
shown by parallelograms, proteins by smoothened rectangles, translations by dashed arrows, 
reactions by arrows, degraded compounds by ∅. The individual steps in this model essentially 
represent/approximate the combinations of several interactions that are explicitly considered in 
the detailed model (Model 3 in Chapter 3 and (Bagci et al., 2006)). Mainly, the first step is a 
combination of the set of reactions/interactions that involve apoptosome formation and casp3 
activation.  
2cyt c → casp3         (2-I) 
 
The corresponding rate constant is k1. This step requires a kinetic cooperativity (Bagci et al., 
2006) because the stoichiometric coefficient of cyt c is greater than unity. The second step 
completes the positive feedback loop where casp3 induces the release of mitochondrial cyt c (cyt 
cmito) to the cytosol which, in turn, promotes an increase in the concentration of casp3. 
casp3 + cyt cmito → casp3 + cyt c       (2-II) 
 
The corresponding rate constant is designated as k2.  
 
The differential rate equations associated with the kinetic scheme displayed in Figure 3A are  
d[casp3]/dt = k1[cyt c]2 – µc3[casp3]        (2-1) 
d[cyt c]/dt = -2k1[cyt c]2 + k2[casp3][cyt cmito] – µcc[cyt c]    (2-2) 
d[cyt cmito]/dt = Ωccm – k2[casp3][cyt cmito] – µccm[cyt cmito]    (2-3) 
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Here µcc, µcasp3 and µccm refer to the degradation rates of the respective compounds (cyt c, 
caspase-3 and mitochondrial cyt c), and Ωccm is the rate of production (de novo synthesis) of 
mitochondria cyt c. Note that the term – k2[casp3][cyt cmito] is not included in eq (2-1) as casp3 
serves therein as a catalyst only, i.e. it does not enter the reaction (as also indicated by the 
diagonal arrow that restores its concentration in Figure 3).  
 
casp3 cyt c
cyt cmito
cyt c
cyt cmito
k1
k2
Ωccm
µccm
µc3
µcc
A
casp3 cyt c
cyt cmito cyt cmito
k1
k2
Ωccm
µccm
µc3
µcc
B
 
Figure 3.  Schematic representations of Models 2-A and B in respective panels A and B. The symbol ∅ refers to 
degraded compounds. The symbol µ refers to degradation rate constant and Ω refers to the rate of formation of the 
species indicated by the subscript..  
 
We use a constant rate of formation of cyt cmito and constant degradation rates for cyt 
cmito, cyt c and casp3 with values comparable to those adopted in our study (Model 3 in Chapter 
3 and (Bagci et al., 2006)). These values (Ωccm = 0.0003 µM/s, µc3 = µcc = µccm = 0.006 s-1) 
ensure that the apoptotic steady state concentration of casp3 is nanomolar. The rate constants are 
assigned the values of k1 = 2 µM-1s-1, k2 = 2 µM-1s-1 that ensure activation of casp3 in about 10 
minutes (Tyas et al., 2000), as illustrated in Figure 4. The initial casp3 concentration, [casp3]0, of 
0.001 µM evolves to 0.018 µM in about 10 minutes. The initial concentrations of cyt c and cyt 
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cmito are taken as zero in the simulations (The same results as in Figure 4 are obtained by 
assuming a non-zero initial concentration of cyt cmito). 
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Figure 4.  Time evolution of casp3 concentration in response to pro-apoptotic stimuli that causes [casp3] to be 0.001 
µM at time = 0. The curve is calculated using Model 2-A and parameters presented in Section 2.1. Caspase-3 is 
activated to nanomolar values in about 10 minutes in accordance with single cell experiments (Tyas et al., 2000).  
2.2 SIMPLIFIED MODEL FOR MITOCHONDRIA-DEPENDENT APOPTOSIS 
WITHOUT KINETIC COOPERATIVITY (MODEL 2-B) 
A schematic description of the simplified mitochondria-dependent apoptotic pathways without 
kinetic cooperativity is presented in Figure 3B. The major difference is the absence of a second 
cyt c molecule that contributes to the reaction with rate constant k1 (compare the lower right 
portions of the two panels A and B). Therefore, the stoichiometric coefficient of cyt c is assigned 
a value of unity, which eliminates kinetic cooperativity. The associated differential rate equations 
become 
d[casp3]/dt = k1[cyt c] – µc3[casp3]       (2-4) 
 25 
d[cyt c]/dt = -k1[cyt c] + k2[casp3][cyt cmito] – µcc[cyt c]    (2-5) 
d[cyt cmito]/dt = Ωccm – k2[casp3][cyt cmito] – µccm[cyt cmito]    (2-6) 
2.3 COMPARISON OF THE TWO SIMPLIFIED MODELS: ROLE OF KINETIC 
COOPERATIVITY IN IMPARTING BISTABILITY 
2.3.1 Rate equations for the two models 
For calculation purposes, we reduce the 3-dimensional models A and B (composed of three 
components) to 2-dimensions upon assuming steady state conditions for cyt cmito, i.e. equating 
d[cyt cmito]/dt to zero, and substituting the identity 
 
[cyt cmito] = Ωccm / (k2[casp3] + µccm)      (2-7) 
for  [cyt cmito] using eq 2-3. The rate of change in cyt c concentration then becomes   
d[cyt c]/dt = -2k1[cyt c]2 + k2 Ωccm[casp3]/(k2[casp3]+µccm) – µcc[cyt c]  (2-8) 
in model 2-A and, 
d[cyt c]/dt = -k1[cyt c] + k2 Ωccm[casp3]/(k2[casp3]+µccm) – µcc[cyt c]  (2-9) 
in Model 2-B, using the respective equations 2-2 and 2-5. 
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2.3.2 Calculation of the corresponding phase planes 
Our goal is to obtain the phase planes for the two systems, as a function of the two variables, [cyt 
c] and [casp3]. To this aim, we plot the nullclines corresponding to each component, i.e. the loci 
of concentration pairs that maintain the concentration of each component fixed such that:   
d[casp3]/dt = 0          (2-10) 
d[cyt c]/dt = 0          (2-11) 
Therefore, [casp3] and [cyt c] nullclines are obtained by equating the respective equations 2-1 
and 2-8 to zero in model A, and 2-4 and 2-9 in model B, which yield  
c3
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for model 2-B. The results are shown in Figure 5, panels A and B for the respective models. We 
observe that the two nullclines in panel A intersect at three points (fixed points), two of them 
being stable (at [cyt c, casp3] = [0,0] and [0.007, 0.018] µM) and the third unstable (at  [cyt c, 
casp3] = [0.0002, 1.4x10  ] µM). The inset in panel A enlarge the portion of the nullcline that 
displays this unstable point, which cannot be discerned in the main figure. Model 2-B, on the 
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other hand, exhibits one unstable ([cyt c, casp3] = [0,0] µM) and one stable ([cyt c, casp3] = 
[0.0001,0.0468] µM) fixed point. Fixed point is the locus of the concentrations of casp3 and cyt 
c where
…), the polynomial would be of the order of 2n-1. 
herefore bistability is expected for n ≥ 3. 
 
 the initial concentrations of the two components evolve to. 
The fixed points of Model 2-A could be obtained by equating the equations for the 
nullclines for casp3 and cyt c (2-12 and 2-13, respectively). The resulting polynomial is third 
order, hence there are three fixed points two of which are bistable. If the order of the reaction 2-I 
in Model 2-A was larger than 2 (n = 3, 4
T
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Figure 5. Nullclines for Models 2-A and 2-B in respective panels A and B. The filled circles indicate stable fixed 
points and open circles indicate the unstable fixed points. The inset in panel A shows the unstable fixed point and 
the stable manifold in red that separates the cell survival and death regions. The arrows in panel A denote the 
trajectories for the time evolutions of [casp3] and [cyt c]. The solid curves on panels A and B are the [casp3] 
nullclines and the dashed curves are the [cyt c] nullclines. Panel A depicts two stable fixed points hence Model 2-A 
is bistable as opposed to Model 2-B that has one stable fixed point. 
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2.3.3 Interpretation of nullclines and assessment of the role of kinetic cooperativity 
The stable fixed points act as attractors, such that any perturbation in their neighborhood drives 
the system back to the original fixed point. Thus, in Model 2-A, an initial casp3 and cyt c 
concentration to the lower left of the red line in inset of Figure 5A results in zero steady-state 
casp3 concentration while an initial casp3 and cyt c concentration to the upper right of the red 
line results in high steady-state [casp3] regime, thus inducing an anti- or pro-apoptotic behavior, 
respectively. Hence the model is bistable, either cell survival or cell death being induced 
depending on the original casp3 concentration. The unstable fixed point and the other repelling 
points on the red line in Figure 5A inset which is called the stable manifold can be viewed as cell 
fate decision points.  
Model 2-B has only one stable fixed point with high casp3 concentration. The other fixed 
point with zero casp3 concentration is an unstable fixed point. Model 2-B is therefore 
monostable with two fixed points for all combinations of parameters as can be proved by 
equating Eq.s 11 and 12 to find fixed points. One fixed point is at the origin and the other one is 
a point with non-zero concentrations of the components. 
The monostable Model 2-B does not involve kinetic cooperativity, in contrast to Model 
2-A that involves kinetic cooperativity and is bistable. Model 2-B cannot be adopted for 
modeling apoptotic response because it predicts that even a minimal apoptotic stimulus would 
result in high casp3 concentration that will lead to apoptosis in the fluctuating environment of 
cells. On the other hand, healthy functioning of cells requires the inititation of apoptosis under 
well-defined conditions, rather than minimal exposure to triggering events. The comparative 
analysis here suggests that kinetic cooperativity may be an important mechanism in regulation of 
apoptotic response and imparting a bistable response.  
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2.4 PASSAGE BETWEEN MONOSTABLE AND BISTABLE RESPONSES 
Craciun et al. (2006) recently presented a theorem that distinguishes between reaction networks 
that might support bistable behavior and those that cannot. First we introduce their theorem with 
an example presented in Figure 2 in the study by Craciun et al. (2006)  and then apply it to the 
bistable models for apoptosis reported in the literature (Bagci et al., 2006; Eissing et al., 2004; 
Legewie et al., 2006).  
2.4.1 Introduction to the theorem by Craciun et al. (2006) 
 
Terminology used in the theorem is illustrated by the example presented in Figure 2 that is in the 
study by Craciun et al. (2006). The reactions and rate equations for the species are: 
A + B ↔ F  k1f, k1r      (2-III) 
C + G ↔ A  k2f, k2r    (2-IV) 
C + D ↔ B  k3f, k3r      (2-V) 
C + E ↔ D  k4f, k4r      (2-VI)  
where the superscript f denotes forward reaction and r denotes reverse reaction. 
d[A]/dt = FA – ξA[A] – k1f[A][B] + k1r[F] + k2f[C][G] – k2r[A]     (2-16) 
d[B]/dt = FB – ξB[B] – k1f[A][B] + k1r[F] + k3f[C][D] – k3r[B]    (2-17) 
d[C]/dt = FC – ξC[C] – k2f[C][G] + k2r[A] – k3f[C][D] + k3r[B] – k4f[C][E] + k4r[D] (2-18) 
d[D]/dt = FD – ξD[D] – k3f[C][D] + k3r[B] + k4f[C][E] – k4r[D]    (2-19) 
d[E]/dt = FE - ξE[E] – k4f[C][E] + k4r[D]       (2-20) 
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d[F]/dt = FF - ξF[F] + k1f[A][B] – k1r[F]       (2-21) 
d[G]/dt = FG - ξG[G] – k2f[C][G] + k2r[A]       (2-22) 
 
The species-reaction (SR) graph of the above network is presented in Figure 6. 
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Figure 6.  Species-reaction graph for the example presented in the study by Craciun et al. (2006) in Figure 2.  
• In the graph, species (A, B, C, D, E, F, G) are shown with a circular symbol. 
 
• Reactions are shown in the boxes. Reversible reactions are also shown in one box. There 
are four reversible reactions hence four reaction boxes in Figure 6. 
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•  Complexes are one or two species that are either at the left or the right of the reaction 
arrows. They are shown with white letters in the SR graph (Figure 6). There are eight 
complexes in the figure. Note that the complexes with only one species (A, B, D and F) 
are presented once in the figure, whereas the complexes with two species (A+B, C + D,  
C+E, C+G) are presented twice.  
 
• The arcs are drawn between a species circle and a reaction box in which the species 
appears. The arcs are labeled with the complex in which the species appears. If a species 
appears in both complexes of a reaction as in A + B ↔ 2A, then two arcs are drawn 
between the reaction box and the species A, each labeled by one of the two different 
complexes (A+B and 2A). 
 
•  Complex pair (c-pair) is a pair of arcs adjacent to the same reaction box which carry the 
same complex label. The two arcs in a c-pair are drawn in the same color. White arcs are 
drawn from a single species complex to a reaction box and two white arcs do not 
constitute a c-pair. There are four c-pairs in Figure 6 because there are four complexes 
with two species in the reactions (A+B, C+G, C+D, C+E). The purple c-pair is for the 
complex A+B, the green c-pair is for the complex C+G, the red c-pair is for the complex 
C+D, and the blue c-pair is for the complex C+E. 
 
• Cycle is a closed path in which no arc or vertex is traversed twice. There are three cycles 
in the Figure 6, cycle 1, 2 and unlabeled outer cycle, traversing species A-C-D-B-A. 
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• There are three kinds of cycles, 1-cycles, odd-cycles and even-cycles. These 
classifications are not mutually exclusive. A cycle can be both odd cycle and 1- cycle or 
both even-cycle and 1-cycle. Odd-cycles have odd number of c-pairs and even-cycles 
have even number of c-pairs or no c-pairs. 1-cycles consist of only arcs labeled with 
species that have stochiometric coefficients of 1. All three cycles are both 1-cycles and 
odd cycles in Figure 6. 
 
• Two cycles split a c-pair if one of the arcs is contained in just one of the cycles and both 
of the arcs are contained within the other cycle, or one of the arcs is contained in one of 
the cycles and the other arc is within the other cycle. In Figure 6, cycles 1 and 2 split the 
red (C+D) c-pair: Both red arcs are among the arcs of the two cycles, but cycle 1 contains 
only one of the red (C+D) arcs. The large outer cycle and cycle 1 also split the red c-pair, 
as do the outer cycle and cycle 2. 
 
After presenting the terminology, we quote the theorem from the study by Craciun et al. 
(2006):  
“Consider a reaction network for which the SR graph has both of the following properties. 
(i) Each cycle in the graph is a 1-cycle, an odd cycle, or both. 
(ii) No c-pair is split by two even-cycles. 
For such a reaction network, the corresponding mass-action differential equations can not 
admit more than one positive steady state, no matter what (positive) values the rate constants, 
effluent coefficients, or species supply rates take.” 
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The assumptions of constant supply rate of substrates, diffusion (or degradation) of 
substrates and products by a first order reaction rate, and constant amounts of enzymes within the 
cell, i.e., no supply and removal of the enzymes, are made in the theorem. 
 It should be noted that when conditions (i) and/or (ii) are not satisfied, the theorem gives 
no information on whether the network is monostable or bistable. 
The theorem also concludes that when there are no cycles in the SR graph, the 
corresponding ordinary differential equations can not give rise to more than one positive 
equilibrium. 
2.4.2 Positive feedback loop with (Model  2-A) and without (Model  2-B) kinetic 
cooperativity 
Model 2-A is converted to an SR graph in Figure 7A (the white arcs are shown with gray arcs in 
this SR graph because the background is white in this SR graph). The theorem tells that the 
model can be bistable. The reason is that it violates both conditions (i) and (ii) in the theorem. It 
violates condition (i) as opposed to Model 2-B (Figure 7B) that violates only condition (ii). 
There are 3 cycles in both Figures 7A and B. The SR graph in Figure 7A has one cycle that does 
not satisfy condition (i), because the outer large cycle is neither a 1-cycle (the coeeficient of 2 in 
cyt c gray arc) nor an odd cycle (because it is an even cycle with zero c-pairs). The SR graph in 
Figure 7B, on the other hand, obeys the condition (i) because all three cycles in the graph are 1-
cycles. The SR graph in Figure 7A violates condition (ii) because the even cycles cycle 1 and 
outer cycle split the red c-pair. Similarly, the SR graph in Figure 7B violates condition (ii). The 
theorem is not conclusive for the mono/bistability of both Model 2-A and B. Both can be 
monostable and bistable for a range of parameter values. We know from previous discussion that 
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Model 2-B is monostable. Violation of condition (i) in Model 2-A as opposed to Model 2-B 
makes it bistable (see Figure 5).  
2.4.3 Positive feedback loop with inhibition (Model  2-C) 
The basic model by Eissing et al. (2004) is used in constructing the SR graph displayed in Figure 
8. The model essentially contains a feedback loop (casp8 reaction with proc3 produces casp3, 
which in turn reacts with proc8 to produce casp8; see the cycle on the left) and takes into 
consideration the inhibition of casp3 by IAP via formation of a complex casp3.IAP following the 
reaction scheme  
casp8 + proc3 → casp8 + casp3       (2-VII) 
casp3 + proc8 → casp3 + casp8       (2-VIII) 
casp3 + IAP ↔ casp3.IAP        (2-IX)  
casp3 + IAP → casp3 + IAPdeg       (2-X) 
 
where IAPdeg is degraded IAP. 
This graph obeys the first condition of the theorem because all cycles are 1-cycles (Figure 
8). However, it does not obey the second condition of the theorem because the orange c-pair is 
split by two even cycles. First even cycle is traversed by species casp8, the left orange arc, casp8 
+ proc3 → casp8 + casp3 reaction box, the lower red arc, species casp8. The second even cycle 
is traversed by species casp8, the lower red arc, casp8 + proc3 → casp8 + casp3 reaction box, the 
right orange arc, species casp3, the upper green arc, casp3 + proc8 → casp3 + casp8 reaction 
box, the left black arc, species casp8. In this case, the theorem is silent, i.e., the theorem cannot 
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indicate if the model can be bistable for some values of parameters. However, Eissing et al. 
(2004) showed that this reaction network is bistable for a range of parameter values. 
Figure 7.  Species-reaction graphs for Models 2-A and 2-B in respective panels A and B. The difference between 
panels A and B is is that all cycles in panel B are 1-cycles as opposed to one of the cycles in panel A which consists 
an arc with a label 2. The label 2 indicates that the stochiometric constant of species cyt c is 2 in the associated 
reaction (2cyt c → casp3). A c-pair consists of two arcs from a given reaction box to two species that are either 
reactants or products in the reaction. Each c-pair is shown by a different color. 
cyt c 
casp3 cyt cmito
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proc3 
casp3 
IAP 
IAPdeg
casp8+proc3 →casp8+casp3 
casp3+proc8 →casp3+casp8 
casp3+IAP →casp3+IAPdeg
casp3+IAP ↔casp3.IAP 
Figure 8.  Species-reaction graph for Model 2-C. The orange c-pair is split between two even cycles. c-pair consists 
of two arcs from the reaction box to two species that are either reactants or products in the reaction. Each c-pair is 
shown by a different color. 
2.4.4 Model without an explicit positive feedback loop (Model  2-D) 
Legewie et al. (2006) showed that a reaction network without an explicit positive feedback can 
also manifest bistability. The example they used was the activation of casp3 by casp9 and the 
inhibition of IAP without a positive feedback from casp3 to casp9. The corresponding set of 
reactions are 
casp9.proc3 → casp9 + casp3        (2-XI) 
casp3.IAP 
proc8 
casp8 + proc3 
casp8  + proc3 casp8+casp3
casp3+casp8 
casp3+casp8
casp3+proc8
casp3  + proc8 
casp3  + IAP
casp3+IAP
casp3.IAP
casp3+IAP 
casp3+IAP
casp3 + IAPdeg
casp3 + IAPdeg
casp8 
casp8 + casp3 
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casp9 + IAP ↔ casp9.IAP        (2-XII) 
casp9.proc3 + IAP ↔ casp9.proc3.IAP      (2-XIII) 
casp9.proc3.IAP ↔ casp9.IAP + proc3      (2-XIV) 
 
We display the SR graph for this model in Figure 9 and show that the network does not obey the 
second condition of the theorem because the red c-pair is split by two even-cycles. Craciun et al. 
(2006) reported that this network is indeed bistable for some set of parameter values (Table 1, 
entry 4). 
2.5 BISTABILITY IN BIOCHEMICAL REACTION NETWORKS 
The analysis in this chapter shows that reaction networks (chemical or biochemical) do not 
necessarily require an explicit feedback loop to manifest bistability ((Legewie et al. 2006)  and 
Model 2-D). However, explicit positive feedbacks can predispose the reaction networks for 
bistability ((Bagci et al., 2006) and Model 2-A; (Eissing et al., 2005) and Model 2-C). We also 
see that inhibitory reactions may also induce bistability ((Eissing et al., 2005) and Model 2-C; 
(Legewie et al. 2006)  and Model 2-D). The analysis also shows that kinetic cooperativity can be 
an alternative mechanism for imparting bistability ((Bagci et al., 2006) and Model 2-A). 
The theorem by Craciun et al. (2006) shows that the reaction networks should have 
unusual properties for imparting bistability, a feature that is not often encountered in non-
biological processes, e.g., in chemical engineering. Some properties leading to bistability, were 
presented in this chapter, such as kinetic cooperativity, explicit and implicit positive feedback 
loops and inhibitory reactions. Those features are common to a large majority of biochemical 
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reaction networks suggesting that bistability is a common regulatory mechanism in biochemical 
pathways. 
 
casp9.IAP 
casp9+IAP↔casp9.IAP 
IAP 
casp9.proc3+IAP↔casp9.proc3.IAP
casp9.proc3.IAP 
casp3 
casp9.proc3 
casp9+proc3↔casp9.proc3 
proc3 
casp9.proc3 → casp9 + casp3 
casp9 + proc3 ↔ casp9.proc3.IAP 
casp9 
Figure 9.  Species-reaction graph for model 2-D. Each c-pair is shown by different colors. 
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3.0  MATHEMATICAL MODELING OF MITOCHONDRIAL APOPTOTIC 
PATHWAYS 
Work discussed in this chapter is published in Biophys. J., 2006, 90(5), 1546-1559. We propose 
a mathematical model for mitochondria-dependent apoptosis, in which kinetic cooperativity in 
the formation of the apoptosome is a key element ensuring bistability. We examine the role of 
Bax and Bcl-2 synthesis and degradation rates, as well as the number of MPTPs, on the cell 
response to apoptotic stimuli. Our analysis suggests that cooperative apoptosome formation is a 
mechanism for inducing bistability, more robust than other mechanisms, such as inhibition of 
casp3 by IAP. Simulations predict a pathological state in which cells will exhibit a monostable 
cell survival if the Bax degradation rate is above a threshold value, or if the Bax expression rate 
is below a threshold value. Resistance of cells to apoptosis in chemotherapy is an example of a 
pathological state exhibiting monostable cell survival. Otherwise, the outcome is either cell death 
or survival depending on the initial casp3 levels. We show that high expression rates of Bcl-2 
can counteract the effects of Bax. Our simulations also demonstrate a monostable apoptotic 
response that is pathological if the number of MPTPs exceeds a threshold value. The present 
study supports our view, based on mathematical modeling, that cooperativity in apoptosome 
formation may be critically important for determining the healthy responses to apoptotic stimuli. 
Furthermore, the analysis sheds light into the roles of Bax and Bcl-2 and MPTP vis-à-vis 
apoptosome formation. 
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3.1 REGULATION OF APOPTOSIS 
The biochemical mechanism of apoptosis is an area of extensive study because the balance 
between cell proliferation and apoptosis is crucial for the healthy functioning of organisms. 
Dysregulation of apoptosis is implicated in many degenerative and autoimmune diseases, 
including cancer, acquired immune deficiency syndrome, neurodegenerative disorders, and viral 
and bacterial infections (Fadeel et al., 1999). Knowing that bistability is a functional feature in 
many cellular networks (Angeli et al., 2004; Ferrell and Xiong, 2001; Ferrell, 2002; Ozbudak et 
al., 2004; Xiong and Ferrell, 2003), it is important to develop a mathematical model of apoptosis 
that can potentially explain how a bistable response can emerge. Of particular interest is to assess 
the conditions necessary for a transition from bistable to monostable behavior.  
Our model demonstrates the possible occurrence of bistability in mitochondria-dependent 
pathways under certain conditions (see below), as well as a transition from bistable to 
monostable behavior -either apoptotic or cytoprotective, beyond threshold concentrations of 
particular components.  Bistability is imparted by kinetic cooperativity in the formation of a 
heptameric complex by Apaf-1 and cyt c molecules (apoptosome), following the release of cyt c 
from the mitochondria. The term kinetic cooperativity refers to an effective reaction order larger 
than unity, and in the present model the formation of the heptameric apoptosome complex is the 
reaction exhibiting this behavior. The cooperativity (Hill, 1985) in the formation of the 
apoptosome complex is a feature that has not been included in previous mathematical models 
(Bentele et al., 2004; Eissing et al., 2004; Fussenegger et al., 2000; Siehs et al., 2002) and it is of 
interest to explore the potential  role of such a cooperativity on the cell fate predicted. 
In the following sections of the chapter, we will present the results obtained for the 
response of the cell to changes in the accessible levels of two members of the Bcl-2 family, Bax 
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and Bcl-2, as well as the numbers of MPTPs. Our analysis indicates that monostable cell survival 
is induced if the expression (or degradation) rate of Bax is lower (or higher) than a particular 
threshold, in qualitative agreement with other studies (Oltvai et al., 1993). We will also show 
that high numbers of MPTPs may have a role in pathological cell death (excessive apoptosis) 
(Green and Kroemer, 2004). Parameter space searches using both reduced and detailed 
mitochondria-dependent apoptosis models suggest that cooperativity in apoptosome formation is 
a plausible mechanism to ensure bistability in response to apoptotic stimuli. The loss of 
bistability manifested by monostable cell survival or cell death implicates Bax, Bcl-2 and MPTP 
in pathologies like cancer and neurodegenerative disorders.  
3.2 MODEL AND METHODS 
3.2.1 Kinetic model for mitochondria-dependent apoptotic pathways (Model 3) 
3.2.1.1. Overview  
A schematic description of the mitochondria-dependent (intrinsic) apoptotic pathways included 
in our model is given in Figure 1. This model is referred to as Model 3. The involved 
reactions/interactions are summarized below, along with the corresponding rate constants (ki) 
and fluxes (Ji). There are a total of 32 compounds involved in our model, and a set of 31 rate 
equations controlling their chemical and physical interactions. The total number of parameters in 
the model is 102, comprised of 41 rate constants, 26 fluxes, 8 production rates, 17 degradation 
rates, 10 known initial concentrations. The sets of reactions controlling the kinetics of these 
intrinsic pathways are described in the next section, and explicit expressions for the differential 
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rate equations and the values of the parameters adopted in the calculations are presented in the 
Tables 1 and 2, respectively. 
 
3.2.1.2. Description of the sequence of reactions and corresponding parameters 
Model 3 (Figure 1) consists of the eleven groups of reactions described below. 
 
 (1) Cleavage of Bid by caspase-8. The cleavage of Bid to truncated Bid (tBid) by casp8 (Luo et 
al., 1998) is described by the following reactions, rate constants and fluxes  
casp8 + Bid ↔ casp8⋅Bid    k0+, k0-  J0 (3-I) 
casp8⋅Bid → casp8 + tBid    k0f  J0f (3-II) 
Upon cleavage, Bid is activated to induce the release of cytochrome c from the 
mitochondria, which will be described below. 
 
(2) Cooperative formation of an apoptosome complex.  The apoptosome complex (apop) 
is a multimeric assembly of seven Apaf-1 and seven cyt c molecules (Acehan et al., 2002; Jiang 
and Wang, 2004). To include in our model the cooperative nature of apoptosome formation, we 
adopt the reactions  
 
cyt c + Apaf-1 ↔ cyt c⋅Apaf-1   k1+, k1-  J1 (3-III) 
7 cyt c⋅Apaf-1 ↔ apop    k1b+, k1b-  J1b (3-IV) 
with the reaction rate of 7k1b+[cyt c⋅Apaf-1]p for the second reaction, such that (see Table 1) 
 d[cyt c⋅Apaf-1]/dt = J1–7J1b      (3-1) 
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where 
 J1 = k1+[cyt c][Apaf-1] - k1-[cyt c⋅Apaf-1]   (3-2) 
 J1b = k1b+[cyt c⋅Apaf-1]p - k1b-[apop]    (3-3) 
 
A reaction order (p) higher than unity for the apoptosome complex entails a kinetic cooperativity 
conducive to bistability, as will be shown in the results from calculations. For illustrative 
purposes, we show below a kinetic mechanism that results in an effective reaction order of p = 4 
Consider the formation of a heptamer by the following series of reactions 
              A + A ↔ A2  k3V (fast)      (3-V) 
             A2 +A ↔ A3  k3VI (fast)      (3-VI) 
             A3 + A → A4  k3VII (slow)      (3-VII) 
             A4 + A → A5  k3VIII (fast)      (3-VIII) 
             A5 + A → A6  k3IX (fast)      (3-IX) 
             A6 + A → A7  k3X (fast)      (3-X) 
Assuming pre-equilibrium for the fast reactions (3-V) and (3-VI), we obtain, after equating the 
forward (superscript f) and reverse (superscript b, for backward) reaction rates in these steps to 
each other, the following identities 
             k3Vf[A]2 = k3Vb[A2]        (3-4) 
             k3VIf[A2][A] = k3VIb[A3]       (3-5) 
 
The rate equation for A4 formation  
             d[A4]/dt = k3VII[A3][A]       (3-6) 
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becomes after substituting equations 3-4 and 3-5,  
              b
3VI
2
2
f
3VI
4 k
][A][Ak]d[A =        (3-7a) 
⇒         b
3VI3V
4f
3V
f
3VI
4 kk
[A]kk
]d[A =        (3-7b) 
Given that the last three reactions of the series (3-VIII) – (3-X), are fast, reaction (3-VII) controls 
the rate of formation of A7 such that d[A4]/dt ~ [A]4. This type of dependence on the 
concentration of the monomers is assumed in our model, i.e. p = 4 in eq (3-3), where [A] is 
replaced by [cyt c⋅Apaf-1]. 
 
(3) Initiator caspase-9 activation involves five reactions; the binding of the  procaspase-9 
(pro9) to the apoptosome complex, followed by the binding of a second pro9 to form the 
complex apop⋅(pro9)2 and the cleavage of the bound procaspases to yield the holoenzyme  
apop⋅(casp9)2 , the dissociation of which finally leads to caspases-9 (Fussenegger et al., 2000; 
Rodriguez and Lazebnik, 1999), i.e.    
apop + pro9 ↔ apop⋅pro9    k2+, k2-  J2 (3-XI) 
apop⋅ pro9 + pro9 ↔ apop⋅(pro9)2   k3+, k3-  J3 (3-XII) 
apop⋅(pro9)2  → apop⋅(casp9)2   k3f  J3f (3-XIII) 
apop⋅(casp9)2 ↔ apop⋅casp9 + casp9   k4+, k4-  J4 (3-XIV) 
apop⋅casp9 ↔ apop + casp9    k4b+, k4b- J4b (3-XV) 
 
 45 
(4) Activation of caspase-3 by caspase-9 is described by two reactions, the complexation 
of casp9 with the pro3, and the following cleavage of pro3 to yield the executioner casp3 
molecule (Fussenegger et al., 2000), i.e. 
casp9 + pro3 ↔ casp9⋅pro3    k6+, k6-  J6 (3-XVI) 
casp9⋅pro3 → casp9 + casp3    k6f  J6f (3-XVII) 
  
(5) Another mechanism of activation of caspase-3 is the complexation of holoenzyme 
apop⋅(casp9)2 with the zymogen pro3, followed by the cleavage of pro3 to yield casp3 (Riedl et 
al., 2005; Rodriguez and Lazebnik, 1999), i.e. 
apop⋅(casp9)2 + pro3 ↔ apop⋅(casp9)2⋅pro3  k6b+, k6b- J6b (3-XVIII) 
apop⋅(casp9)2⋅pro3 → apop⋅(casp9)2 + casp3 k6bf  J6bf (3-XIX) 
 
(6) Inhibition of caspase-9 and -3 by IAPs.  IAP inhibits both casp9 (Shiozaki et al., 
2003) and casp3 molecules following the reactions (Fussenegger et al., 2000): 
casp9 + IAP ↔ casp9⋅IAP    k5+, k5-  J5 (3-XX) 
apop⋅casp9 + IAP ↔ apop⋅casp9⋅IAP   k5b+, k5b- J5b (3-XXI) 
apop⋅(casp9)2 + IAP ↔ apop⋅(casp9)2⋅IAP  k5c+, k5c- J5c (3-XXII) 
casp3 + IAP ↔ casp3⋅IAP                   k7+, k7-  J7 (3-XXIII) 
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(7) Cleavage of Bid by caspase-3.  In addition to caspase-8 that initiates the cleavage of 
Bid, casp3 produced downstream also truncates Bid to tBid  in Type II cells (Luo et al., 1998; 
Slee et al., 2000). The corresponding reactions are  
casp3 + Bid ↔ casp3⋅Bid    k8+, k8-  J8 (3-XXIV) 
casp3⋅Bid → casp3 + tBid    k8f  J8f (3-XXV) 
The activation of Bid by casp3 completes the first of two positive feedback loops present in our 
model. The second is due to the cleavage of the inhibitory protein Bcl-2 by casp3 (see item 9 
below). Upon cleavage, Bcl-2 can no longer inhibit the channel-opening activity of Bax 
(Antonsson et al., 1997). Therefore, casp3 indirectly enhances the formation of channels for pro-
apoptotic cyt c release. 
 
(8) Cyt c release from mitochondria to cytoplasm.  In the model proposed by Fussenegger 
and co-workers (Fussenegger et al., 2000), cyt c is released when the concentration of casp3 
relative to that of Bcl-2 exceeds a threshold value. Here, we adopt a different mechanism based 
on experimental observations (Lutter et al., 2001; Wei et al., 2001; Wolter et al., 1997; Yi et al., 
2003), summarized by the following sequence of events 
tBid → tBidmito     k11  J11 (3-XXVI) 
tBidmito + Bax → tBid⋅Bax    k12a  J12a (3-XXVII) 
tBid⋅Bax  + Bax → tBid + Bax2   k12b  J12b (3-XXVIII) 
Bax2 + cyt cmito → Bax2 + cyt c   k14  J14 (3-XXIX) 
Accordingly, tBid translocates to the mitochondria (k11), forms a complex with Bax (k12a) 
to initiate Bax oligomerization and channel (Bax2) formation (k12b). Cyt c is then released 
through the channel (k14).  
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 (9) Inhibition of Bax by Bcl-2, and cleavage (inactivation) of Bcl-2 by caspase-3. The 
cleavage of anti-apoptotic Bcl-2 by casp3 (Kim et al., 1998), which otherwise would inhibit Bax, 
is described by 
Bcl-2 + Bax → (Bcl-2⋅Bax)inactive   k13  J13 (3-XXX) 
casp3 + Bcl-2 ↔ casp3⋅Bcl-2    k9+, k9-  J9 (3-XXXI) 
casp3⋅Bcl-2 → casp3 + Bcl-2cleaved   k9f  J9f (3-XXXII) 
 
(10)  p53 regulation of Bax and Bcl-2 synthesis.  p53 upregulates the synthesis of Bax 
and downregulates that of Bcl-2  (Karpinich et al., 2002; Weller, 1998). Joers et al. (2004) 
observed that although p53 levels increase in all cells subject to DNA damage, only in some cells 
is the transcriptional activity of p53 switched on, whereas in the remainder it is switched off.  To 
account for this switch-like response of p53 to DNA damage, the following expressions are used 
for the rates of formation of Bax and Bcl-2 
ΩBcl-2 = ΩoBcl-2[p53] 4thresh / ([p53]4+[p53] 4thresh)    (3-8) 
ΩBax = ΩoBax (1+ [p53] 4/([p53]4+[p53] 4thresh))    (3-9)  
The above two expressions closely approximate the qualitative switch-like activity of 
p53.  The adoption of continuous functions as opposed to discrete threshold values permits us to 
perform a bifurcation analysis using the AUTO package. Note that these two equations represent 
the only expressions different from simple mass-action kinetics adopted in this text. The 
expression (3-8) originates from the assumption that Bcl-2 is expressed with a rate of ΩoBcl-2 
when [p53] = 0, however, the expression rate ΩBcl-2 approaches zero when [p53] >> [p53]thresh. 
Hence, there is a switch for Bcl-2 expression rate dependant on [p53] value. The exponent 4 is 
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chosen in the expression as opposed to a lower integer value to approximate a sharp switching 
function, i.e., step function. Expression (3-9) is adopted by similar arguments. We explored the 
effect of using other numbers for the exponents and we will discuss the results in Section 3.6.2. 
 
(11) Synthesis and degradation reactions. In addition to the above sets of reactions, the 
model includes the synthesis and degradation of a number of components. The proteins being 
synthesized (and corresponding synthesis rates) are Apaf-1 (ΩApaf-1), IAP (ΩIAP), pro3 (Ωpro3), 
pro9 (Ωpro9), Bid (ΩBid), Bcl-2 (ΩBcl2), Bax (ΩBax), and cyt cmito (Ωcytmit). Recent studies show that 
many molecules involved in apoptotic pathways are regulated by the ubiquitin-proteasome 
pathway (Yang and Yu, 2003). A first order degradation kinetics with a uniform rate constant of 
µ is adopted here for casp8, casp9, casp3, pro9, pro3, Apaf-1, IAP, Bcl-2, Bid, tBid, tBidmito, 
Bax, Bax2, tBid.Bax cyt c and cyt cmito. The initial concentrations of all compounds are zero, 
except for pro3 and pro9, Apaf-1, Bid, Bax, Bcl-2, IAP and cyt cmito that are all taken as 0.004 
µM since the concentrations of proteins are usually in the nanomolar range (Chen et al., 2000), 
unless otherwise stated or varied. Initial concentrations of casp8 and casp3 are indicated for each 
simulation. 
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Table 1. The set of differential rate equations adopted in Model 3 
d[Apaf-1]/dt = -J1+JApaf-1 d[apop⋅(casp9)2⋅pro3]/dt = J6b–J6bf
d[cyt c⋅Apaf-1]/dt = J1–7J1b d[casp3]/dt = J6f+J6bf–J7–J8+J8f–J9+J9f+Jcasp3
d[apop]/dt = J1b–J2+J4b d[casp8]/dt =  -J0+J0f +Jcasp8
d[apop⋅pro9]/dt = J2–J3 d[Bid]/dt = -Jo–J8+JBid
d[apop⋅(pro9)2]/dt = J3–J3f d[casp8⋅Bid]/dt = J0–J0f 
d[apop⋅(casp9)2]/dt=J3f–J4–J5c–J6b+J6bf  d[Bcl-2]/dt = -J9–J13+JBcl2
d[apop⋅casp9]/dt = J4–J4b–J5b  d[casp3⋅Bid]/dt = J8–J8f
d[casp9]/dt = J4–J4b–J5–J6+J6f+Jcasp9 d[casp3⋅Bcl-2]/dt = J9–J9f
d[pro9]/dt = - J2–J3+Jpro9  d[Bax]/dt = -J12a–J12b–J13+JBax
d[IAP]/dt = - J5–J5b–J5c–J7+JIAP d[tBid]/dt =  Jo+J8f–J11+J12b+JtBid
d[casp9⋅IAP]/dt = J5 d[tBid⋅Bax]/dt = J12a–J12b+JtBidBax
d[apop⋅casp9⋅IAP]/dt = J5b  d[cyt cmito]/dt = -J14+Jcytmit
d[apop⋅(casp9)2⋅IAP]/dt = J5c  d[Bax2]/dt = J12b+JBax2
d[casp3⋅IAP]/dt = J7 d[tBidmito]/dt = J11–J12a+JtBidmit
d[pro3]/dt = - J6–J6b+Jpro3 d[cyt c]/dt = J14–J1+Jcytc
d[casp9⋅pro3]/dt = J6–J6f  
with 
J0' = k0+[casp8][Bid] – k0-[casp8⋅Bid] JApaf-1 = ΩApaf-1 - µ[Apaf-1] 
J0f = k0f[casp8⋅Bid] JIAP = ΩIAP - µ[IAP] 
J1 = k1+[cyt c][Apaf-1] - k1-[cyt c⋅Apaf-1] Jpro3 = Ωpro3 - µ[pro3] 
J1b = k1b+[cyt c⋅Apaf-1]p - k1b-[apop] Jpro9 = Ωpro9 - µ[pro9] 
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J2 = k2+[apop][pro9] - k2-[apop⋅pro9] JBid = ΩBid - µ[Bid] 
J3 = k3+[apop⋅pro9][pro9] - k3[apop⋅(pro9)2] JBcl2 = ΩBcl2 - µBcl2[Bcl-2] 
J3f = k3f[apop⋅(pro9)2] JBax = ΩBax - µBax[Bax] 
J4 = k4+[apop⋅(casp9)2] - k4-[apop⋅casp9][casp9] Jcytmit = Ωcytmit -  µ[cyt cmito] 
J4b = k4b+[apop⋅casp9] - k4b-[apop][casp9] Jcasp9 = - µ[casp9] 
J5 = k5+[casp9][IAP] – k5-[casp9⋅IAP] Jcasp3 =  - µ[casp3] 
J5b = k5b+[apop⋅casp9][IAP] – k5b-[ apop⋅casp9⋅IAP] JtBid  = - µ[tBid] 
J5c = k5c+[apop⋅(casp9)2][IAP] – k5c-[apop⋅(casp9)2⋅IAP] J11 = k11[tBid]  
J6 = k6+[casp9][pro3] – k6-[casp9⋅pro3] J6f = k6f[casp9⋅pro3]  
J9 = k9+[casp3][Bcl2] - k9-[casp3⋅Bcl2] J12a = k12a[tBidmito][Bax]  
J6b = k6b+[apop⋅(casp9)2][pro3] – k6b-[apop⋅(casp9)2⋅pro3] J12b = k12b[tBid⋅Bax][Bax] 
J6bf = k6bf[apop⋅(casp9)2⋅pro3] J14 = k14[Bax2][cyt cmito] 
J7 = k7+[casp3][IAP] – k7-[casp3⋅IAP] J9f = k9f[casp3⋅Bcl2] 
J8 = k8+[casp3][Bid] – k8-[casp3⋅Bid] J8f = k8f[casp3⋅Bid] 
J13 = k13[Bcl2][Bax] and J14 = k14[Bax2][cyt cmito] J8f = k8f[casp3⋅Bid] 
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Table 2.  The parameters used in Model 3* 
Rate constants Other parameters 
k0+ = 10  µM-1s-1 k0- = 0.5 s-1 p = 4  
k0f = 0.1 s-1   k1+ = 5 µM-1s-1   [p53thresh] = 0.004 µM 
k1- = 0.5 s-1 k1b+ = 5x104 µM-3s-1  µ  = 0.006 s-1        
k1b- = 0.5 s-1 k2+ = 10 µM-1s-1      ΩApaf-1 = 3x10-4 µM/s 
k2- = 0.5 s-1 k3+ =10 µM-1s-1      ΩIAP = 3x10-5 µM/s 
k3- = 0.5 s-1 k3f = 0.1 s-1 Ωpro3 = 3x10-4 µM/s 
k4+ = 5  µM-1s-1 k4- = 0.5 s-1 Ωpro9 = 3x10-4 µM/s 
k4b+ = 5  µM-1s-1 k4b- = 0.5 s-1 ΩBid =  3x10-5 µM/s 
k5+ = 5 µM-1s-1 k5- = 0.0035 s-1 ΩoBcl2 = 8x10-5 µM/s 
k5b+ = 5 µM-1s-1 k5b- = 0.0035 s-1  ΩoBax = 3x10-5 µM/s 
k5c+ = 5 µM-1s-1 k5c- = 0.0035 s-1   Ωcytmit = 3x10-4 µM/s 
k6+ = 10 µM-1s-1 k6- = 0.5 s-1   [p53] = 0.0066 µM 
k6f = 0.001 s-1 k6b+ = 10 µM-1s-1  
k6b- = 0.5 s-1 k6bf = 0.1 s-1   
k7+ = 5 µM-1s-1 k7- = 0.0035 s-1  
k8+ = 10 µM-1s-1 k8- = 0.5 s-1   
k8f = 0.1 s-1 k9+ = 10 µM-1s-1         
k9- = 0.5 s-1 k9f = 0.1 s-1  
k11 = 10 s-1 k12a = 10 µM-1s-1  
k12b = 10 µM-1s-1 k13 = 10 µM-1s-1  
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k14 = 10 µM-1s-1   
* All rate constants, except for k7-, k5-, k5b-. k5c-.  k1b+, k11, k12a, k12b, k13, k14, [p53thresh] are set up to within one order 
of magnitude difference with respect to those used by Asthagiri and Lauffenburger (2001) in their simulations of 
mitogen-activated protein kinase (MAPK) pathways. The ratio of k7+ to k7- ensures an equilibrium constant of 0.7 
nM (Deveraux et al., 1997), as well as those used for defining k5-, k5b-. and k5c-. The values of k1b+, k11, k12a, k12b, k13, 
k14, [p53thresh] are suitably set to achieve fluxes comparable to other compounds’ fluxes. k6f is assigned a value 
smaller than k6bf because of experimental observations by Riedl et al. (2005). The degradation constant of all species 
is assigned as 0.006 s-1 unless specified otherwise in the text. This value is within the range of parameters used for 
degradation rate constants adopted by Chen et al. (2000) The rates of synthesis are within the range of values used 
by Chen et al. (2000). 
3.2.2 Adoption of simple mass-action kinetics 
Model 3 contains 31 components, including the different forms of the same molecule (e.g. Bid 
and tBid) and the same protein in different subcellular environments (e.g. cyt c in the cytosol and 
in the mitochondria). As presented above, all interactions (chemical or physical) are treated as 
chemical reactions, and their time-evolution is described by classical chemical reaction kinetics. 
We do not have conservation of the enzyme and thus do not use Michaelis-Menten (MM) 
simplifications for our reactions. We use the standard mass action models from which MM 
kinetics is derived when the total enzyme concentration is constant. In all of our reactants, we 
maintain a small source as well as degradation for the enzyme, such that the total enzyme 
concentration is not conserved until steady state conditions are reached. This provides robustness 
to the model which a simple conservation model lacks. In the absence of the source and 
degradation, and by the assumption of steady state conditions for particular products, the kinetics 
reduces to MM kinetics.  In the present approach, the equations for the concentrations of 
enzyme, [E], and for the enzyme-substrate concentration, [ES], obey the general form 
 
d[E]/dt = ΣiJi + Jsource – Jdecay       (3-10) 
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d[ES]/dt = - ΣiJi        (3-11) 
 
where J is the contribution from the reactions in which they participate, and the latter two terms 
refer to their production and degradation rates, so that there is no longer conservation of the total 
enzyme and the MM assumption is violated.  
 
In the case of MM kinetics, on the other hand, the set of reactions and equations would be 
E + S ↔ ES  kf, kb       (3-XXXIII) 
ES → E + P  kcat       (3-XXXIV) 
where P is the product, kf is the rate constant of forward reaction and kb is the rate constant of 
reverse reaction in (3-XXXIII) and kcat is the rate constant for catalytic reaction in (3-XXXIV). 
The differential rate equations for the enzyme and enzyme-substrate complex read in this case 
 d[E]/dt = ΣiJi = - kf[E][S] + kb[ES] + kcat[ES]    (3-12) 
d[ES]/dt = - ΣiJi = kf[E][S] – kb[ES] – kcat[ES]    (3-13) 
The total concentration of enzyme (in isolated and complexed form) is constant over time and 
equal to 
 [E] + [ES] = ET        (3-14) 
as follows from Eqs 3-12 and 3-13 that lead to the identity  
d[E]/dt + d[ES]/dt = 0        (3-15) 
In the reaction cascade, enzyme and substrate first form the enzyme-substrate complex with a 
rapid and reversible step with no chemical changes taking place. The enzyme and substrate are 
held together by noncovalent interactions. The chemical conversion of substrate to product takes 
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place in second step with a rate constant kcat in reaction (3-XXXIV). Assuming pre-equilibrium 
for the fast reactions in (3-XXXIII), 
 kf[E][S] = kb[ES]        (3-16) 
  [E][S]/[ES] = kb/kf = KM       (3-17) 
where KM is is Michaelis constant. 
The rate of production of P is 
  ν ≡ d[P]/dt =  kcat[ES]        (3-18) 
Inserting Eq. (3-14) into Eq. (3-17) to eliminate [E] and rearranging, we obtain    
 [ES] = [E]T[S] / (KM+[S])       (3-19) 
which, upon substitution in eq 3-18 leads to the so-called Michaelis-Menten equation (Fersht, 
2002)  
 ν = [E]T[S]kcat / (KM+[S])        (3-20) 
3.2.3 Approximations in model parameters 
The model parameters are listed in Table 2. Most of them have been assigned values within an 
order of magnitude of those used in previous studies (Asthagiri and Lauffenburger, 2001; Chen 
et al., 2000). These parameters, corresponding to MAP kinase pathways, were adopted in view of 
the lack of experimental data on the rate parameters of the above listed reactions, and 
experimental data have been incorporated when available (see Table 2 footnote). With these 
choices of parameters, it will be shown that the model exhibits resistance to caspase-3 activation 
when p53 level is low and and bistability to apoptotic stimuli when p53 level is high in 
agreement with experiments (44). In view of the lack of precise quantitative information on most 
parameters, the present results should be viewed as qualitative, rather than quantitative. The 
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coefficient p was chosen to be 4. Smaller values were also observed to lead to bistability, 
although the associated threshold concentrations of caspase-3 were unrealistically low (e.g., 
0.004 molecules per cell for p = 3 and 3.2x10-6 molecules per cell for p = 2).  The simulations 
and bifurcation analysis have been performed using the software XPPAUT 
(http://www.math.pitt.edu/~bard/xpp/xpp.html) developed by Professor Bard Ermentrout at the 
University of Pittsburgh, Department of Mathematics (Ermentrout, 2002). 
3.3 COOPERATIVITY IN APOPTOSOME FORMATION CAUSES BISTABILITY 
IN THE MITOCHONDRIA-DEPENDENT MODEL OF APOPTOSIS 
Any stimulus that produces casp8 may initiate mitochondria-dependent apoptotic interactions 
(Figure 1). Caspase-8 truncates Bid to tBid, which results in the activation of casp3 by a cascade 
of reactions following the translocation of tBid to the mitochondria. The activation of casp3 
gives rise to two positive feedback loops that amplify the response to the initial triggering effect 
of casp8. Our model does not include the pathways upstream of casp8 activation. We assume 
that a transient pro-apoptotic stimulation results in the production of casp8 in proportion to the 
exposure of the cell to death signal ligands. Here the coefficient p involved in the formation of 
apoptosome is taken as p = 4. The upper limit p = 7 can not be adopted because in this case, the 
model is not bistable but monostable cell survival where casp3 is not activated even for very high 
apoptotic stimulus. Although p might be as large as seven for a fully cooperative formation of a 
heptameric structure, a value of four was observed to be sufficient to ensure bistability, while 
lower p values would necessitate unrealistic (picomolar) concentrations of casp3 to ensure a 
bistable response. 
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Figure 10 panels A and B illustrate two opposite behaviors observed in response to small 
changes in pro-apoptotic stimuli (represented here by the initial casp8 concentration [casp8]0) 
provided that the apoptotic pathways involve a cooperative step. When [casp8]0 is relatively low, 
[casp8]0 = 10-5 µM, for example, cell survival is observed as a monostable response (Figure 10A) 
using the differential rate equations and parameters listed in the respective Tables 1 and 2. Cell 
survival is manifested therein by a decrease in the concentration of casp3 to negligibly small 
values. On the other hand, the opposite behavior, i.e. monostable PCD, is induced (Figure 10B) 
if the pro-apoptotic stimulus exceeds a threshold level (see below). The concentration of casp3 is 
shown to increase in this case by two orders of magnitude, to 4.5 x 10-3 µM, from the same 
initial concentration (10-5 µM) as in Figure 10A.  The only different input for generating the 
result displayed in panel B as compared to panel A is the increase (from 10-5 µM  to 10-4 µM) in 
the initial concentration of [casp8]0. 
We note that the model is not restricted to apoptosis caused by extracellular stimuli 
exclusively. The PCD in panel B was verified to also occur with a zero initial casp8 
concentration and non-zero initial casp3 concentration (e.g. [casp3]0 = 5 x 10-4 µM, which 
eventually leads to [casp3] = 4.8 x 10-3 µM - data not shown). Therefore, apoptosis may be 
equally driven by intrinsic pro-apoptotic stimuli that induce casp3 activation. In our analysis, 
casp3 steady state concentrations of the order of nanomolar were accepted to be indicative of 
apoptosis, whereas cell survival would refer to vanishingly small concentrations.  
Finally, in the absence of cooperativity (p = 1), the same initial conditions for caspase-8 
and caspase-3 that led to cell survival in Figure 10A, are now observed to induce apoptosis, as 
implied by the high concentrations (6 x 10-3 µM) caspase-3 reaches at steady state (Figure 10C). 
This is an example of pathological cell death rather than a normal response to small apoptotic 
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stimuli (cell survival/protection). The system does not exhibit a bistable behavior in response to 
variations in [casp8]0. Instead, apoptosis is the only stable state, despite the low original 
concentration of casp8.  
 
0
2 10-6
4 10-6
6 10-6
8 10-6
1 10-5
1 10 100 1000 104
[c
as
pa
se
-3
] (
µM
)
time (s)
A
p = 4
[caspase-8]
o
 = 10-5 µM
 
0
0.001
0.002
0.003
0.004
0.005
0 2000 4000 6000 8000 1 104
time (s)
B
p = 4
[caspase-8]
o
 = 10-4 µM
 
0
0.002
0.004
0.006
0.008
0 2000 4000 6000 8000 1 104
time (s)
C
p = 1
[caspase-8]
o
 = 10-5 µM
 
Figure 10. Time evolution of caspase-3 in response to minor changes in initial caspase-8 concentration [casp8]0. (A) 
cell survival when [casp8]0 is small (10-5 µM), indicated by the decrease in the caspase-3 concentration (initially 10-5 
µM) to zero at steady state. The abscissa is shown in logarithmic scale to display the time evolution of caspase-3 
more clearly; (B) apoptosis, implied by the increase in caspase-3 concentration to a high value (4.5 x 10-3 µM) at 
steady state despite the same initial value of caspase-3 as in panel A, when [casp8]0 is higher (10-4 µM);  (C) 
monostable apoptosis, in the absence of cooperativity (p = 1) using the same initial concentrations of caspase-3 and 
caspase-8 as in panel A. Here caspase-3 concentration reaches a high value (6 x 10-3 µM) at long times indicative of 
apoptotic response. Note that the ordinate scales are different in the panels.  
 
Taken together, these results suggest that the cooperativity in apoptosome formation, 
might be a mechanism in cells to ensure healthy functioning of cells to apoptotic stimuli, instead 
of invariably leading to apoptosis in response to minimal stimulation.   
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3.4 BIOLOGICAL SIGNIFICANCE OF BISTABILITY. ROLES OF BAX, BCL-2, 
AND MPTP IN PATHOLOGICAL APOPTOSIS 
3.4.1 Bax degradation and expression rates can determine the transition between 
bistable and monostable responses 
Apoptosis can be controlled by the degradation rate of pro-apoptotic proteins such as Bax (Li 
and Dou, 2000). We examined if our mathematical model confirms this behavior. Figure 11A 
depicts the bifurcation diagram as a function of the degradation rate (µBax) of Bax and the initial 
concentration of casp3. The limit point for saddle-node bifurcation is found as µBax = 0.11 s-1 
using the parameters listed in Table 2.  Below this limit point, there exist three steady states, two 
of which are stable and one unstable. Therefore, the system is bistable in this regime and the 
response may be either apoptosis or cell survival depending on the combination of the original 
caspase-3 concentration and Bax degradation rate. Conversely, above the limit point, there is 
only one stable state (cell survival), i.e. the system is monostable due to the depletion of pro-
apoptotic Bax.  
The arrows in Figure 11A, indicate the direction of evolution of casp3 levels, starting 
from any region of the diagram (i.e. any combination of the two parameters).  The solid curve 
represents the stable apoptosis loci achieved with casp3 concentrations above the dotted curve, 
and the lower solid line represents the stable cell survival state, characterized by zero casp3 
concentration. The dashed curve represents the loci of unstable steady-state leading to either cell 
death or cell survival, upon slight perturbation. It also defines the threshold concentration of 
apoptotic stimuli [casp3]0 to trigger apoptosis as a function of the degradation rate of Bax. In the 
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monostable regime, even very high initial casp3 concentrations decay to zero. Therefore, when 
the rate of degradation of Bax is higher than the limit point, apoptosis cannot occur.  
Figure 11B illustrates the time evolution towards monostable cell survival. With µBax = 
0.2 s-1 (higher than the limit point), the concentration of casp3 decays from [casp3]0 = 0.1 µM to 
zero, even when [casp8]0 is also high (0.1 µM). Notably, our results are in accord with those of 
Li and Dou, who demonstrated that elevated Bax degradation is a survival mechanism in human 
cancer cells (Li and Dou, 2000).  
Figure 11C is the bifurcation diagram for rate of formation of Bax. The limit point for the 
saddle-node bifurcation is ΩoBax = 6.03 x 10-6 µM/s. Above this point, a bistable behavior is 
predicted in response to pro-apoptotic stimuli. For ΩoBax < 6.03 x 10-6 µM/s, on the other hand, 
the response is monostable cell survival, even in the presence of high apoptotic stimuli. This 
result is consistent with observations of decreased Bax expression in human breast cancers 
(Schorr et al., 1999). 
The present model thus predicts that cells will exhibit a monostable cell survival response 
to apoptotic stimuli if the degradation rate of Bax is above some threshold value or if the 
expression rate of Bax is below some threshold value (shown in the respective panels A and C of 
Figure 11). In this monostable regime, the casp3 concentration always diminishes to zero 
because there is not a sufficiently high concentration of Bax to open up channels on 
mitochondrial membrane for releasing cyt c. The net result is that the activation rate of casp3 
becomes lower than its degradation rate, eventually leading to vanishingly low concentrations of 
casp3. In the bistable regime, on the other hand, a dichotomous response favoring either cell 
survival (vanishingly small casp3 concentration) or programmed cell death (casp3 above 
nanomolar concentration) is elicited, depending on the original casp3 concentrations. Overall, the 
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model predicts that there exists a critical point at which the amount of Bax leads to monostable 
cell survival that might be associated with the onset of cancer in living cells.  
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Figure 11. Effect of Bax degradation rate 
(µBax) on cell fate. Calculations are performed 
using Model 3. (A) Bifurcation diagram for 
casp3 concentration with the bifurcation 
parameter µBax along the abscissa. Limit point 
for saddle-node bifurcation is µBax = 0.11 s-1.  
Below this limit point, there are three steady 
states, two of which are stable and one 
unstable; and above the limit point, there is 
only one stable state, cell survival. The arrows 
indicate the equilibrium concentrations 
reached when starting from any point in the 
diagram; (B) The high initial concentration of 
caspase-3 (0.1 µM) decreases to zero when 
µBax is in the monostable cell survival region 
(0.2 s-1) despite the high [casp8]0 value; (C) 
Bifurcation diagram for  casp3 with the 
bifurcation parameter ΩoBax. Limit point for 
saddle-node bifurcation is ΩoBax = 6.03 x 10-6 
µM /s. The stable cell survival line ([casp3]o = 
0) is not shown because the y-axis is 
logarithmic.  
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3.4.2 Bcl-2 modulates the effect of Bax 
Bcl-2 is the classical, anti-apoptotic member of the Bcl-2 family. Danial and Korsmeyer state in 
their review (Danial and Korsmeyer, 2004) that the ratio of Bcl-2 to Bax constitutes a rheostat 
that sets the threshold of susceptibility to apoptosis for the mitochondria-dependent pathway. 
Accordingly, we tested if our mathematical model would demonstrate a counteracting role of 
Bcl-2 vis-à-vis the effects of Bax. We illustrate the effect of Bcl-2 on the pro-apoptotic effects of 
Bax in Figure 12A.  The series of curves in this figure represent the bifurcation diagrams as a 
function of the degradation rate of Bax for different expression rates of Bcl-2.  Figure 12B 
displays the results as a function of the synthesis rate of Bax. Therefore, Figure 12A and Figure 
12B are the counterparts of the respective Figure 11A and Figure 11C obtained for different rates 
of formation of Bcl-2. 
The increase in the rate of formation of Bcl-2, ΩοBcl-2, is observed to have several effects 
(Figure 12A). First, the limit point for the saddle-node bifurcation decreased to lower Bax 
degradation rates, i.e. cell survival becomes even more prominent.  When ΩοBcl-2 = 8x10-5 µM/s, 
the limit point was µBax = 0.11 s-1 (Figure 11A). This result is included in Figure 12A for 
comparative purposes. The limit point decreased to µBax = 0.085 s-1 for ΩοBcl-2 = 3.2x10-4 µM/s, 
and to µBax = 0.042 s-1 for ΩοBcl-2 = 8x10-4 µM/s. Hence, the bistable cell survival region, which 
may possibly give rise to apoptosis becomes narrower, while the monostable cell survival region 
becomes broader, when Bcl-2 is over-expressed. This result is consistent with the observation 
that Bcl-2 is over-expressed in many types of tumors that exhibit low rates of apoptosis (Reed, 
1999). Second, the threshold concentration of casp3 for undergoing apoptosis with a given Bax 
degradation rate µBax, tends to increase with increase in Bcl-2 expression rate, as indicated by the 
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vertical shifting of the dashed portions of the curves in Figure 12A. This result implies that larger 
or more potent pro-apoptotic stimuli are needed for PCD when Bcl-2 expression levels are 
relatively high. Third, the apoptotic concentration of casp3 for given degradation rates of Bax 
(i.e. the solid portions of the bifurcation curves) are lowered with increasing Bcl-2 expression 
rates. 
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Figure 12.  Effects of Bcl-2 expression rate on cell behavior in response to changes in Bax levels. Calculations are 
performed using Model 3. (A) Effect on the bifurcation diagram for µBax; (B) Effect on the bifurcation diagram for 
ΩoBax.  
In Figure 12B, we observe the equilibrium caspase-3 concentrations as a function of Bax 
expression rate, ΩοBax, again for various rates of formation of Bcl-2, ΩοBcl2: First, the limit point 
for the saddle-node bifurcation shifts to higher ΩοBax values with increasing ΩοBcl-2. The limit 
point of ΩοBax = 6.03x10-6 µM/s (also shown in Figure 11C) is shifted to 1.17x10-5 µM/s, and 
then to 2.16x10-5 µM/s as ΩοBcl-2 increases from 8x10-5 µM/s to 3.2x10-4 µM/s, and then to 8x10-
4 µM/s. Hence, the bistable region becomes narrower and the monostable cell survival region, 
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broader, when Bcl-2 expression levels increase. Second, the threshold [casp3]0 for entering 
apoptosis shift to higher values in the bistable regions. Third, the steady-state concentrations of 
casp3 in the case of apoptosis slightly shift to lower values, similarly to their counterparts in 
Figure 12A. 
These results suggest that the pro-apoptotic effect of a low rate of Bax degradation or 
high rate of Bax expression can be counteracted by high rate of Bcl-2 expression. This behavior 
is in line with the known interaction of these proteins (Danial and Korsmeyer, 2004). High Bcl-2 
oncogene expression has been shown to sensitize the cells to cancer. Conversely, down-
regulation of Bcl-2 can sensitize melanoma cells to apoptosis (Chawla-Sarkar et al., 2004; 
Zangemeister-Wittke et al., 2000). In a broader sense, the relative production and degradation 
rates of Bax and Bcl-2 determine whether the cell will survive or undergo apoptosis (Danial and 
Korsmeyer, 2004), consistent with our analysis.   
3.4.3 Effect of MPTP on the detailed mitochondria-dependent apoptosis model 
The mechanisms of cyt c release from mitochondria are highly diverse and controversial  
(Newmeyer and Ferguson-Miller, 2003; Nakagawa et al., 2005). In Model 3, we assume that cyt 
c release is closely dependent on the formation/activation of MPTPs (Green and Kroemer, 2004; 
Halestrap and Brenner, 2003) irrespective of Bax channel formation on mitochondria. The non-
specific MPTP involved in cyt c release is proposed to be a complex formed by the proteins 
VDAC-ANT-CyP-D (Halestrap and Brenner, 2003). We will denote this non-specific pore by 
PTPC here. The release of cyt c from the non-specific pore, cyt cmito + PTPC → cyt c is included 
in the model to account for this dependence. 
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The bifurcation diagram in Figure 13 illustrates the effect of PTPC level on the steady 
state concentration of caspase-3. In these calculations, the p53 concentration was assigned a 
relatively low value (0.0022 µM) so that the response to apoptotic stimulus (here [casp3]0) would 
be monostable cell survival in the absence of PTPC. At low levels of PTPC (< 2.3x10-4 µM), the 
system exhibits a monostable cell survival. At intermediate PTPC levels (2.3x10-4 µM < [PTPC] 
< 9.0x10-4 µM), a bistable behavior is observed, in accord with the healthy functioning of cells. 
At PTPC levels above the limit point of 9.0x10-4 µM, apoptosis is induced, which may be 
pathological in some cases (Green and Kroemer, 2004).  
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Figure 13. Bifurcation diagram as a function of the concentration of mitochondrial permeability transition pore 
complex [PTPC]. The limit points for saddle-node bifurcation are at [PTPC] =2.3x10-4 µM and 9.0x10-4 µM.  
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3.5 ROBUSTNESS OF COOPERATIVE APOPTOSOME FORMATION AS A 
MECHANISM THAT IMPARTS BISTABILITY 
Inhibition of caspases (Eissing et al., 2004) was proposed previously as a mechanism that can 
lead to bistability. We compared the robustness of two different mechanisms in inducing 
bistability: inhibition of casp3 by IAP and cooperative formation of apoptosome. To this aim, we 
organized the parameters into 13 groups and varied them within an order of magnitude, which 
led to 213 = 8192 parameter sets. In the absence of cooperativity (i.e. when the coefficient p was 
set equal to unity), none of the 8192 simulations led to a bistable response to apoptotic stimuli 
despite the IAP inhibition of casp3. In the presence of cooperativity, or when p was assigned the 
respective values of 2 and 3, we observed that 320 and 736 of the runs resulted in a bistable 
response, supporting the importance of cooperative apoptosome formation for inducing 
bistability over a wide range of parameters.   
Eissing et al. (2007) recently studied simplified models that include kinetic cooperativity, 
zero-order ultrasensitivity or inhibitors. Using the previously described measures for robustness 
in bistable systems (Ma and Iglesias, 2002; Eissing et al., 2005), they find that theoretically all 
three model structures are robust in terms of bistability. In all cases, the bistability and its 
robustness depend on the right combination of parameters. That may explain why our choice of 
parameters resulted in different findings than theirs. What happens in vivo is probably a 
combination of these mechanisms to secure a tight switch (Manoharan et al., 2006). 
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3.6 COMPARISON WITH EXPERIMENTS 
3.6.1 Inhibition of Bax degradation induces apoptosis in Bcl-2 overexpressing cells 
Li and Dou (2000) studied the effect of a proteasome inhibitor, N-carbobenzoxy-L-leucyl-
norvalinal (LLnV), on Bcl-2 overexpressing Jurkat T-cells that are protected from apoptosis. 
LLnV was shown to induce caspase-mediated apoptosis after cyt c release. It was also shown 
that LLnV inhibited Bax degradation in a cell-free assay. These findings are consistent with a 
role for the ubiquitin-proteasome pathway in regulating key players in the apoptotic cascade 
(Yang and Yu, 2003).  
In order to test this conjecture, we carried out the following simulations. First, we 
examined the response of Bcl-2-overexpressing cells to apoptotic stimuli in the absence of a 
proteasome inhibitor. We assigned the values of µBax = 0.1 s-1 and ΩοBcl-2 = 3.2x10-4 µM/s, which 
result in monostable cell survival as the Bax degradation rate is higher than the limit point (0.085 
s-1) (See Figure 12A).  The curve with the filled circles in Figure 14A and B displays the time 
evolution of cyt c and caspase-3, respectively, under these conditions. Both curves show the 
depression of apoptotic molecules to negligibly low concentrations, suggesting the occurrence of 
monostable cell survival under these conditions. Second, we simulated the time evolution of the 
same Bcl-2-overexpressing cells in the presence of a proteasome inhibitor, by linearly decreasing 
µBax to 0.04 s-1 in 1200 seconds, and maintaining this rate constant thereafter. The initial 
concentrations for both casp8 and pro3 were assigned to be 0.1 µM. This simulation resulted in 
an increase in cyt c release and an increase in casp3 level (curves with open circles in panels A 
and B of Figure 14). The qualitative agreement between simulations and experiments suggests 
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that the onset of cancer may be associated with a Bax degradation rate higher than a certain 
threshold value (the limit point in the bifurcation diagram shown in Figure 12A). 
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Figure 14. Time evolution of (A) cyt c; (B) caspase-3 levels with (open circles) and without (filled circles) inhibition 
of Bax degradation. Inhibition of Bax degradation induces an accumulation in cyt c and caspase-3 levels. 
Calculations are performed using Model 3. 
3.6.2 Simulating the effect of Silymarin on apoptosis 
In an experimental study by Katiyar et al. (2005), it was shown that silymarin, a plant flavonoid 
that is known to inhibit skin carcinogenesis in mice, induced casp3 activation in JB6 C141 cells 
(preneoplastic epidermal keratinocytes). The concentration of silymarin was shown therein to be 
correlated with p53 concentrations, suggesting that silymarin acts via increasing the p53 levels.  
In order to explore if our model could explain/interpret the experimental data collected by 
Katiyar et al., we performed a mathematical analysis of the effect of changes in p53. We varied 
p53 concentration from a low value (0.0022 µM) characteristic of monostable cell survival, to 
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higher values in accord with the relative increases reported in Figure 3 of Katiyar et al. (2005). 
The selected [p53]0 values and resulting caspase-3 concentrations are shown in panel A of Figure 
15. The accompanying changes in the relative levels of Bax, Bcl-2 and cyt c are displayed in the 
respective panels B-D of the same figure. The comparison of the computational results (filled 
bars) with those from experiments Katiyar et al. (2005), shown by the crisscrossed bars, shows 
that there is a good qualitative agreement between the two sets,  except for Bcl-2 concentrations 
at relatively high p53 levels, which seem to deplete faster in computations than in experiments. 
This discrepancy may be due to the adoption of equations 3-8 and 3-9 for describing the time 
evolution of Bcl-2 and Bax expression levels as a function of p53 concentration. The threshold 
p53 concentration for inducing transcriptional activity refers to a relative increase in [p53]0 of 
approximately two (abscissa in Figure 15), and the computed abrupt decrease in Bcl-2 may be 
attributed to this change in regime. Additionally, experiments show the average behavior of an 
ensemble of cells (with a distribution of p53 concentrations), which would be expected to lead to 
a smoother change in [Bcl-2] compared to that predicted by computations. We examined the 
effect of exponent in equations 3-8 and 3-9. We can not adopt an exponent smaller than four 
because the normalized steady-state concentration of caspase-3 is 0.7 for concentration of unity 
for [p53]0. This is in disagreement with the experimental results (See the vanishingly low 
concentration of casp3 in Figure 16, panel A for relative [p53]0 = 1). Additionally, the agreement 
between the theoretical results and experimental results does not improve when the exponent is 
greater than four. 
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Figure 15. Comparison of the experimental and theoretical changes in casp3, Bax, Bcl-2 and cyt c concentrations in 
response the relative changes in [p53] (that are induced by changes in the flavanoid silymarin concentrations). Panel 
A displays the caspase-3 levels corresponding to each selected [p53] computed by present simulations using Model 
3. Panels B-D display the results from computations (solid bars) and those from experiments (crisscrossed bars) for 
each choice of relative [p53] shown in panel A. 
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3.7 SUGGESTED EXPERIMENT TO REVEAL THE MECHANISM OF CASPASE-3 
ACTIVATION 
The mechanism of regulation in apoptosis is unclear. One hypothesis is that the regulation 
mechanisms due to positive feedback mechanisms involving casp3 and causing bistability (Bagci 
et al., 2006; Eissing et al., 2004; Legewie et al. 2006) and the other is switch mechanism in 
mitochondria (Bentele et al., 2004). One way to understand if the regulation is caused by positive 
feedback involving casp3 or not, is to do cell-free experiments in the absence of procaspase-3. 
The extract can then be loaded with wild-type and mutated procaspase-3 that lack the catalytic 
cysteine residue. If the positive feedback mechanisms are ensuring the control, casp3 would not 
be activated in the cell-free extract in the presence of mutated procaspase-3 (this is also predicted 
by the Model 3 by equating rates of catalytic reactions of casp3 to zero). However, if 
mitochondrial switch mechanisms are alone ensuring all or none behaviour in apoptosis, casp3 
would be activated in the presence of mutated casp3. 
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4.0  COMPETING EFFECTS OF NITRIC OXIDE IN REGULATING APOPTOSIS: 
INSIGHTS FROM COMPUTATIONAL MODELING 
We propose a new mathematical model for simulating the effects of nitric oxide (NO) on 
apoptosis. The new model integrates mitochondria-dependent apoptotic pathways with NO-
related reactions, to provide information on the regulatory effect of the reactive NO species 
N2O3, non-heme iron nitrosyl species (FeLnNO), and peroxynitrite (ONOO-). In the absence of 
NO, the model predicts either cell survival or apoptosis (a bistable behavior) with shifts in the 
onset time of apoptotic response depending on the strength of extracellular stimuli. 
Computations shed light on experimentally observed dichotomous effects of NO, demonstrating 
that the relative concentrations of anti-apoptotic and pro-apoptotic reactive NO species, and their 
interplay with glutathione, determine the net anti- or pro-apoptotic effects at long time points. 
Interestingly, transient effects on apoptosis are also observed, the duration of which may reach 
up to hours, despite the eventual convergence to an anti-apoptotic state. Our computations point 
to the importance of precise timing of NO production and external stimulation in determining the 
eventual pro- or anti-apoptotic role of NO. 
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 4.1 NITRIC OXIDE EFFECTS ON APOPTOSIS 
Nitric oxide has opposite, competing effects in regulating apoptosis: it exerts an anti-apoptotic 
effect on hepatocytes (Kim et al., 2004; Vodovotz et al., 2004; Wang et al., 2002), endothelial 
cells (Bulotta et al., 2001; Ceneviva et al., 1998; Dimmeler et al., 1997b; Dimmeler et al., 1997a; 
Tzeng et al., 1997) and keratinocytes (Weller et al., 2003), whereas it is pro-apoptotic in the case 
of macrophages (Albina et al., 1993; Messmer and Brune, 1996; Messmer et al., 1995; Sarih et 
al., 1993).  
The variability and complexity of the effects of NO on ultimate cellular fate may arise 
from this molecule’s ability to react with oxygen, reactive oxygen species, metal ions, small 
thiol-containing molecules, and proteins. The resulting reactive NO species can either trigger or 
suppress apoptosis through various mechanisms. Chief among them is the S-nitrosative 
suppression of caspase activation, subsequent to the generation of FeLnNO or other species 
capable of carrying out S-nitrosation reactions (see below) (Li et al., 1997; Vodovotz et al., 
2004).  
Differences in the levels of NO and its reaction products may also arise from diverse 
inflammatory settings in which the expression of nitric oxide synthases (NOS) is affected. For 
example, quiescent endothelial cells express constitutive NOS (eNOS) that directly produce NO 
molecules and mediate the so-called “direct” effects (Wink et al., 1999).  Some inflammatory 
stimuli, on the other hand, lead to inducible NOS (iNOS) expression that subsequently generates 
reactive NO species, which in turn mediate “indirect” effects of NO. The simultaneous presence 
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of oxygen radicals can generate other reactive NO species that mediate further indirect effects of 
NO (Wink et al., 1999). As another example, hepatocytes and macrophages have different 
amounts of non-heme iron complexes, which affect the levels of iron-nitrosyl species when NO 
is produced (Kim et al., 2000). Finally, different intracellular levels of glutathione (GSH) can 
also modulate the time evolution of NO-related compounds (Hu et al., 2006). 
Computational approaches have been used previously to help unravel the complex 
biology of NO. Biotransport of NO was first modeled by Lancaster (Lancaster, 1994; Lancaster, 
1997) followed by other groups (reviewed by Buerk (2001)), recently by Zhang and Edwards 
(2006). Recently, Hu and coworkers focused on a detailed reaction mechanism of NO (Hu et al., 
2006). These models have improved our understanding of the biotransport of NO and the types 
of chemical reactions that involve NO and related reactive species. Additionally, a number of 
mathematical models have been proposed for understanding the mechanisms of apoptosis 
(Aldridge et al., 2006; Bagci et al., 2006; Bentele et al., 2004; Eissing et al., 2004; Fussenegger 
et al., 2000; Legewie et al., 2006; Rehm et al., 2006; Siehs et al., 2002; Stucki and Simon, 2005).  
The work of Eissing et al. (2004) is of interest, in particular, which demonstrated the importance 
of IAP inhibition for imparting bistability in type I cells (Eissing et al., 2004). The studies by 
Rehm et al. (2006) and Legewie et al. (2006) also showed the same effect in type II cells. These 
studies have improved our understanding of the robustness of switch mechanisms for regulating 
apoptosis, but none of these models has addressed the dichotomous effects of NO (Aldridge et 
al., 2006; Bagci et al., 2006; Bentele et al., 2004; Eissing et al., 2004; Fussenegger et al., 2000; 
Legewie et al., 2006; Rehm et al., 2006; Siehs et al., 2002; Stucki and Simon, 2005).  
Herein, we propose a mathematical model that can potentially shed light on the pro- and 
anti-apoptotic effects of NO in specific contexts. The model we propose here couples the 
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apoptotic cascade ((Bagci et al., 2006) and chapter 3 of this thesis) to an extended model of NO 
reaction pathways initially proposed by Hu et al. (2006). First, we illustrate how identical cells 
can undergo apoptosis at different time points after being exposed to apoptotic stimuli, in accord 
with experimental data collected on single cells (Rehm et al., 2002; Tyas et al., 2000). Then, we 
examine the apoptotic behavior in response to changes in N2O3, FeLnNO, ONOO- and GSH 
levels, in the presence of NO production by iNOS. 
4.2 MODELS 
Three models are considered in this chapter.  Model 3, presented in chapter 3, focuses on the 
pathways involved in mitochondria-dependent apoptosis (Figure 1). Model 4-A is an extension 
of the kinetic model of NO-associated reactions recently proposed by Hu et al. (2006) (Figure 2). 
Finally, Model 4-B is the integration of Models 3 and 4-A, constructed to examine the pro-
apoptotic and anti-apoptotic effects of NO. 
4.2.1 Generation of NO-related oxidative and nitrosative species ONOO-, N2O3, and 
FeLnNO (Model 4-A). 
We extended the network originally proposed by Hu at al. (2006) to introduce additional 
reactions involving NO, as well as additional compounds such as the NO-related species 
FeLnNO (L denotes ligands that do not contain heme), NO2, and cytochrome c oxidase (CcOx). 
Figure 2 illustrates the extended network of interactions. Table 3 lists the corresponding 
reactions (indexed as (4-I) – (4-XX)) and rate constants. The reactions (4-XII) and (4-XVIII) 
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break down the production of N2O3 from NO and O2 into two steps that replace the 
corresponding reaction (with rate constant k12) used in the model of Hu et al. (2006). Reactions 
(4-XVI) – (4-XX) are introduced in the present study. The identity of the products is not written 
when these compounds do not serve as reactants in any of the reactions listed in Table 3.  
Table 4 lists the rate laws for these reactions (Eq.s 4-1 – 4-20), which are used in the 
differential rate equations (Eq.s 4-21 – 4-29) that control the time evolution of the concentration 
of the individual compounds. Model 4-A contains 16 components. Eleven of them reach steady-
state concentrations within a short time interval (~ 20 minutes) after initiation of the simulations 
for [GSH]0 ≤ 103 µM and within four and half hours for [GSH]0 = 104 µM, whereas five 
compounds (superoxide dismutase (SOD), glutathione peroxidase (GPX), CO2, O2, and cyt c) 
retain their equilibrium concentrations. Table 5 lists the initial and equilibrium concentrations 
different from zero, adopted in Model 4-A, and the corresponding references. 
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Table 3.  Reactions included in Model 4-A 
Description of the 
reaction/interaction 
Rate constant (*) Reference Reaction 
index 
Production of NO k1NO = 1 µM/s (Hu et al., 2006) 
(Beckman and 
Koppenol, 1996) 
(4-I) 
Production of O2- k2NO = 0.1 µM/s (Hu et al., 2006) 
(Antunes et al., 1996) 
(4-II) 
Production of GSH k3NO = 0 (Hu et al., 2006) (4-III) 
NO + O2- → ONOO- k4NO = 6700 µM-1s-1 (Huie and Padmaja, 
1993) 
(4-IV) 
SOD + O2- + H+ → SOD + ½ O2 + ½ 
H2O2
k5NO = 2400 µM-1s-1 (Fielden et al., 1974) (4-V) 
ONOO- + GSH → GSNO + products k6NO = 0.00135 µM-1s-1 (Koppenol et al., 
1992) 
(4-VI) 
ONOO- + GPX → GPX + products k7NO = 2 µM-1s-1 (Sies et al., 1997) (4-VII) 
ONOO- + CO2 → products k8NO = 0.058 µM-1s-1 (Denicola et al., 
1996; Squadrito and 
PRYOR, 1998) 
(4-VIII) 
ONOO- + cyt c → cyt c + products k9NO = 0.025 µM-1s-1 (Thomson et al., 
1995) 
(4-IX) 
2GSNO + O2- + H2O → GSSG + 
products  
k10NO = 0.0006 µM-2s-1 (Jourd'Heuil et al., 
1998) 
(4-X) 
N2O3 + GSH → GSNO + NO2- + H+ k11NO = 66 µM-1s-1 (Keshive et al., 1996) (4-XI) 
2NO + O2 → 2NO2 k12aNO = 0.000006 µM-
2s-1
(Czapski and 
Goldstein, 1995) 
(4-XII) 
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NO2 + NO ↔ N2O3 k12bNO+ = 1100 µM-1s-1 
k12bNO- = 81000 s-1
(Czapski and 
Goldstein, 1995) 
(4-XIII) 
N2O3 + H2O → products    k13NO = 1600 s-1 (Licht et al., 1988; 
Czapski and 
Goldstein, 1995) 
(4-XIV) 
GSSG + NADPH + H+ → 2GSH + 
NADP+   
Vm = 320 µMs-1  
Km = 50 µM 
(Antunes et al., 1996) (4-XV) 
          Cu+
GSNO → ½ GSSG + NO 
k14NO = 0.0002 s-1 (Gorren et al., 1996; 
Hofseth et al., 2003) 
(4-XVI) 
CcOx + NO → CcOX.NO k15NO = 100 µM-1s-1  (Sarti et al., 2003) (4-XVII) 
FeLn + NO → FeLnNO                         k16NO = 1.21 µM-1s-1  (Pou et al., 1999) (4-XVIII) 
FeLnNO + GSH → GSNO + FeLn k17NO = 66 µM-1s-1 a  (Afshar et al., 2004) (4-XIX) 
GSH + O2- → ½ GSSG + products k17bNO = 0.0002 µM-1s-1  (Jones et al., 2002) (4-XX) 
a Same as k11NO  
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Table 4. Rate equations for Model 4-A 
Rate laws (Eq.s 4-1 – 4-20) and differential rate equations (Eq.s 4-21 
– 4-29) 
Equation 
numbers 
r1NO = k1NO (4-1) 
r2NO = k2NO (4-2) 
r3NO = k3NO (4-3) 
r4NO = k4NO[NO][O2-] (4-4) 
r5NO = k5NO[SOD][O2-] (4-5) 
r6NO = k6NO[ONOO-][GSH] (4-6) 
r7NO = k7NO[ONOO-][GPX] (4-7) 
r8NO = k8NO[ONOO-][CO2] (4-8) 
r9NO = k9NO[ONOO-][cyt c] (4-9) 
r10NO = k10NO[GSNO]2[O2-] (4-10) 
r11NO = k11NO[N2O3 ][GSH] (4-11) 
r12aNO = k12aNO[NO]2[O2] (4-12) 
r12bNO+ = k12bNO+[NO2][NO] (4-13) 
r12bNO- = k12bNO-[N2O3] (4-14) 
r13NO = k13NO[N2O3] (4-15) 
rm = Vm[GSSG]/(Km+[GSSG]) (4-16) 
r14NO = k14NO[GSNO] (4-17) 
r15NO = k15NO[CcOx][NO] (4-18) 
r16NO = k16NO[FeLn][NO] (4-19) 
r17NO = k17NO[FeLnNO][GSH] (4-20) 
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d[NO]/dt = r1NO – r4NO – 2r12aNO – r12bNO+ + r12bNO- + r14NO –r15NO – r16NO (4-21) 
d[O2-]/dt = r2NO – r4NO – r5NO – r10NO (4-22) 
d[ONOO-]/dt = r4NO – r6NO – r7NO – r8NO – r9NO (4-23) 
d[GSH]/dt = r3NO – r6NO – r11NO + 2rm – r17NO (4-24) 
d[GSNO]/dt = r6NO – 2r10NO + r11NO –r14NO + r17NO (4-25) 
d[N2O3]/dt = – r11NO + r12bNO+ – r12bNO- – r13NO (4-26) 
d[NO2]/dt = 2r12aNO – r12bNO+ + r12bNO- (4-27) 
d[CcOx]/dt = – r15NO (4-28) 
d[FeLn]/dt= – r16NO + r17NO (4-29) 
(*) Note that [FeLnNO] = [FeLn]0 - [FeLn],  and [GSSG] = ([GSH]0 – [GSH] – [GSNO]) / 2 
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Table 5.  Equilibrium levels and initial concentrations used in Model 4-A 
Equilibrium concentrations References 
[SOD]∞ = 10 µM  (Squadrito and Pryor, 1998) 
[GPX]∞ = 5.8 µM  (Antunes et al., 1996) 
[CO2]∞ = 103 µM  (Radi et al., 2000) 
[O2]∞ = 35 µM   (Beckman and Koppenol, 1996) 
[cyt c]∞ = 400 µM  (Antunes et al., 1996) 
Initial concentrations References 
[CcOx]0 = 0.1 µM  (De Visscher et al., 2005) 
[FeLn]0 = 0.05 µM  (Pourzand et al., 1999) 
[GSH]0 = 104 µM (or otherwise specified)  (Hu et al., 2006) 
 
4.2.2 Effects of NO-related reactions on apoptotic pathways (Model 4-B). 
Model 4-B combines Models 3 and 4-A upon inclusion of the additional reactions presented in 
Table 6. See the orange compounds in Figure 2, which are the species that couple the NO 
pathways to apoptotic pathways. We note that ONOO- has a pro-apoptotic effect, while N2O3 and 
FeLnNO (reactions labeled (4-XXIII) – (4-XXV)) deactivate the caspases, thus inducing anti-
apoptotic effects.  The associated rate constants and references are given in Table 6. Table 7 
provides the rate expressions (Eq.s 4-30 – 4-34) and differential rate equations (Eq.s 4-35 – 4-43) 
for these reactions and involved compounds, respectively.  
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The steady-state concentrations [H+]∞ in reaction (4-V), [H2O]∞ in reactions (4-X) and (4-
XIV), [NADPH]∞ and [H+]∞ in reaction (4-XV), [Cu+]∞ in reaction (4-XVI) are incorporated into 
the corresponding rate constants. 
 
Table 6. Reactions bridging between Models 3 to 4-A (*) 
Equilibrium concentrations Rate 
Constant 
Reference Reaction 
index 
ONOO- + PTPC → PTPCact + 
products 
k18NO accounts for ONOO- induced 
formation of non-specific pore 
associated with mitochondrial 
permeability transition (Vieira 
et al., 2001) 
(4-XXI) 
N2O3 + casp8 → casp8.NO + FeLn k19NO  (Wink et al., 1994) (4-XXII) 
FeLnNO + casp8 → casp8.NO + FeLn k20NO  (Kim et al., 2001) (4-XXIII) 
FeLnNO + casp9 → casp9.NO + FeLn k21NO  (Kim et al., 2001) (4-XXIV) 
FeLnNO + casp3 → casp3.NO + FeLn k22NO  (Kim et al., 2001) (4-XXV) 
(*) The parameters used in the present study are k18NO = 1 µM-1s-1 (varying the value between 0.01 µM-1s-1 and 100 
µM-1s-1 does not affect the results), k19NO = 10 µM-1s-1 (Wink et al., 1994), k20NO = k21NO = k22NO = 66 µM-1s-1 (the 
same value as k11NO). PTPC is mitochondrial permeability transition pore complex. 
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Table 7. Modified differential equations from either Model 3 or 4-A 
Rate laws (Eq.s 4-30 – 34) and differential rate equations (Eq.s 4-35 – 43) Equation 
numbers 
r18NO = k18NO[ONOO-][PTPC] (4-30) 
r19NO = k19NO[N2O3][casp8] (4-31) 
r20NO = k20NO[FeLnNO][casp8] (4-32) 
r21NO = k21NO[FeLnNO][casp9] (4-33) 
r22NO = k22NO[FeLnNO][casp3] (4-34) 
d[ONOO-]/dt = r4NO – r6NO – r7NO – r8NO – r9NO – r18NO (4-35) 
d[PTPC]/dt =  – r19NO  (4-36) 
d[N2O3]/dt = – r11NO + r12bNO+ – r12bNO- – r13NO – r19NO (4-37) 
d[casp8]/dt = - J0 + J0f + Jcasp8 – r19NO – r20NO (*) (4-38) 
d[FeLnNO]/dt = r16NO – r17NO – r20NO – r21NO – r22NO (4-39) 
d[FeLn]/dt = – r16NO + r17NO + r20NO + r21NO + r22NO (4-40) 
d[casp9]/dt = J4 –J4b – J5 – J6 +J6f + Jcasp9 – r21NO (*) (4-41) 
d[casp3]/dt = J6f + J6bf – J7 –J8 + J8f – J9 + J9f + Jcasp3 – r22NO (*) (4-42) 
d[cyt c]/dt = J14 – J1 + Jcytc + k[PTPCact][cyt cmit] where k = 1 µM-1s-1 (*) (4-43) 
(*) J refers to fluxes of components, for details see ref (Bagci et al., 2006) and Chapter 3 of this thesis. PTPCact 
refers to the nonspecific pore at the mitochondria that releases cyt c. Note that [PTPCact] = [PTPC]0 – [PTPC]. 
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4.3 RESULTS AND DISCUSSION 
First, we illustrate how different strengths of EC pro-apoptotic signals may result in opposite 
qualitative responses or different quantitative (time-dependent) responses in the same type of 
cells (Tyas et al., 2000), using our recently introduced bistable model (Bagci et al., 2006). Then, 
we examine the differences in the bistable response of diverse NO producing cells, e.g. cells with 
different concentrations of GSH and FeLn - and in different settings, i.e., with or without 
production of superoxide. 
4.3.1 Delay in apoptosis induction (Model 3). 
Tyas et al. (2000) showed that cells of the same type simultaneously subjected to EC stimuli 
initiate their apoptotic response at different times. Figure 16 panels A-C illustrate the theoretical 
time evolutions of casp3 levels in three identical cells subjected to different strengths of EC 
apoptotic stimuli (represented here by the [casp8]0) in the absence of NO. For these simulations, 
we used Model 3 with three different values of [casp8]0; 10-5 µM, 10-4 µM, and 1.5x10-4 µM in 
the respective panels A-C, while [casp3]0 was 10-5 µM in all three cases. Panel A shows that low 
[casp8]0 leads to the depletion of [casp3], while [casp8]0 above a certain threshold (8.35x10-5 
µM) (panels B and C) lead to increase in [casp3] and thereby onset of cell death. Furthermore, 
comparison of panels B and C shows that a relatively lower [casp8]0 (or weaker EC apoptotic 
signal) results in a time-delayed initiation of apoptosis, in agreement with the single cell 
experiments done by Tyas et al. (2000). The sharp increase in [casp3] to its equilibrium level 
indeed starts about 30 minutes later in panel B, compared to panel C.  
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Next, we examined how this onset time varies with [casp8]0. Figure 16D displays the 
results. An increase in onset time is predicted with decreasing [casp8]0 up to [casp8]0 = 8.35x10-5 
µM, after which no apoptotic effect is observed. This value (8.35x10-5 µM) also represents the 
threshold value for [casp8]0 to initiate apoptosis. The time delay is found to obey a logarithmic 
decay with increasing ∆[casp8]0 ≡ [casp8]0 - 8.35x10-5 µM, as indicated by the best fitting curve. 
This analysis shows that cells of the same type may undergo apoptosis at different times 
due to their different EC microenvironments. Hence, the difference in the onset times among 
cells of the same type in a given cell culture may be explained without recourse to alterations in 
the underlying network of biochemical reactions (2006). 
4.3.2 Nitric oxide associated network (Model 4-A). 
The results from our calculations using Model 4-A are shown in Figure 17. Here, we focused on 
the time evolution of four compounds, GSH, N2O3, FeLnNO and ONOO-, displayed in respective 
panels A-D.  The NO species N2O3, FeLnNO and ONOO- have been proposed to carry out 
various indirect effects of NO on cellular pathways, including apoptosis, during inflammation 
(Wink et al., 1999).  
GSH is an anti-oxidant reduced to GSSG by reacting with nitrosative N2O3 and FeLnNO, 
and with oxidative ONOO- (Table 3). GSH is depleted to low levels in a switch-like manner due 
to those reactions (panel A). The depletion of GSH is accompanied by increases in N2O3 and 
FeLnNO concentrations (panels B-C). On the other hand, this switch-like behavior is not that 
pronounced in [ONOO-] time dependence (panel D). Simulations performed with different initial 
GSH concentrations (three different curves in each panel) change the steady-state concentrations 
of all three NO-related compounds that interfere with apoptotic pathways (panels B-D). The 
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switch-like increase in [N2O3] and non-switch-like increase in [ONOO-] is in agreement with the 
results of Hu et al. (2006). 
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Figure 16.  Time evolution of [casp3] predicted by the bistable Model 3 in response to different strengths of 
apoptotic stimuli, A) in a cell subjected to a weak EC apoptotic signal (reflected by the low concentration [caps8]0); 
B) in a cell that is subjected to a stronger EC pro-apoptotic signal. Caspase-3 is activated at 60 minutes; C) in a cell 
that is subjected to a stronger EC pro-apoptotic signal than one in panel B. Caspase-3 is activated at 30 minutes. 
Panels A and B illustrate two opposite effects induced by different initial concentrations of caspase-8. The threshold 
concentration [caps8]0 required for the switch from anti-apoptotic to pro-apoptotic response is calculated to be 
8.35x10-5 µM. Panels B and C illustrate the shift in the onset time of apoptosis depending on [caps8]0. D) 
Dependence of apoptotic response time on the initial caspase-8 concentration. The ordinate is the onset time of 
caspase-3 activation, and  the abscissa is the initial concentration of caspase-8 in excess of the threshold 
concentration required for the initiation of apoptosis (evidenced by increase in [casp3], see panels B-C). The onset 
time of caspase-3 activation exhibits a logarithmic decrease with ∆[casp8]0 ([casp8]0 – 8.35x10-5 µM).  
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4.3.3 Anti-apoptotic and pro-apoptotic effects of NO (Model 4-B). 
We analyze here the dynamics of the mitochondria-dependent apoptosis model coupled to anti- 
and pro-apoptotic pathways associated with NO; see Table 6 for the list of new 
reactions/interactions/steps that come into play in this model (4-B). As mentioned above, NO-
related pathways are coupled to apoptotic pathways through N2O3, FeLnNO, and ONOO- that are 
produced by the reaction of NO with O2, FeLn and O2-, respectively. For simplicity, those effects 
of NO mediated by cGMP (Kim et al., 2001b; Kim et al., 1997) are not included in our 
mathematical model. 
 
4.3.3.1. Modulating roles of N2O3 and GSH in apoptosis 
We initially excluded non-heme iron compounds in order to assess the effect of N2O3 
exclusively. The production rate of superoxide was likewise assumed to be zero. N2O3 is 
produced by reactions (4-XXII) and (4-XIII) in Table 3.  NO production and EC stimulation were 
initiated simultaneously. Figures 18A-C are the counterparts of Figures 16A-C, respectively 
(same initial conditions, except for the interference of NO pathways through N2O3), where the 
time-dependence of [casp3] (solid curve) and [GSH] are shown. The bistable response to 
apoptotic stimuli, dependent on [casp8]0, is shown to be maintained despite the interference of 
NO pathways through N2O3. The three columns refer to different initial concentrations of GSH, 
decreasing from [GSH]0 = 103 (Panels A-C), to [GSH]0 = 102 (panels D-F) and GSH]0 = 0 
(panels G-I). The threshold [casp8]0 value for casp3 activation was 8.35x10-5 µM in Figure 16, 
where NO was not produced at all. This value remains the same for both [GSH]0 = 104 µM (not 
shown) and 103 µM (panels A-C) in the presence of NO, but increases to 9.9 x10-5 µM when 
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[GSH]0 is 102 µM (panels D-F) and to 1.26 x10-4 µM when [GSH]0 is zero (panels G-I), hence 
the different (pro-apoptotic) behavior observed in panel H. 
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Figure 17. Time evolution of A) GSH, B) N2O3, C) FeLnNO, and D) ONOO- concentrations predicted by Model 4-
A. N2O3 and FeLnNO increase to high concentrations by a switch-like mechanism induced by a decrease in [GSH] 
due to conversion of GSH to GSNO and subsequently to GSSG.  [ONOO-] does not follow a similar switch-like 
increase in its concentration. Solid curve is for [GSH]0 = 104 µM, dotted curve for [GSH]0 = 103 µM, and dashed 
curve with diamonds for [GSH]0 = 102 µM. The response is thus sharper and earlier in the presence of lower initial 
concentrations of GSH. 
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 These results suggest that N2O3 does not affect the bistable character of the response to 
EC stimuli, except for modifying the threshold for onset of apoptosis, which is shifted to higher 
[casp8]0 (i.e. rendered more difficult) with decreasing [GSH]0. However, high initial 
concentrations of GSH restore the threshold back to 8.35x10-5 µM. Therefore, N2O3 can serve as 
an effective modulator of apoptosis provided that the level of GSH in the system is sufficiently 
low. 
 
4.3.3.2. How does N2O3 affect the threshold degradation rates of Bax for transition from 
bistable to monostable behavior? 
In our computational study of apoptotic pathways, we observe a bistable behavior (selecting 
between cell death and survival) for degradation rates of Bax (µBax) lower than a threshold value 
(0.11 s-1), while monostable cell survival was predicted when µBax > 0.11 s-1 (Figure 12A). This 
critical value of µBax for the transition from bistability to monostability is called a limit point. We 
explored how the inclusion of NO reactions affects these findings. The limit point value of the 
Bax degradation rate for monostable cell survival is found to remain unchanged (at 0.11 s-1) for 
the range 103 ≤ [GSH]0 ≤ 104 µM. However, it decreases to 0.098 s-1 for [GSH]0 = 102 µM and 
0.096 s-1 for [GSH]0 = 0 µM in the present model. The model again predicts that N2O3 is not 
influential when the GSH level is sufficiently high in the cell. 
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Figure 18. Time evolution of [GSH] and [casp3] predicted by Model 4-B in the presence of N2O3 effects.  Here, in 
order to visualize the effect of N2O3 exclusively, the reaction (4-XXII) in Table 6 is included in the model while 
those involving FeLnNO and ONOO- (reactions (4-XX,4-XXIII-XXV) are not, assuming FeLn concentration and rate 
of formation of superoxide to be zero. The solid curves depict the time evolution of [casp3], and dotted curves refer 
to [GSH].  The three rows of panels are the counterparts of those in Figure 16A-C, with the different columns 
referring to different initial concentrations of GSH:  A-C) [GSH]0 = 103 µM; D-F) [GSH]0 = 102 µM; G-I) [GSH]0 = 
0 µM. 
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4.3.3.3. Roles of non-heme iron complexes and GSH in apoptotic response. 
One of the important anti-apoptotic effects of NO is presumed to occur via its ability to react 
with non-heme iron complexes (FeLn) to form FeLnNO. These species inhibit caspases by S-
nitrosating the catalytic cysteine in the active site of these enzymes (Li et al., 1997; Mannick et 
al., 1999; Rossig et al., 1999). 
The results are presented in Figure 19, panels A-F, organized similarly to Figure 18 (i.e. 
using different [casp8]0 in each row, and different [GSH]0 in the two columns). Our calculations 
suggest that when the FeLn concentration is higher than 0.03 µM, there are no longer two stable 
steady-states at long times: casp3 levels always decrease to zero, even though their time 
evolutions depend on [casp8]0 and [GSH]0. Yet, depending on the level of GSH, both apoptosis 
and cell survival may be possible. Panels A-C correspond to relatively high [GSH]0.  In panel A, 
[casp3] decreases to 10-8 µM that is less than 1 molecule per cell, hence zero, from 10-5 µM 
within the first two hours. However, in panels B and C, [casp3] increases to nanomolar values 
and remains at those levels for more than three hours. Caspase-3 may cause enough damage to 
kill the cell before it is depleted at longer times. We note that lower [GSH]0 (e.g. [GSH]0 = 103 
µM, panels D-F and [GSH]0 < 103 µM, data not shown) do not permit the casp3 concentration to 
reach such pro-apoptotic levels and monostable cell survival is observed irrespective of [casp8]0. 
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 k2NO (prod. rate of O2-) = 0,  [FeLn]0 = 0.05 µM,  [O2] = 35 µM 
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Figure 19. Time evolution of [GSH] and [casp3] predicted by Model 4-B in the presence of N2O3 and FeLnNO. 
N2O3 is present in the model ([O2] is non-zero) as well as FeLnNO ([FeLn]0 is non-zero). Each column is a 
counterpart of Figure 16A-C with different initial concentrations of GSH. A-C) [GSH]0 = 104 µM; D-F) [GSH]0 = 
103 µM. Solid curve shows the time evolution of [casp3], and dotted curve that of [GSH]. 
 
 
 
 
 92 
Various cell types subject to different intracellular microenvironments, or even the same 
cells under different settings (e.g. healthy state vs. inflammation or oxidative stress), may 
produce or experience different reactive NO intermediates (Stamler, 1994; Vodovotz et al., 2004; 
Wink et al., 1999). For example, more FeLnNO may be produced in hepatocytes than in 
RAW264.7 macrophage-like cells due to the high level of non-heme iron complexes in 
hepatocytes (Kim et al., 2000). In a previous study, RAW264.7 cells underwent apoptosis in the 
presence of NO; conversely, no casp3 activation was observed in either hepatocytes or iron 
loaded RAW 264.7 cells (Kim et al., 2000).  The results  (Figure 18 and data not shown) 
suggests that in cells with iron concentrations lower than 0.03 µM (e.g. RAW264.7 cells), both 
cell survival and apoptosis are possible depending on the strength of apoptotic stimuli (in 
agreement with our experimental results) (Kim et al., 2000). However, a change in the 
intracellular environment of the same cell can change the response. Figure 19D-F shows that 
casp3 is not activated in the presence of non-heme iron ([FeLn]0 = 0.05 µM) when [GSH]0 = 103 
µM and [GSH]0 < 103 µM (data not shown). We also checked if casp3 is activated when [casp8]0 
is as high as 0.1 µM when [GSH] =103 µM. In this case, caspase-3 concentration increased to 
0.0007 µM for approximately 5 minutes, an apoptotic stimulus that is likely insufficient for 
apoptosis. This prediction is in good agreement with the observation that caspase-3 is not 
activated in non-heme iron-loaded RAW264.7 cells whose [GSH]0 does not reach 104 µM (Kim 
et al., 2000).  
 
4.3.3.4. Roles of ONOO- and GSH in apoptotic response 
The mechanism by which NO or its reactive species exert pro-apoptotic effects is not well 
established (Benhar and Stamler, 2005). In the present study, we assume that the pro-apoptotic 
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effect of NO occurs via formation of ONOO-, as has been suggested from a large number of 
experimental studies both in vitro and in vivo (Ghafourifar et al., 2005; Radi et al., 2002). 
Experimental studies suggest that ONOO- may induce the opening of mitochondrial permeability 
transition pores (MPTPs) and subsequent cyt c release from mitochondria (Kim et al., 2001). 
 The possible mechanisms of cyt c release from mitochondria are diverse and 
controversial (Nakagawa et al., 2005; Newmeyer and Ferguson-Miller, 2003). In our model, we 
assume that cyt c release is mediated by activation of MPTPs, independent of Bax channel 
formation on mitochondria. The complex that forms the MPTPs is called mitochondrial 
permeability transition pore complex (PTPC). The complex consists of peripheral 
benzodiazepine receptor, cyclophilin D, adenine nucleotide translocator (ANT), voltage-
dependent anion channel (VDAC), and other proteins (Vieira et al., 2000). ANT is proposed to 
be converted from a specific transporter to a non-specific pore which then releases cyt c into the 
cytoplasm and subsequently induces apoptosis. It has been suggested that ONOO- acts on PTPC, 
specifically on ANT, to convert it to a non-specific pore (PTPCact) (Vieira et al., 2001). We 
represent this process as: 
 ONOO- + PTPC → PTPCact + products    (4-XXVI) 
 Cytochrome c is then released from the pore formed by PTPCact
 cyt cmito + PTPCact → cyt c + PTPCact    (4-XXVII) 
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k2NO (prod. rate of O2-) = 0.1 µM/s,   [FeLn]0 = 0.05 µM 
[O2] = 35 µM,   [PTPC]0 = 0.01 µM 
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Figure 20. Time evolutions of [GSH] and [casp3] predicted by Model 4-B in the presence of N2O3, FeLnNO and 
ONOO-.  The initial concentration of PTPC is 0.01 µM. Each column is a counterpart of Figure 16A-C and has a 
different initial concentration for GSH. A-C) [GSH]0 = 104 µM; D-F) [GSH]0 = 103 µM. Solid curve is for time 
evolution of [casp3], and dashed curve for time evolution of [GSH]. Caspase-3 concentrations at long times are 2.4 
x10-4 µM and 2.5x10-8 µM for panels A-C and D-F, respectively. 
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 The results are shown in Figure 20. The initial concentration of PTPC is assumed to be 
high (0.01 µM). At that value, Model 3 predicts the response to apoptotic stimuli to be 
monostable apoptosis (Figure 13). We see a similar response in Figure 20A; a low initial value of 
casp8 (10-5 µM) results in an increase of [casp3] to nanomolar levels. Casp3 activation was 
observed with even lower values of [casp8]0.  However, casp3 does not reach nanomolar 
concentrations when [GSH]0 = 103 µM (Figures 20D-F) and  [GSH]0 < 103 µM (data not shown).  
Initial concentrations [casp8]0 higher than 1.5x10-4 µM did not change this prediction. 
These results suggest that in cells with large numbers of MPTPs (probably with high 
numbers of mitochondria), there are two possible outcomes in the presence of NO and O2- 
production: pathological cell death when GSH level is high (104 µM) and solely cell survival 
when GSH level is low ([GSH] ≤ 103 µM) in the presence of O2 and FeLn. This result stands in 
contrast with studies in which GSH protects against oxidative stress (high concentrations of O2- 
and ONOO-) that can cause apoptosis. The reason for this paradoxical prediction is that GSH has 
both protective and pro-apoptotic effects: it has apoptotic effects due to its reaction with anti-
apoptotic N2O3 and FeLn, and protective effects due to its reaction with pro-apoptotic O2- and 
ONOO-. Simulations (Figure 20) suggest that the pro-apoptotic effect of GSH is stronger than its 
protective effect using the interactions and parameters adopted in current simulations. 
 To examine the possibility of an alternative response, we repeated the computations 
depicted in Figure 20 in the absence of O2 (so that N2O3 is not produced) and FeLn. We also used 
initial PTPC concentration of 0.0001 µM, at which Model 3 predicts bistability (Figure 13). As 
seen in Figure 21, both cell survival and apoptosis are possible under these conditions, depending 
on [casp8]0. Higher [GSH]0 (104 µM) results in cell survival (Figure 21B) in contrast to lower 
[GSH]0 resulting in apoptosis (Figure 21E) under the same amount of EC stimulus ([casp8]0 = 
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7x10-5 µM). The present analysis thus shows that the protection by GSH against oxidative stress 
is possible provided that O2 and FeLn levels are sufficiently low. 
 
k2NO (prod. rate of O2-) = 0.1 µM/s,     [FeLn]0 = 0 µM 
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Figure 21. Time evolutions of [GSH] and [casp3] predicted by Model 4-B in the absence of N2O3, FeLnNO and 
presence of ONOO-. The initial concentration of PTPC is 0.0001 µM. A-C) [GSH]0 = 104 µM; D-F) [GSH]0 = 102 
µM. Solid and dashed curves refer to the time evolutions of [casp3] and [GSH], respectively. 
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5.0  CONCLUSION 
 
5.1 INSIGHTS ON APOPTOSIS FROM MATHEMATICAL MODELING AND 
SIMULATIONS AND RELEVANT EXPERIMENTAL DATA 
In the present study, the cooperative formation of heptameric apoptosome complex is proposed 
to be an important mechanism for the bistable behavior (survival or apoptosis) of cells in 
response to apoptotic stimuli.  
To gain a better understanding of the role of different components in regulating 
apoptosis, we examined the effects of Bax, Bcl-2, and MPTP levels on the time evolution of 
mitochondria-dependent apoptotic events, and show that there are subtle changes from 
monostable to bistable response, which may also be counteracted, depending on the relative 
concentrations of these components.  
We concentrated on two positive feedback loops in particular, which are suggested to 
play an important role in ensuring bistability (Angeli et al., 2004). The former is initiated by the 
cleavage/inhibition of Bcl-2,  and the latter by the truncation of Bid to tBid, both by the 
executioner caspase-3 (Cherry and Adler, 2000; Ferrell and Xiong, 2001; Ferrell, 2002; Xiong 
and Ferrell, 2003). 
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Several conclusions with possible biomedical implications are inferred from the present 
analysis:  
• There are critical values for the minimal synthesis rate or maximal degradation rate of 
Bax, a pro-apoptotic protein,  beyond which cells will switch from bistable behavior to a 
monostable cell survival. This result is in accord with observations suggesting that human 
prostate cancer cells might use Bax degradation as a survival mechanism (Li and Dou, 
2000). Our results are also consistent with the observed decreases in Bax expression 
levels in primary human breast tumors (Schorr et al., 1999).  
• Bcl-2 can counteract the pro-apoptotic effect of Bax to result in monostable cell survival, 
in line with the over-expression of Bcl-2 in many types of tumors (Reed, 1999) and the 
known role of Bcl-2 in countering the effects of Bax (Danial and Korsmeyer, 2004).  
• The extent of MPTP may result in a diversity of responses, ranging from monostable cell 
survival, to bistable behavior, or monostable apoptosis. As shown in Fig.13, an increase 
in mitochondrial permeability transition pore complex concentration ([PTPC]) converts 
monostable cell survival response into a bistable response. The figure also shows that 
high [PTPC] can lead to pathological cell death, in accord with the role of MPTPs in 
pathological cell death suggested by Green and Kroemer (Green and Kroemer, 2004).  
• The inhibition of Bax degradation can induce apoptosis. This result is in agreement with 
the observation of Li and Dou (2000).  
• Our model predictions are in quantitative agreement with the experimental data reported 
by Katiyar et al. (2005) where p53 was induced by silymarin which activates casp3.  The 
concentrations of cyt c and Bax are shown in both analyses to increase with the increases 
in p53 levels, while that of Bcl-2 would decrease.  
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Taken together, our results suggest that there might be a transition from bistable to 
monostable behavior depending on the apoptotic stimuli and/or concentrations of particular 
compounds.  The changes in synthesis and degradation rates of Bax and Bcl-2 and in the number 
of MPTPs may have a role in leading to aberrant phenotypes such as cancer, and 
neurodegenerative disorders (Fadeel et al., 1999). 
5.2 SUMMARY OF NO EFFECTS ON APOPTOSIS, AND RELEVANT 
EXPERIMENTAL DATA 
We presented here the results from simulations that incorporate the main chemical interactions of 
NO with components of the apoptotic interactions network, with the goal of shedding light on the 
dichotomous effects of NO on apoptosis.  Based on previously published studies, we considered 
N2O3 and FeLnNO to be anti-apoptotic and ONOO- pro-apoptotic. The results predict that cell 
survival or apoptosis is determined by a complex interplay among these reactive NO species and 
GSH. We observed that relative concentrations of anti-apoptotic and pro-apoptotic species 
determine the anti- or pro-apoptotic effects at long times. Interestingly, transient apoptotic effects 
were observed under specific conditions (e.g. Figure 19 panels B-C). These intriguing findings 
point to the importance of the timing of NO production and apoptotic stimuli in determining the 
actual anti- or pro-apoptotic response, even if steady state conditions favor cell survival. Another 
interesting effect we observed in our simulations was the time shift/delay in the onset of 
apoptosis in the presence of weak EC stimulus (panel B-D in Figure 16), consistent with the 
experiments of Tyas et al. (2000).  
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Our simulations suggest that N2O3 and non-heme iron nitrosyl form in a switch-like 
manner after depletion of GSH. ONOO- formation, on the other hand, hardly shows any switch-
like behavior. We further found that N2O3 does not eliminate the bistability between cell survival 
and apoptosis, but rather increases the threshold [casp8]0 for onset of apoptosis. However, high 
initial concentrations of GSH restore the threshold back to its original value. Therefore, we 
would predict, non-intuitively, that N2O3 does not influence cell survival when [GSH]0 level is 
high.  
On the other hand, our simulations suggest that there are no longer two stable steady 
states (cell survival and apoptosis) in the presence of non-heme iron at a level higher than a 
threshold value. Caspase-3 levels always decrease to zero even though their time evolution may 
depend on [casp8]0 and [GSH]0. Yet, despite the steady state conditions that favor cell survival, 
executioner caspase concentrations can reach and retain apoptotic levels for several hours before 
they level off, when [GSH]0 is high. When [GSH]0 is low, on the other hand, our simulations 
predict resistance to apoptosis, in agreement with experimental observation (Wink et al., 1999). 
In cells with high numbers of MPTPs (probably cells that contain high numbers of 
mitochondria), our simulations suggest two possibilities in the presence of simultaneous NO and 
O2- production and sufficiently high [FeLn]0: pathological cell death when [GSH]0 is high (104 
µM) or solely cell survival when [GSH]0 level is low ([GSH]0 ≤ 103 µM). On the other hand, 
GSH is protective against oxidative stress when O2 and FeLn levels are low in cells with low 
numbers of MPTPs. 
Recent experimental data by Billiar and coworkers demonstrated that GSH depletion 
renders hepatocytes sensitive to NO-mediated toxicity (Chen et al., 2005). These experiments 
also showed that hypoxia causes hepatocytes to be susceptible to cell death by NO (Kim et al., 
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2005). These data point to the complexity of NO-related reactions network in agreement with the 
present computational study. We note that our experimental studies suggested that treatment with 
NO in the setting of GSH depletion or hypoxia led to death by necrosis; nonetheless, it is still 
possible that other types of cells than hepatocytes may react to these changes in apoptosis. In our 
experimental results on hepatocytes (Chen et al., 2005; Kim et al., 2005), the levels of ATP were 
decreased. This decrease might have prevented apoptosis, which requires ATP, and switched the 
cellular death of cells to necrosis (Nicotera et al., 1998).  
5.3 LIMITATIONS AND FUTURE DIRECTIONS 
Our results are subject to several limitations. While we have adopted values for kinetic 
parameters and concentrations in accord with experimental data whenever available, many of the 
true intracellular rate constants for the reactions in our simulations are unknown. Given that the 
observed apoptotic responses are so sensitive to model parameters, detailed knowledge of 
reaction mechanisms and accurate values of rate constants are needed in modeling reaction 
networks as complicated as the ones presented here.  
Additionally, the hypotheses raised by our simulations remain to be tested by further 
experiments. Some of the predictions could be tested by iron chelation and/or treatment with 
superoxide donors in a cell-free system or in single-cell studies, though each of these 
manipulations may have additional, artifactual effects. The hypothesis of bistability with regards 
to the apoptotic response can be tested as suggested by Legewie et al. (2006), either in cell free-
systems by adding casp3 or in single living cells by microinjecting casp3. The time evolution of 
casp3 can be monitored by fluorescent casp3 substrates. The time needed for casp3 activation 
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will increase abruptly as casp3 concentration added will approach threshold value in a bistable 
system (Figure 16D). Our study does not consider NO-induced cGMP production which 
regulates many important biological processes along with apoptosis. The present model that 
combines apoptotic pathways with NO-related reactions can thus be extended to incorporate the 
effect of NO on apoptosis mediated by cGMP. Such combined experimental and computational 
studies may potentially help us understand and design therapeutics for diseases associated with 
apoptosis dysregulation. 
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APPENDIX A 
 
A.1 SCRIPTS USED IN THE CALCULATIONS 
A.1.1 Script used in Figure 4 
# figure4.ode 
# REACTIONS 
# 2cc -> c3                  k1 
# c3 + ccm -> c3 + cc        k2 
# ODE'S 
c3'=k1*cc^2-muc3*c3 
cc'=-2*k1*cc^2+k2*c3*ccm-mucc*cc 
ccm'=om-k2*c3*ccm-muccm*ccm 
# PARAMETERS 
par k1=2,k2=2,om=0.0003,muc3=0.006,mucc=0.006,muccm=0.006 
# INITIAL CONDITIONS 
init cc=0,c3=0.001 
# DISPLAY 
@ xlo=0,xhi=4,ylo=0,yhi=2 
@ nplot=1,yp=c3 
# METHOD 
@ meth=cvode,atol=1e-10,tol=1e-11,total=2000,dt=0.1,bounds=1000 
done 
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A.1.2 Scripts used in Figure 10 
# figure10A.ode 
# REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
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# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
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r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=0.0001*a6*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=0.0001*a7*(1+p53^4/(p53^4+p53thresh^4))-mu*bax 
jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
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cc'=j14-j1-mu*cc+mptp*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a 
c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
# PARAMETERS 
par MPTP=0 
par nop=0 
par tbid0=0 
par p53=0.0066 
par p=4 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
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par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a6=0.8,a7=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
# INITIAL CONDITIONS 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00,IAP3=0 
init IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.00001,c3B=0,c3L=0 
init c8a=0.00001,c8B=0 
init cc=0,ccmito=.004 
# DISPLAY 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=1,yp=c3a 
# METHOD 
@ meth=cvode,atol=1e-8,tol=1e-9,total=200000,dt=5,bounds=100000 
done 
****************************************************************************** 
# figure10B.ode 
# REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
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# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
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r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
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j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=0.0001*a6*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=0.0001*a7*(1+p53^4/(p53^4+p53thresh^4))-mu*bax 
jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a 
c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp*ccmito 
bax2'=j12b-mu*bax2 
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tbidmito'=j11-j12a-mu*tbidmito 
# INITIAL CONDITIONS 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00,IAP3=0 
init IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.00001,c3B=0,c3L=0 
init c8a=0.0001,c8B=0 
init cc=0,ccmito=.004 
# PARAMETERS 
par MPTP=0 
par nop=0 
par tbid0=0 
par p53=0.0066 
par p=4 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a6=0.8,a7=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
# display 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=1,yp=c3a 
# METHOD 
@ meth=cvode,atol=1e-8,tol=1e-9,total=200000,dt=5,bounds=100000 
done 
****************************************************************************** 
 
# figure10C.ode 
# REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
 113 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
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# Bax2 + Ccmito -> Cc + Bax2  k14 
# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
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J2=r2p-r2m 
J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=0.0001*a6*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=0.0001*a7*(1+p53^4/(p53^4+p53thresh^4))-mu*bax 
jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
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c9a'=J4+J4b-J5-J6+J6f-mu*c9a 
c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
# INITIAL CONDITIONS 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00,IAP3=0 
init IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.00001,c3B=0,c3L=0 
init c8a=0.00001,c8B=0 
init cc=0,ccmito=.004 
# PARAMETERS 
par p=1 
par MPTP=0 
par nop=0 
par tbid0=0 
par p53=0.0066 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
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par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a6=0.8,a7=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
# DISPLAY 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=1,yp=c3a 
# METHOD 
@ meth=cvode,atol=1e-8,tol=1e-9,total=200000,dt=5,bounds=100000 
done 
A.1.3 Scripts used in Figure 11 
# figure11A.ode 
# REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
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# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
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r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
 120 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=0.0001*a6*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=0.0001*a7*(1+p53^4/(p53^4+p53thresh^4))-mubax*bax 
jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a 
c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
# PARAMETERS 
par mubax=0.001 
par MPTP=0 
par nop=0 
par tbid0=0 
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par p53=0.0066 
par p=4 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a6=0.8,a7=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
# INITIAL CONDITIONS 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00 
init IAP3=0,IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.004,c3B=0,c3L=0 
init c8a=0.0000,c8B=0 
init cc=0,ccmito=.004 
# DISPLAY 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=1,yp=c3a 
# METHOD 
@ meth=cvode,atol=1e-8,tol=1e-9,total=200000,dt=5,bounds=100000 
done 
****************************************************************************** 
 
# figure11B.ode 
# REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
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# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
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r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
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J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=0.0001*a6*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=0.0001*a7*(1+p53^4/(p53^4+p53thresh^4))-mubax*bax 
jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a 
c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
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IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
# PARAMETERS 
par mubax=0.2 
par MPTP=0 
par nop=0 
par tbid0=0 
par p53=0.0066 
par p=4 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a6=0.8,a7=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
# INITIAL CONDITIONS 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00 
init IAP3=0,IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.1,c3B=0,c3L=0 
init c8a=0.1,c8B=0 
init cc=0,ccmito=.004 
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# DISPLAY 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=1,yp=c3a 
# METHOD 
@ meth=cvode,atol=1e-8,tol=1e-9,total=200000,dt=5,bounds=100000 
done 
****************************************************************************** 
 
# figure11C.ode 
# REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
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# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
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r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
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jbcl2p=0.0001*a6*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=ombax*(1+p53^4/(p53^4+p53thresh^4))-mu*bax 
jccmito=0.0001*a8-mu*ccmito 
#ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a 
c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
# PARAMETERS 
par ombax=0.000024 
par MPTP=0 
par nop=0 
par tbid0=0 
par p53=0.0066 
par p=4 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
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par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a6=0.8,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
# INITIAL CONDITIONS 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00 
init IAP3=0,IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.004,c3B=0,c3L=0 
init c8a=0.00005,c8B=0 
init cc=0,ccmito=.004 
# DISPLAY 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=1,yp=c3a 
# METHOD 
@ meth=cvode,atol=1e-8,tol=1e-9,total=200000,dt=5,bounds=100000 
done 
A.1.4 Scripts used in Figure 12 
# figure12A-point00008.ode 
# REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
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# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
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r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
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J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=0.0001*a6*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=0.0001*a7*(1+p53^4/(p53^4+p53thresh^4))-mubax*bax 
jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a 
c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
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cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
# PARAMETERS 
par p=4 
par mubax=0.001 
par MPTP=0 
par nop=0 
par tbid0=0 
par p53=0.0066 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a6=0.8,a7=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
# INITIAL CONDITIONS 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00 
init IAP3=0,IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.004,c3B=0,c3L=0 
init c8a=0.0000,c8B=0 
init cc=0,ccmito=.004 
# DISPLAY 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=1,yp=c3a 
# METHOD 
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@ meth=cvode,atol=1e-8,tol=1e-9,total=200000,dt=5,bounds=100000 
done 
****************************************************************************** 
 
# figure12A-point00032.ode 
# REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
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# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
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r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=ombcl2*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=0.0001*a7*(1+p53^4/(p53^4+p53thresh^4))-mubax*bax 
jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
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bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a 
c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
# PARAMETERS 
par mubax=0.001 
par MPTP=0 
par nop=0 
par tbid0=0 
par p53=0.0066 
par ombcl2=0.00032 
par p=4 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
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par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a7=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
# INITIAL CONDITIONS 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00 
init IAP3=0,IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.1,c3B=0,c3L=0 
init c8a=0.0000,c8B=0 
init cc=0,ccmito=.004 
# DISPLAY 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=1,yp=c3a 
# METHOD 
@ meth=cvode,atol=1e-8,tol=1e-9,total=200000,dt=5,bounds=100000 
done 
****************************************************************************** 
 
# figure12A-point0008.ode 
# REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
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# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
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r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
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J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=ombcl2*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=0.0001*a7*(1+p53^4/(p53^4+p53thresh^4))-mubax*bax 
jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a 
c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
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c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
# PARAMETERS 
par mubax=0.001 
par MPTP=0 
par nop=0 
par tbid0=0 
par p53=0.0066 
par ombcl2=0.0008 
par p=4 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a7=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
# INITIAL CONDITIONS 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00 
init IAP3=0,IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.1,c3B=0,c3L=0 
init c8a=0.0000,c8B=0 
init cc=0,ccmito=.004 
# DISPLAY 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=1,yp=c3a 
# METHOD 
@ meth=cvode,atol=1e-8,tol=1e-9,total=200000,dt=5,bounds=100000 
done 
****************************************************************************** 
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# figure12B-point00008.ode 
# REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
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# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
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r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=0.0001*a6*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=ombax*(1+p53^4/(p53^4+p53thresh^4))-mu*bax 
jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a 
AP'=-J1+JAp 
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CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a 
c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
# PARAMETERS 
par ombax=0.000024 
par MPTP=0 
par nop=0 
par tbid0=0 
par p53=0.0066 
par p=4 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
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par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a6=0.8,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
# INITIAL CONDITIONS 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00 
init IAP3=0,IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.004,c3B=0,c3L=0 
init c8a=0.00005,c8B=0 
init cc=0,ccmito=.004 
# DISPLAY 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=1,yp=c3a 
# METHOD 
@ meth=cvode,atol=1e-8,tol=1e-9,total=200000,dt=5,bounds=100000 
done 
****************************************************************************** 
# figure12B-point00032.ode 
# REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
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# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
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r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
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j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=ombcl2*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=ombax*(1+p53^4/(p53^4+p53thresh^4))-mu*bax 
jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a 
c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
# PARAMETERS 
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par ombax=0.000024 
par MPTP=0 
par nop=0 
par tbid0=0 
par p53=0.0066 
par ombcl2=0.00032 
par p=4 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
# INITIAL CONDITIONS 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00 
init IAP3=0,IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.004,c3B=0,c3L=0 
init c8a=0.00005,c8B=0 
init cc=0,ccmito=.004 
# DISPLAY 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=1,yp=c3a 
# METHOD 
@ meth=cvode,atol=1e-8,tol=1e-9,total=200000,dt=5,bounds=100000 
done 
****************************************************************************** 
# figure12B-point0008.ode 
# REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
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# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
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# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
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J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=ombcl2*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=ombax*(1+p53^4/(p53^4+p53thresh^4))-mu*bax 
jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a 
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c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
# PARAMETERS 
par ombax=0.000024 
par MPTP=0 
par nop=0 
par tbid0=0 
par p53=0.0066 
par ombcl2=0.0008 
par p=4 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
# INITIAL CONDITIONS 
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init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00 
init IAP3=0,IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.04,c3B=0,c3L=0 
init c8a=0.00005,c8B=0 
init cc=0,ccmito=.004 
# DISPLAY 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=1,yp=c3a 
# METHOD 
@ meth=cvode,atol=1e-8,tol=1e-9,total=200000,dt=5,bounds=100000 
done 
A.1.5 Script used in Figure 13 
# figure13.ode 
# REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
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# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
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r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
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# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=0.0001*a6*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=0.0001*a7*(1+p53^4/(p53^4+p53thresh^4))-mu*bax 
jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a 
c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
# PARAMETERS 
par MPTP=0.01 
par nop=0 
par tbid0=0 
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par p53=0.0022 
par p=4 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a6=0.8,a7=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
# INITIAL CONDITIONS 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00 
init IAP3=0,IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.04,c3B=0,c3L=0 
init c8a=0.0000,c8B=0 
init cc=0,ccmito=.004 
# DISPLAY 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=1,yp=c3a 
# METHOD 
@ meth=cvode,atol=1e-8,tol=1e-9,total=200000,dt=5,bounds=100000 
done 
A.1.6 Scripts used in Figure 14 
# figure14-point00032-withinh.ode 
#REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
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# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
# FUNCTION 
mubax(t)=if(t<1200)then(0.1-t*5*10^(-5))else(0.04) 
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# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
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J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=ombcl2*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=0.0001*a7*(1+p53^4/(p53^4+p53thresh^4))-mubax(t)*bax 
jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a 
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c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
# PARAMETERS 
par MPTP=0 
par nop=0 
par tbid0=0 
par p53=0.0066 
par ombcl2=0.00032 
par p=4 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a7=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
# INITIAL CONDITIONS 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
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init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00 
init IAP3=0,IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.1,c3B=0,c3L=0 
init c8a=0.1,c8B=0 
init cc=0,ccmito=.004 
# DISPLAY 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=2,yp=c3a,yp2=Cc 
# METHOD 
@ meth=cvode,atol=1e-8,tol=1e-9,total=200000,dt=5,bounds=100000 
done 
****************************************************************************** 
# figure14-point00032-withoutinh.ode 
# REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
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# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
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r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
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Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=ombcl2*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=0.0001*a7*(1+p53^4/(p53^4+p53thresh^4))-mubax*bax 
jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a 
c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
# PARAMETERS 
par mubax=0.1 
par MPTP=0 
par nop=0 
par tbid0=0 
par p53=0.0066 
par ombcl2=0.00032 
par p=4 
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par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a7=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
# INITIAL CONDITIONS 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00 
init IAP3=0,IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.1,c3B=0,c3L=0 
init c8a=0.1,c8B=0 
init cc=0,ccmito=.004 
# DISPLAY 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=2,yp=c3a,yp2=Cc 
# METHOD 
@ meth=cvode,atol=1e-8,tol=1e-9,total=200000,dt=5,bounds=100000 
done 
A.1.7 Scripts used in Figure 15 
# figure15-p53-0022.ode 
# REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
 171 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
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r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
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J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=0.0001*a6*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=0.0001*a7*(1+p53^4/(p53^4+p53thresh^4))-mu*bax 
jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a 
c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
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IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
# PARAMETERS 
par MPTP=0 
par nop=0 
par tbid0=0 
par p53=0.0022 
par p=4 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a6=0.8,a7=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
# INITIAL CONDITIONS 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00,IAP3=0 
init IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.04,c3B=0,c3L=0 
init c8a=0.0001,c8B=0 
init cc=0,ccmito=.004 
# DISPLAY 
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@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=1,yp=c3a 
# METHOD 
@ meth=cvode,atol=1e-8,tol=1e-9,total=200000,dt=5,bounds=100000 
done 
****************************************************************************** 
# figure15-p53-00308.ode 
# REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
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# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
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r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=0.0001*a6*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=0.0001*a7*(1+p53^4/(p53^4+p53thresh^4))-mu*bax 
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jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a 
c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
# PARAMETERS 
par MPTP=0 
par nop=0 
par tbid0=0 
par p53=0.00308 
par p=4 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
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par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a6=0.8,a7=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
# INITIAL CONDITIONS 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00,IAP3=0 
init IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.04,c3B=0,c3L=0 
init c8a=0.0001,c8B=0 
init cc=0,ccmito=.004 
# DISPLAY 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=1,yp=c3a 
# METHOD 
@ meth=cvode,atol=1e-8,tol=1e-9,total=200000,dt=5,bounds=100000 
done 
****************************************************************************** 
# figure15-p53-0088.ode 
# REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
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# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
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r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
 182 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=0.0001*a6*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=0.0001*a7*(1+p53^4/(p53^4+p53thresh^4))-mu*bax 
jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a 
c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
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tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
# PARAMETERS 
par MPTP=0 
par nop=0 
par tbid0=0 
par p53=0.0088 
par p=4 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a6=0.8,a7=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
# INITIAL CONDITIONS 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00,IAP3=0 
init IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.04,c3B=0,c3L=0 
init c8a=0.0001,c8B=0 
init cc=0,ccmito=.004 
# DISPLAY 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=1,yp=c3a 
# METHOD 
@ meth=cvode,atol=1e-8,tol=1e-9,total=200000,dt=5,bounds=100000 
done 
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A.1.8 Scripts used in Figure 16 
# figure16A.ode 
# REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
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# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
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r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=0.0001*a6*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=0.0001*a7*(1+p53^4/(p53^4+p53thresh^4))-mu*bax 
jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
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cc'=j14-j1-mu*cc+mptp*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a 
c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
# PARAMETERS 
par MPTP=0 
par nop=0 
par tbid0=0 
par p53=0.0066 
par p=4 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
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par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a6=0.8,a7=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
# INITIAL CONDITIONS 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00 
init IAP3=0,IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.00001,c3B=0,c3L=0 
init c8a=0.00001,c8B=0 
init cc=0,ccmito=.004 
# DISPLAY 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=1,yp=c3a 
# METHOD 
@ meth=cvode,atol=1e-8,tol=1e-9,total=18000,dt=5,bounds=100000 
done 
****************************************************************************** 
# figure16B.ode 
# REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
 189 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
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r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
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j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=0.0001*a6*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=0.0001*a7*(1+p53^4/(p53^4+p53thresh^4))-mu*bax 
jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a 
c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp*ccmito 
bax2'=j12b-mu*bax2 
 192 
tbidmito'=j11-j12a-mu*tbidmito 
# PARAMETERS 
par MPTP=0 
par nop=0 
par tbid0=0 
par p53=0.0066 
par p=4 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a6=0.8,a7=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
# INITIAL CONDITIONS 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00 
init IAP3=0,IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.00001,c3B=0,c3L=0 
init c8a=0.0001,c8B=0 
init cc=0,ccmito=.004 
# DISPLAY 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=1,yp=c3a 
# METHOD 
@ meth=cvode,atol=1e-8,tol=1e-9,total=18000,dt=5,bounds=100000 
done 
****************************************************************************** 
# figure16C.ode 
# REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
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# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
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# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
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J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=0.0001*a6*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=0.0001*a7*(1+p53^4/(p53^4+p53thresh^4))-mu*bax 
jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a 
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c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
# PARAMETERS 
par MPTP=0 
par nop=0 
par tbid0=0 
par p53=0.0066 
par p=4 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a6=0.8,a7=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
# INITIAL CONDITIONS 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00 
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init IAP3=0,IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.00001,c3B=0,c3L=0 
init c8a=0.00015,c8B=0 
init cc=0,ccmito=.004 
# DISPLAY 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=1,yp=c3a 
# METHOD 
@ meth=cvode,atol=1e-8,tol=1e-9,total=18000,dt=5,bounds=100000 
done 
A.1.9 Scripts used in Figure 17 
# figure17-GSH100.ode 
# REACTIONS 
# * -> NO                                   k1NO 
# * -> O2m                                  k2NO 
# * -> GSH                                  k3NO 
# NO + O2m -> ONOOm                         k4NO 
# SOD + O2m + Hp -> SOD + 1/2O2 + 1/2 H2O2  k5NO 
# ONOOm + GSH -> GSNO + products            k6NO 
# ONOOm + GPX -> GPX + products             k7NO 
# ONOOm + CO2 -> products                   k8NO 
# ONOOm + Cc -> Cc + products               k9NO 
# 2GSNO + O2m + H2O -> GSSG + products      k10NO 
# N2O3 + GSH -> GSNO + products             k11NO 
# 2NO + O2 -> 2NO2                          k12aNO 
# N2O3 + H2O -> products                    k13NO 
# GSSG + NADPH +Hp -> 2GSH + NADPp          Vm,Km 
# NO2 + NO <-> N2O3                         k12bNOp,k12bNOm 
# GSNO (Cu+) -> 1/2GSSG + NO                k14NO 
# CcOx + NO -> CcOX.NO                      k15NO 
# FeL + NO -> FeLNO                         k16NO 
# FeLNO + GSH -> GSNO + FeL                 k17NO 
# GSH + O2m -> 1/2 GSSG + products          k17NOb 
# REACTION RATES 
r1NO=k1NO 
r2NO=k2NO 
r3NO=k3NO 
r4NO=k4NO*NO*O2m 
r5NO=k5NO*SOD*O2m 
r6NO=k6NO*ONOOm*GSH 
r7NO=k7NO*ONOOm*GPX 
r8NO=k8NO*ONOOm*CO2 
r9NO=k9NO*ONOOm*Cc 
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r10NO=k10NO*GSNO^2*O2m 
r11NO=k11NO*N2O3*GSH 
r12aNO=k12aNO*NO*NO*O2 
r12bNOp=k12bNOp*NO2*NO 
r12bNOm=k12bNOm*N2O3 
r13NO=k13NO*N2O3 
rm=Vm*GSSG(GSH,GSNO)/(Km+GSSG(GSH,GSNO)) 
r14NO=k14NO*GSNO 
r15NO=k15NO*CcOx*NO 
r16NO=k16NO*FeL*NO 
r17NO=k17NO*FeLNO(FeL)*GSH 
r17NOb=k17NOb*GSH*O2m 
# ODE'S 
N2O3'=-r11NO-r13NO+r12bNOp-r12bNOm 
GSH'=r3NO-r6NO-r11NO+2*rm-r17NO-r17NOb 
NO'=r1NO-r4NO-2*r12aNO-r12bNOp+r12bNOm+r14NO-r15NO-r16NO 
O2m'=r2NO-r4NO-r5NO-r10NO-r17NOb 
ONOOm'=r4NO-r6NO-r7NO-r8NO-r9NO 
GSNO'=r6NO-2*r10NO+r11NO-r14NO+r17NO 
NO2'=2*r12aNO-r12bNOp+r12bNOm 
CcOX'=-r15NO 
FeL'=-r16NO+r17NO 
# EXPRESSIONS 
GSSG(GSH,GSNO)=(100-GSH-GSNO)/2 
FeLNO(FeL)=0.05-FeL 
aux FeLNOstf=FeLNO(FeL) 
# PARAMETERS 
# k1NO is varied, i used a bigger number (1) 
par k1NO=1 
# k2NO is varied 
par k2NO=0.1 
# k3NO is varied 
par k3NO=0 
par O2=35 
par Cc=400 
# SOD is between 1 and 10 
par SOD=10 
par GPX=5.8 
# CO2 is between 1000 and 25000 
par CO2=1000 
par Km=50 
par k4NO=6700 
par k5NO=2400 
par k6NO=0.00135 
par k7NO=2 
par k8NO=0.058 
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par k9NO=0.025 
par k10NO=0.0006 
par k11NO=66 
par k12aNO=0.000006 
par k13NO=1600 
par Vm=320 
par k12bNOp=1100 
par k12bNOm=81000 
par k14NO=0.0002 
par k15NO=100 
par k16NO=1.21 
#the same value as k11NO is used for k17NO as a first guess 
par k17NO=66 
par k17NOb=0.0002 
# INITIAL CONDITIONS 
init CcOx=0.1 
init FeL=0.05 
init GSH=100 
# DISPLAY 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=3,yp=FeLNOstf,yp2=N2O3,yp3=GSH 
# METHOD 
@ meth=cvode,atol=1e-8,tol=1e-9,total=60000,dt=5,bounds=1000000000 
done 
****************************************************************************** 
# figure17-GSH1000.ode 
# REACTIONS 
# * -> NO                                   k1NO 
# * -> O2m                                  k2NO 
# * -> GSH                                  k3NO 
# NO + O2m -> ONOOm                         k4NO 
# SOD + O2m + Hp -> SOD + 1/2O2 + 1/2 H2O2  k5NO 
# ONOOm + GSH -> GSNO + products            k6NO 
# ONOOm + GPX -> GPX + products             k7NO 
# ONOOm + CO2 -> products                   k8NO 
# ONOOm + Cc -> Cc + products               k9NO 
# 2GSNO + O2m + H2O -> GSSG + products      k10NO 
# N2O3 + GSH -> GSNO + products             k11NO 
# 2NO + O2 -> 2NO2                          k12aNO 
# N2O3 + H2O -> products                    k13NO 
# GSSG + NADPH +Hp -> 2GSH + NADPp          Vm,Km 
# NO2 + NO <-> N2O3                         k12bNOp,k12bNOm 
# GSNO (Cu+) -> 1/2GSSG + NO                k14NO 
# CcOx + NO -> CcOX.NO                      k15NO 
# FeL + NO -> FeLNO                         k16NO 
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# FeLNO + GSH -> GSNO + FeL                 k17NO 
# GSH + O2m -> 1/2 GSSG + products          k17NOb 
# REACTION RATES 
r1NO=k1NO 
r2NO=k2NO 
r3NO=k3NO 
r4NO=k4NO*NO*O2m 
r5NO=k5NO*SOD*O2m 
r6NO=k6NO*ONOOm*GSH 
r7NO=k7NO*ONOOm*GPX 
r8NO=k8NO*ONOOm*CO2 
r9NO=k9NO*ONOOm*Cc 
r10NO=k10NO*GSNO^2*O2m 
r11NO=k11NO*N2O3*GSH 
r12aNO=k12aNO*NO*NO*O2 
r12bNOp=k12bNOp*NO2*NO 
r12bNOm=k12bNOm*N2O3 
r13NO=k13NO*N2O3 
rm=Vm*GSSG(GSH,GSNO)/(Km+GSSG(GSH,GSNO)) 
r14NO=k14NO*GSNO 
r15NO=k15NO*CcOx*NO 
r16NO=k16NO*FeL*NO 
r17NO=k17NO*FeLNO(FeL)*GSH 
r17NOb=k17NOb*GSH*O2m 
# ODE'S 
N2O3'=-r11NO-r13NO+r12bNOp-r12bNOm 
GSH'=r3NO-r6NO-r11NO+2*rm-r17NO-r17NOb 
NO'=r1NO-r4NO-2*r12aNO-r12bNOp+r12bNOm+r14NO-r15NO-r16NO 
O2m'=r2NO-r4NO-r5NO-r10NO-r17NOb 
ONOOm'=r4NO-r6NO-r7NO-r8NO-r9NO 
GSNO'=r6NO-2*r10NO+r11NO-r14NO+r17NO 
NO2'=2*r12aNO-r12bNOp+r12bNOm 
CcOX'=-r15NO 
FeL'=-r16NO+r17NO 
# EXPRESSIONS 
GSSG(GSH,GSNO)=(1000-GSH-GSNO)/2 
FeLNO(FeL)=0.05-FeL 
aux FeLNOstf=FeLNO(FeL) 
# PARAMETERS 
# k1NO is varied, i used a bigger number (1) 
par k1NO=1 
# k2NO is varied 
par k2NO=0.1 
# k3NO is varied 
par k3NO=0 
par O2=35 
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par Cc=400 
# SOD is between 1 and 10 
par SOD=10 
par GPX=5.8 
# CO2 is between 1000 and 25000 
par CO2=1000 
par Km=50 
par k4NO=6700 
par k5NO=2400 
par k6NO=0.00135 
par k7NO=2 
par k8NO=0.058 
par k9NO=0.025 
par k10NO=0.0006 
par k11NO=66 
par k12aNO=0.000006 
par k13NO=1600 
par Vm=320 
par k12bNOp=1100 
par k12bNOm=81000 
par k14NO=0.0002 
par k15NO=100 
par k16NO=1.21 
#the same value as k11NO is used for k17NO as a first guess 
par k17NO=66 
par k17NOb=0.0002 
# INITIAL CONDITIONS 
init CcOx=0.1 
init FeL=0.05 
init GSH=1000 
# DISPLAY 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=3,yp=FeLNOstf,yp2=N2O3,yp3=GSH 
# METHOD 
@ meth=cvode,atol=1e-8,tol=1e-9,total=60000,dt=5,bounds=1000000000 
done 
****************************************************************************** 
# figure17-GSH10000.ode 
# REACTIONS 
# * -> NO                                   k1NO 
# * -> O2m                                  k2NO 
# * -> GSH                                  k3NO 
# NO + O2m -> ONOOm                         k4NO 
# SOD + O2m + Hp -> SOD + 1/2O2 + 1/2 H2O2  k5NO 
# ONOOm + GSH -> GSNO + products            k6NO 
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# ONOOm + GPX -> GPX + products             k7NO 
# ONOOm + CO2 -> products                   k8NO 
# ONOOm + Cc -> Cc + products               k9NO 
# 2GSNO + O2m + H2O -> GSSG + products      k10NO 
# N2O3 + GSH -> GSNO + products             k11NO 
# 2NO + O2 -> 2NO2                          k12aNO 
# N2O3 + H2O -> products                    k13NO 
# GSSG + NADPH +Hp -> 2GSH + NADPp          Vm,Km 
# NO2 + NO <-> N2O3                         k12bNOp,k12bNOm 
# GSNO (Cu+) -> 1/2GSSG + NO                k14NO 
# CcOx + NO -> CcOX.NO                      k15NO 
# FeL + NO -> FeLNO                         k16NO 
# FeLNO + GSH -> GSNO + FeL                 k17NO 
# GSH + O2m -> 1/2 GSSG + products          k17NOb 
# REACTION RATES 
r1NO=k1NO 
r2NO=k2NO 
r3NO=k3NO 
r4NO=k4NO*NO*O2m 
r5NO=k5NO*SOD*O2m 
r6NO=k6NO*ONOOm*GSH 
r7NO=k7NO*ONOOm*GPX 
r8NO=k8NO*ONOOm*CO2 
r9NO=k9NO*ONOOm*Cc 
r10NO=k10NO*GSNO^2*O2m 
r11NO=k11NO*N2O3*GSH 
r12aNO=k12aNO*NO*NO*O2 
r12bNOp=k12bNOp*NO2*NO 
r12bNOm=k12bNOm*N2O3 
r13NO=k13NO*N2O3 
rm=Vm*GSSG(GSH,GSNO)/(Km+GSSG(GSH,GSNO)) 
r14NO=k14NO*GSNO 
r15NO=k15NO*CcOx*NO 
r16NO=k16NO*FeL*NO 
r17NO=k17NO*FeLNO(FeL)*GSH 
r17NOb=k17NOb*GSH*O2m 
# ODE'S 
N2O3'=-r11NO-r13NO+r12bNOp-r12bNOm 
GSH'=r3NO-r6NO-r11NO+2*rm-r17NO-r17NOb 
NO'=r1NO-r4NO-2*r12aNO-r12bNOp+r12bNOm+r14NO-r15NO-r16NO 
O2m'=r2NO-r4NO-r5NO-r10NO-r17NOb 
ONOOm'=r4NO-r6NO-r7NO-r8NO-r9NO 
GSNO'=r6NO-2*r10NO+r11NO-r14NO+r17NO 
NO2'=2*r12aNO-r12bNOp+r12bNOm 
CcOX'=-r15NO 
FeL'=-r16NO+r17NO 
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# EXPRESSIONS 
GSSG(GSH,GSNO)=(10000-GSH-GSNO)/2 
FeLNO(FeL)=0.05-FeL 
aux FeLNOstf=FeLNO(FeL) 
# PARAMETERS 
# k1NO is varied, i used a bigger number (1) 
par k1NO=1 
# k2NO is varied 
par k2NO=0.1 
# k3NO is varied 
par k3NO=0 
par O2=35 
par Cc=400 
# SOD is between 1 and 10 
par SOD=10 
par GPX=5.8 
# CO2 is between 1000 and 25000 
par CO2=1000 
par Km=50 
par k4NO=6700 
par k5NO=2400 
par k6NO=0.00135 
par k7NO=2 
par k8NO=0.058 
par k9NO=0.025 
par k10NO=0.0006 
par k11NO=66 
par k12aNO=0.000006 
par k13NO=1600 
par Vm=320 
par k12bNOp=1100 
par k12bNOm=81000 
par k14NO=0.0002 
par k15NO=100 
par k16NO=1.21 
#the same value as k11NO is used for k17NO as a first guess 
par k17NO=66 
par k17NOb=0.0002 
# INITIAL CONDITIONS 
init CcOx=0.1 
init FeL=0.05 
init GSH=10000 
# DISPLAY 
@ xhi=10000,ylo=0,yhi=0.001 
@ nplot=3,yp=FeLNOstf,yp2=N2O3,yp3=GSH 
# METHOD 
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@ meth=cvode,atol=1e-8,tol=1e-9,total=60000,dt=5,bounds=1000000000 
done 
A.1.10 Script used in Figure 18A 
# figure18A.ode 
##### figure16A.ode START ##### 
# REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
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# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
par nop=0 
par tbid0=0 
par p53=0.0066 
# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
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r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
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Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=0.0001*a6*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=0.0001*a7*(1+p53^4/(p53^4+p53thresh^4))-mu*bax 
jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp(MPTPcl)*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a-r22NO 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a-r21NO 
c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp-r19NO-r20NO 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp(MPTPcl)*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
par p=4 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00 
init IAP3=0,IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.00001,c3B=0,c3L=0 
init c8a=0.00001,c8B=0 
init cc=0,ccmito=.004 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
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par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a6=0.8,a7=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
##### figure16A.ode FINISH ##### 
##### figure17-GSH10000.ode START ##### 
# REACTIONS 
# * -> NO                                   k1NO 
# * -> O2m                                  k2NO 
# * -> GSH                                  k3NO 
# NO + O2m -> ONOOm                         k4NO 
# SOD + O2m + Hp -> SOD + 1/2O2 + 1/2 H2O2  k5NO 
# ONOOm + GSH -> GSNO + products            k6NO 
# ONOOm + GPX -> GPX + products             k7NO 
# ONOOm + CO2 -> products                   k8NO 
# ONOOm + Cc -> Cc + products               k9NO 
# 2GSNO + O2m + H2O -> GSSG + products      k10NO 
# N2O3 + GSH -> GSNO + products             k11NO 
# 2NO + O2 -> 2NO2                          k12aNO 
# N2O3 + H2O -> products                    k13NO 
# GSSG + NADPH +Hp -> 2GSH + NADPp          Vm,Km 
# NO2 + NO <-> N2O3                         k12bNOp,k12bNOm 
# GSNO (Cu+) -> 1/2GSSG + NO                k14NO 
# CcOx + NO -> CcOX.NO                      k15NO 
# FeL + NO -> FeLNO                         k16NO 
# FeLNO + GSH -> GSNO + FeL                 k17NO 
# REACTION RATES 
r1NO=k1NO 
r2NO=k2NO 
r3NO=k3NO 
r4NO=k4NO*NO*O2m 
r5NO=k5NO*SOD*O2m 
r6NO=k6NO*ONOOm*GSH 
r7NO=k7NO*ONOOm*GPX 
r8NO=k8NO*ONOOm*CO2 
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r9NO=k9NO*ONOOm*Cc 
r10NO=k10NO*GSNO^2*O2m 
r11NO=k11NO*N2O3*GSH 
r12aNO=k12aNO*NO*NO*O2 
r12bNOp=k12bNOp*NO2*NO 
r12bNOm=k12bNOm*N2O3 
r13NO=k13NO*N2O3 
rm=Vm*GSSG(GSH,GSNO)/(Km+GSSG(GSH,GSNO)) 
r14NO=k14NO*GSNO 
r15NO=k15NO*CcOx*NO 
r16NO=k16NO*FeL*NO 
r17NO=k17NO*FeLNO(FeL)*GSH 
# ODE'S 
N2O3'=-r11NO-r13NO+r12bNOp-r12bNOm-r19NO 
GSH'=r3NO-r6NO-r11NO+2*rm-r17NO 
NO'=r1NO-r4NO-2*r12aNO-r12bNOp+r12bNOm+r14NO-r15NO-r16NO 
O2m'=r2NO-r4NO-r5NO-r10NO 
ONOOm'=r4NO-r6NO-r7NO-r8NO-r9NO-r18NO 
GSNO'=r6NO-2*r10NO+r11NO-r14NO+r17NO 
GSSG(GSH,GSNO)=(10000-GSH-GSNO)/2 
NO2'=2*r12aNO-r12bNOp+r12bNOm 
CcOX'=-r15NO 
FeL'=-r16NO+r17NO+r20NO+r21NO+r22NO 
FeLNO(FeL)=0.-FeL 
aux FeLNOstf=FeLNO(FeL) 
# k1NO is varied, i used a bigger number (1) 
par k1NO=1 
# k2NO is varied 
par k2NO=0. 
# k3NO is varied 
par k3NO=0 
par O2=35 
#par Cc=400 
# SOD is between 1 and 10 
par SOD=10 
par GPX=5.8 
# CO2 is between 1000 and 25000 
par CO2=1000 
par Km=50 
par k4NO=6700 
par k5NO=2400 
par k6NO=0.00135 
par k7NO=2 
par k8NO=0.058 
par k9NO=0.025 
par k10NO=0.0006 
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par k11NO=66 
par k12aNO=0.000006 
par k13NO=1600 
par Vm=320 
par k12bNOp=1100 
par k12bNOm=81000 
par k14NO=0.0002 
par k15NO=100 
init CcOx=0.1 
par k16NO=1.21 
init FeL=0. 
#the same value as k11NO is used for k17NO as a first guess 
par k17NO=66 
init GSH=10000 
##### figure17-GSH10000.ode FINISH ##### 
##### coupling START ##### 
# REACTIONS 
# ONOOm + MPTPcl -> MPTP                k18NO 
# N2O3 + c8a -> c8aNO + products k19NO 
# FeLNO + c8a -> c8aNO + FeL      k20NO 
# FeLNO + c9a -> c9aNO + FeL     k21NO 
# FeLNO + c3a -> c3aNO + FeL     k22NO 
# REACTION RATES 
r18NO=k18NO*ONOOm*MPTPcl 
r19NO=k19NO*N2O3*c8a 
r20NO=k20NO*FeLNO(FeL)*c8a 
r21NO=k21NO*FeLNO(FeL)*c9a 
r22NO=k22NO*FeLNO(FeL)*c3a 
# ODE'S 
MPTPcl'=-r18NO 
MPTP(MPTPcl)=0.01-MPTPcl 
init MPTPcl=0.01 
# assume black box 
par k18NO=1 
par k19NO=10 
#the same value as k11NO is used for k20NO,k21NO,k22NO as a first guess 
par k20NO=66 
par k21NO=66 
par k22NO=66 
##### coupling FINISH ##### 
@ xhi=10000,ylo=0,yhi=0.001 
@ meth=cvode,atol=1e-8,tol=1e-9,total=60000,dt=5,bounds=1000000000 
@ nplot=2,yp=c3a,yp2=gsh 
done 
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A.1.11 Script used in Figure 19A 
# figure19A.ode 
##### figure16A.ode START ##### 
# REACTIONS 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
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# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
par nop=0 
par tbid0=0 
par p53=0.0066 
# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
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r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=0.0001*a6*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=0.0001*a7*(1+p53^4/(p53^4+p53thresh^4))-mu*bax 
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jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp(MPTPcl)*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a-r22NO 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a-r21NO 
c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp-r19NO-r20NO 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp(MPTPcl)*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
par p=4 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00 
init IAP3=0,IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.00001,c3B=0,c3L=0 
init c8a=0.00001,c8B=0 
init cc=0,ccmito=.004 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
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par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a6=0.8,a7=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
##### figure16A.ode FINISH ##### 
##### figure17-GSH10000.ode START ##### 
# REACTIONS 
# * -> NO                                   k1NO 
# * -> O2m                                  k2NO 
# * -> GSH                                  k3NO 
# NO + O2m -> ONOOm                         k4NO 
# SOD + O2m + Hp -> SOD + 1/2O2 + 1/2 H2O2  k5NO 
# ONOOm + GSH -> GSNO + products            k6NO 
# ONOOm + GPX -> GPX + products             k7NO 
# ONOOm + CO2 -> products                   k8NO 
# ONOOm + Cc -> Cc + products               k9NO 
# 2GSNO + O2m + H2O -> GSSG + products      k10NO 
# N2O3 + GSH -> GSNO + products             k11NO 
# 2NO + O2 -> 2NO2                          k12aNO 
# N2O3 + H2O -> products                    k13NO 
# GSSG + NADPH +Hp -> 2GSH + NADPp          Vm,Km 
# NO2 + NO <-> N2O3                         k12bNOp,k12bNOm 
# GSNO (Cu+) -> 1/2GSSG + NO                k14NO 
# CcOx + NO -> CcOX.NO                      k15NO 
# FeL + NO -> FeLNO                         k16NO 
# FeLNO + GSH -> GSNO + FeL                 k17NO 
# REACTION RATES 
r1NO=k1NO 
r2NO=k2NO 
r3NO=k3NO 
r4NO=k4NO*NO*O2m 
r5NO=k5NO*SOD*O2m 
r6NO=k6NO*ONOOm*GSH 
r7NO=k7NO*ONOOm*GPX 
r8NO=k8NO*ONOOm*CO2 
r9NO=k9NO*ONOOm*Cc 
r10NO=k10NO*GSNO^2*O2m 
r11NO=k11NO*N2O3*GSH 
r12aNO=k12aNO*NO*NO*O2 
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r12bNOp=k12bNOp*NO2*NO 
r12bNOm=k12bNOm*N2O3 
r13NO=k13NO*N2O3 
rm=Vm*GSSG(GSH,GSNO)/(Km+GSSG(GSH,GSNO)) 
r14NO=k14NO*GSNO 
r15NO=k15NO*CcOx*NO 
r16NO=k16NO*FeL*NO 
r17NO=k17NO*FeLNO(FeL)*GSH 
# ODE'S 
N2O3'=-r11NO-r13NO+r12bNOp-r12bNOm-r19NO 
GSH'=r3NO-r6NO-r11NO+2*rm-r17NO 
NO'=r1NO-r4NO-2*r12aNO-r12bNOp+r12bNOm+r14NO-r15NO-r16NO 
O2m'=r2NO-r4NO-r5NO-r10NO 
ONOOm'=r4NO-r6NO-r7NO-r8NO-r9NO-r18NO 
GSNO'=r6NO-2*r10NO+r11NO-r14NO+r17NO 
GSSG(GSH,GSNO)=(10000-GSH-GSNO)/2 
NO2'=2*r12aNO-r12bNOp+r12bNOm 
CcOX'=-r15NO 
FeL'=-r16NO+r17NO+r20NO+r21NO+r22NO 
FeLNO(FeL)=0.05-FeL 
aux FeLNOstf=FeLNO(FeL) 
# k1NO is varied, i used a bigger number (1) 
par k1NO=1 
# k2NO is varied 
par k2NO=0. 
# k3NO is varied 
par k3NO=0 
par O2=35 
#par Cc=400 
# SOD is between 1 and 10 
par SOD=10 
par GPX=5.8 
# CO2 is between 1000 and 25000 
par CO2=1000 
par Km=50 
par k4NO=6700 
par k5NO=2400 
par k6NO=0.00135 
par k7NO=2 
par k8NO=0.058 
par k9NO=0.025 
par k10NO=0.0006 
par k11NO=66 
par k12aNO=0.000006 
par k13NO=1600 
par Vm=320 
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par k12bNOp=1100 
par k12bNOm=81000 
par k14NO=0.0002 
par k15NO=100 
init CcOx=0.1 
par k16NO=1.21 
init FeL=0.05 
#the same value as k11NO is used for k17NO as a first guess 
par k17NO=66 
init GSH=10000 
##### figure17-GSH10000.ode FINISH ##### 
##### coupling START ##### 
# REACTIONS 
# ONOOm + MPTPcl -> MPTP                k18NO 
# N2O3 + c8a -> c8aNO + products k19NO 
# FeLNO + c8a -> c8aNO + FeL      k20NO 
# FeLNO + c9a -> c9aNO + FeL     k21NO 
# FeLNO + c3a -> c3aNO + FeL     k22NO 
# REACTION RATES 
r18NO=k18NO*ONOOm*MPTPcl 
r19NO=k19NO*N2O3*c8a 
r20NO=k20NO*FeLNO(FeL)*c8a 
r21NO=k21NO*FeLNO(FeL)*c9a 
r22NO=k22NO*FeLNO(FeL)*c3a 
# ODE 
MPTPcl'=-r18NO 
MPTP(MPTPcl)=0.01-MPTPcl 
init MPTPcl=0.01 
# assume black box 
par k18NO=1 
par k19NO=10 
#the same value as k11NO is used for k20NO,k21NO,k22NO as a first guess 
par k20NO=66 
par k21NO=66 
par k22NO=66 
##### coupling FINISH ##### 
@ xhi=10000,ylo=0,yhi=0.001 
@ meth=cvode,atol=1e-8,tol=1e-9,total=60000,dt=5,bounds=1000000000 
@ nplot=2,yp=c3a,yp2=gsh 
done 
A.1.12 Script used in Figure 20A 
# figure20A.ode 
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##### figure16A.ode START ##### 
# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
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# c3L -> c3a + B2c       k9f 
# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
par nop=0 
par tbid0=0 
par p53=0.0066 
# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
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r11=k11*tbid 
r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=0.0001*a6*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=0.0001*a7*(1+p53^4/(p53^4+p53thresh^4))-mu*bax 
jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp(MPTPcl)*ccmito 
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c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a-r22NO 
AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a-r21NO 
c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp-r19NO-r20NO 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp(MPTPcl)*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
par p=4 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00 
init IAP3=0,IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.00001,c3B=0,c3L=0 
init c8a=0.00001,c8B=0 
init cc=0,ccmito=.004 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
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par k8p=10,k8m=0.5,k8f=0.1 
par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a6=0.8,a7=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
##### figure16A.ode FINISH ##### 
##### figure17-GSH10000.ode START ##### 
# REACTIONS 
# * -> NO                                   k1NO 
# * -> O2m                                  k2NO 
# * -> GSH                                  k3NO 
# NO + O2m -> ONOOm                         k4NO 
# SOD + O2m + Hp -> SOD + 1/2O2 + 1/2 H2O2  k5NO 
# ONOOm + GSH -> GSNO + products            k6NO 
# ONOOm + GPX -> GPX + products             k7NO 
# ONOOm + CO2 -> products                   k8NO 
# ONOOm + Cc -> Cc + products               k9NO 
# 2GSNO + O2m + H2O -> GSSG + products      k10NO 
# N2O3 + GSH -> GSNO + products             k11NO 
# 2NO + O2 -> 2NO2                          k12aNO 
# N2O3 + H2O -> products                    k13NO 
# GSSG + NADPH +Hp -> 2GSH + NADPp          Vm,Km 
# NO2 + NO <-> N2O3                         k12bNOp,k12bNOm 
# GSNO (Cu+) -> 1/2GSSG + NO                k14NO 
# CcOx + NO -> CcOX.NO                      k15NO 
# FeL + NO -> FeLNO                         k16NO 
# FeLNO + GSH -> GSNO + FeL                 k17NO 
# GSH + O2m -> 1/2 GSSG + products          k17NOb 
# REACTION RATES 
r1NO=k1NO 
r2NO=k2NO 
r3NO=k3NO 
r4NO=k4NO*NO*O2m 
r5NO=k5NO*SOD*O2m 
r6NO=k6NO*ONOOm*GSH 
r7NO=k7NO*ONOOm*GPX 
r8NO=k8NO*ONOOm*CO2 
r9NO=k9NO*ONOOm*Cc 
r10NO=k10NO*GSNO^2*O2m 
r11NO=k11NO*N2O3*GSH 
r12aNO=k12aNO*NO*NO*O2 
r12bNOp=k12bNOp*NO2*NO 
r12bNOm=k12bNOm*N2O3 
r13NO=k13NO*N2O3 
rm=Vm*GSSG(GSH,GSNO)/(Km+GSSG(GSH,GSNO)) 
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r14NO=k14NO*GSNO 
r15NO=k15NO*CcOx*NO 
r16NO=k16NO*FeL*NO 
r17NO=k17NO*FeLNO(FeL)*GSH 
r17NOb=k17NOb*GSH*O2m 
# ODE'S 
N2O3'=-r11NO-r13NO+r12bNOp-r12bNOm-r19NO 
GSH'=r3NO-r6NO-r11NO+2*rm-r17NO-r17NOb 
NO'=r1NO-r4NO-2*r12aNO-r12bNOp+r12bNOm+r14NO-r15NO-r16NO 
O2m'=r2NO-r4NO-r5NO-r10NO-r17NOb 
ONOOm'=r4NO-r6NO-r7NO-r8NO-r9NO-r18NO 
GSNO'=r6NO-2*r10NO+r11NO-r14NO+r17NO 
GSSG(GSH,GSNO)=(10000-GSH-GSNO)/2 
NO2'=2*r12aNO-r12bNOp+r12bNOm 
CcOX'=-r15NO 
FeL'=-r16NO+r17NO+r20NO+r21NO+r22NO 
FeLNO(FeL)=0.05-FeL 
aux FeLNOstf=FeLNO(FeL) 
# k1NO is varied, i used a bigger number (1) 
par k1NO=1 
# k2NO is varied 
par k2NO=0.1 
# k3NO is varied 
par k3NO=0 
par O2=35 
#par Cc=400 
# SOD is between 1 and 10 
par SOD=10 
par GPX=5.8 
# CO2 is between 1000 and 25000 
par CO2=1000 
par Km=50 
par k4NO=6700 
par k5NO=2400 
par k6NO=0.00135 
par k7NO=2 
par k8NO=0.058 
par k9NO=0.025 
par k10NO=0.0006 
par k11NO=66 
par k12aNO=0.000006 
par k13NO=1600 
par Vm=320 
par k12bNOp=1100 
par k12bNOm=81000 
par k14NO=0.0002 
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par k15NO=100 
init CcOx=0.1 
par k16NO=1.21 
init FeL=0.05 
#the same value as k11NO is used for k17NO as a first guess 
par k17NO=66 
par k17NOb=0.0002 
init GSH=10000 
##### figure17-GSH10000.ode FINISH ##### 
##### coupling START ##### 
# REACTIONS 
# ONOOm + MPTPcl -> MPTP                k18NO 
# N2O3 + c8a -> c8aNO + products k19NO 
# FeLNO + c8a -> c8aNO + FeL      k20NO 
# FeLNO + c9a -> c9aNO + FeL     k21NO 
# FeLNO + c3a -> c3aNO + FeL     k22NO 
# REACTION RATES 
r18NO=k18NO*ONOOm*MPTPcl 
r19NO=k19NO*N2O3*c8a 
r20NO=k20NO*FeLNO(FeL)*c8a 
r21NO=k21NO*FeLNO(FeL)*c9a 
r22NO=k22NO*FeLNO(FeL)*c3a 
# ODE 
MPTPcl'=-r18NO 
MPTP(MPTPcl)=0.01-MPTPcl 
init MPTPcl=0.01 
# assume black box 
par k18NO=1 
par k19NO=10 
#the same value as k11NO is used for k20NO,k21NO,k22NO as a first guess 
par k20NO=66 
par k21NO=66 
par k22NO=66 
##### coupling FINISH ##### 
@ xhi=10000,ylo=0,yhi=0.001 
@ meth=cvode,atol=1e-8,tol=1e-9,total=60000,dt=5,bounds=1000000000 
@ nplot=2,yp=c3a,yp2=gsh 
done 
A.1.13 Script used in Figure 21A 
# figure21A.ode 
##### figure16A.ode START ##### 
# REACTIONS 
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# om -> Ap 
# om -> IAP 
# om -> c3z 
# om -> c9z 
# om -> Bid 
# om -> Bcl2 
# om -> Bax 
# om -> Ccmito 
# c8a -> * 
# c9a -> * 
# c3a -> * 
# Ap -> * 
# IAP -> * 
# c3z -> * 
# c9z -> * 
# Bcl2 -> * 
# Bid -> * 
# Bax -> * 
# Ccmito -> * 
# Bax -> * 
# Bax2 -> * 
# Cc -> * 
# tBid -> * 
# tBidBax -> * 
# tBidmito -> * 
# Cc + Ap <-> CcAp            k1p,k1m 
# 7 CcAp <-> Apop       k1bp,k1bm 
# Apop + c9z <-> Apopc9z      k2p,k2m 
# Apopc9z + c9z <-> Apopc9z2  k3p,k3m 
# Apopc9z2 -> Apopc9a2       k3f 
# Apopc9a2 <-> Apopc9a + c9a  k4p,k4m 
# Apopc9a <-> Apop + c9a      k4bp,k4bm 
# c9a + IAP <-> IAP9       k5p,k5m 
# Apopc9a + IAP <-> IAPA9     k5bp,k5bm 
# Apopc9a2 + IAP <-> IAPA29   k5cp,k5cm 
# c3z + c9a <-> c93       k6p,k6m 
# c93 -> c3a + c9a       k6f 
# c3z + Apopc9a2 <-> cA93     k6bp,k6bm 
# cA93 -> c3a + Apopc9a2      k6bf 
# c3a + IAP <-> IAP3       k7p,k7m 
# c8a + Bid <-> c8B       k8p,k8m 
# c8B -> c8a + tBid       k8f 
# c3a + Bid <-> c3B       k8p,k8m 
# c3B -> c3a + tBid       k8f 
# c3a + Bcl2 <-> c3L       k9p,k9m 
# c3L -> c3a + B2c       k9f 
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# tBid -> tBidmito       k11 
# tBidmito + Bax -> tBidBax   k12a 
# tBidBax + Bax -> tBid + Bax2 k12b 
# Bcl2 + Bax -> *       k13 
# Bax2 + Ccmito -> Cc + Bax2  k14 
par nop=0 
par tbid0=0 
par p53=0.0066 
# REACTION RATES 
r1p=k1p*Cc*Ap 
r1m=k1m*CcAp 
r1bp=k1bp*CcAp^p 
r1bm=k1bm*Apop 
r2p=k2p*Apop*c9z 
r2m=k2m*Apopc9z 
r3p=k3p*Apopc9z*c9z 
r3m=k3m*Apopc9z2 
r3f=k3f*Apopc9z2 
r4p=k4p*Apopc9a2 
r4m=k4m*Apopc9a*c9a 
r4bp=k4bp*Apopc9a 
r4bm=k4bm*Apop*c9a 
r5p=k5p*c9a*IAP 
r5m=k5m*IAP9 
r5bp=k5bp*Apopc9a*IAP 
r5bm=k5bm*IAPA9 
r5cp=k5cp*Apopc9a2*IAP 
r5cm=k5cm*IAPA29 
r6p=k6p*c3z*c9a 
r6m=k6m*c93 
r6f=k6f*c93 
r6bp=k6p*c3z*Apopc9a2 
r6bm=k6m*cA93 
r6bf=k6f*cA93 
r7p=k7p*c3a*IAP 
r7m=k7m*IAP3 
r8p=k8p*c3a*Bid 
r8m=k8m*c3B 
r8f=k8f*c3B 
r8pp=k8p*c8a*Bid 
r8mp=k8m*c8B 
r8fp=k8f*c8B 
r9p=k9p*c3a*Bcl2 
r9m=k9m*c3L 
r9f=k9f*c3L 
r11=k11*tbid 
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r12a=k12a*tbidmito*bax 
r12b=k12b*tbidbax*bax 
r13=k13*bcl2*bax 
r14=k14*bax2*ccmito 
# FLUXES 
J1=r1p-r1m 
J1b=r1bp-r1bm 
J2=r2p-r2m 
J3=r3p-r3m 
J3f=r3f 
J4=r4p-r4m 
J4b=r4bp-r4bm 
J5=r5p-r5m 
J5b=r5bp-r5bm 
J5c=r5cp-r5cm 
J6=r6p-r6m 
J6f=r6f 
J6b=r6bp-r6bm 
J6bf=r6bf 
J7=r7p-r7m 
J8=r8p-r8m 
J8f=r8f 
J8p=r8pp-r8mp 
J8fp=r8fp 
J9=r9p-r9m 
J9f=r9f 
j11=r11 
j12a=r12a 
j12b=r12b 
j13=r13 
j14=r14 
# PRODUCTION AND DEGRADATION RATES 
Jp8=-mu*c8a 
JAp=0.0001*a1-mu*Ap 
JIAP=0.0001*a2-mu*IAP 
Jp3=0.0001*a3-mu*c3z 
Jp9=0.0001*a4-mu*c9z 
jbidp=0.0001*a5-mu*bid 
jbcl2p=0.0001*a6*p53thresh^4/(p53^4+p53thresh^4)-mu*bcl2 
jbax=0.0001*a7*(1+p53^4/(p53^4+p53thresh^4))-mu*bax 
jccmito=0.0001*a8-mu*ccmito 
# ODE'S 
bax'=jbax-j12a-j12b-j13 
Bcl2'=-J9+jbcl2p-j13 
cc'=j14-j1-mu*cc+mptp(MPTPcl)*ccmito 
c3a'=J6f+J6bf-J7-J8+J8f-J9+J9f-mu*c3a-r22NO 
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AP'=-J1+JAp 
CcAp'=J1-7*J1b 
Apop'=J1b-J2+J4b 
Apopc9z'=J2-J3 
Apopc9z2'=J3-J3f 
Apopc9a2'=J3f-J4-J5c-J6b+J6bf 
Apopc9a'=J4-J4b-J5b 
c9a'=J4+J4b-J5-J6+J6f-mu*c9a-r21NO 
c9z'=-J2-J3+Jp9 
IAP'=-J5-J5b-J5c-J7+JIAP 
IAP9'=J5 
IAPA9'=J5b 
IAPA29'=J5c 
IAP3'=J7 
c3z'=-J6-J6b+Jp3-10*nop*c3z 
c93'=J6-J6f 
cA93'=J6b-J6bf 
c8a'=Jp8-J8p+J8fp-r19NO-r20NO 
Bid'=-J8-J8p+jbidp 
c8B'=J8p-J8fp 
c3B'=J8-J8f 
c3L'=J9-J9f 
tbid'=j8f+j8fp-j11+j12b-mu*tbid+tbid0 
tbidbax'=j12a-j12b-mu*tbidbax 
ccmito'=jccmito-j14-mptp(MPTPcl)*ccmito 
bax2'=j12b-mu*bax2 
tbidmito'=j11-j12a-mu*tbidmito 
par p=4 
init Ap=.004,c9z=.004,c3z=.004,IAP=.004,Bid=.004,Bcl2=.004,bax=.004 
init CcAp=0,Apop=0,Apopc9z=0,Apopc9z2=0,Apopc9a2=0,Apopc9a=0,c9a=0.00 
init IAP3=0,IAP9=0,IAPA9=0,IAPA29=0,c93=0,cA93=0,c3a=0.00001,c3B=0,c3L=0 
init c8a=0.00007,c8B=0 
init cc=0,ccmito=.004 
par k1p=5,k1m=0.5 
par k1bp=50000*a9,k1bm=0.5*a9 
par k2p=10,k2m=0.5 
par k3p=10,k3m=0.5,k3f=0.1 
par k4p=5,k4m=0.5 
par k4bp=5,k4bm=0.5 
par k5p=5*a10,k5m=0.0035*a10 
par k5bp=5*a10,k5bm=0.0035*a10 
par k5cp=5*a10,k5cm=0.0035*a10 
par k6p=10*a11,k6m=0.5*a11,k6f=0.001*a11 
par k6bp=10*a11,k6bm=0.5*a11,k6bf=0.1*a11 
par k7p=5*a10,k7m=0.0035*a10 
par k8p=10,k8m=0.5,k8f=0.1 
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par k9p=10,k9m=0.5,k9f=0.1 
par k11=10*a12,k12a=10*a12,k12b=10*a12,k13=10*a12,k14=10*a12 
par a1=3,a2=0.3,a3=3,a4=3,a5=0.3,a6=0.8,a7=0.3,a8=3,a9=1,a10=1,a11=1,a12=1,a13=3 
mu=0.002*a13 
par p53thresh=0.004 
##### figure16A.ode FINISH ##### 
##### figure17-GSH10000.ode START ##### 
# REACTIONS 
# * -> NO                                   k1NO 
# * -> O2m                                  k2NO 
# * -> GSH                                  k3NO 
# NO + O2m -> ONOOm                         k4NO 
# SOD + O2m + Hp -> SOD + 1/2O2 + 1/2 H2O2  k5NO 
# ONOOm + GSH -> GSNO + products            k6NO 
# ONOOm + GPX -> GPX + products             k7NO 
# ONOOm + CO2 -> products                   k8NO 
# ONOOm + Cc -> Cc + products               k9NO 
# 2GSNO + O2m + H2O -> GSSG + products      k10NO 
# N2O3 + GSH -> GSNO + products             k11NO 
# 2NO + O2 -> 2NO2                          k12aNO 
# N2O3 + H2O -> products                    k13NO 
# GSSG + NADPH +Hp -> 2GSH + NADPp          Vm,Km 
# NO2 + NO <-> N2O3                         k12bNOp,k12bNOm 
# GSNO (Cu+) -> 1/2GSSG + NO                k14NO 
# CcOx + NO -> CcOX.NO                      k15NO 
# FeL + NO -> FeLNO                         k16NO 
# FeLNO + GSH -> GSNO + FeL                 k17NO 
# GSH + O2m -> 1/2 GSSG + products          k17NOb 
# REACTION RATES 
r1NO=k1NO 
r2NO=k2NO 
r3NO=k3NO 
r4NO=k4NO*NO*O2m 
r5NO=k5NO*SOD*O2m 
r6NO=k6NO*ONOOm*GSH 
r7NO=k7NO*ONOOm*GPX 
r8NO=k8NO*ONOOm*CO2 
r9NO=k9NO*ONOOm*Cc 
r10NO=k10NO*GSNO^2*O2m 
r11NO=k11NO*N2O3*GSH 
r12aNO=k12aNO*NO*NO*O2 
r12bNOp=k12bNOp*NO2*NO 
r12bNOm=k12bNOm*N2O3 
r13NO=k13NO*N2O3 
rm=Vm*GSSG(GSH,GSNO)/(Km+GSSG(GSH,GSNO)) 
r14NO=k14NO*GSNO 
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r15NO=k15NO*CcOx*NO 
r16NO=k16NO*FeL*NO 
r17NO=k17NO*FeLNO(FeL)*GSH 
r17NOb=k17NOb*GSH*O2m 
# ODE'S 
N2O3'=-r11NO-r13NO+r12bNOp-r12bNOm-r19NO 
GSH'=r3NO-r6NO-r11NO+2*rm-r17NO-r17NOb 
NO'=r1NO-r4NO-2*r12aNO-r12bNOp+r12bNOm+r14NO-r15NO-r16NO 
O2m'=r2NO-r4NO-r5NO-r10NO-r17NOb 
ONOOm'=r4NO-r6NO-r7NO-r8NO-r9NO-r18NO 
GSNO'=r6NO-2*r10NO+r11NO-r14NO+r17NO 
GSSG(GSH,GSNO)=(100-GSH-GSNO)/2 
NO2'=2*r12aNO-r12bNOp+r12bNOm 
CcOX'=-r15NO 
FeL'=-r16NO+r17NO+r20NO+r21NO+r22NO 
FeLNO(FeL)=0.0-FeL 
aux FeLNOstf=FeLNO(FeL) 
# k1NO is varied, i used a bigger number (1) 
par k1NO=1 
# k2NO is varied 
par k2NO=0.1 
# k3NO is varied 
par k3NO=0 
par O2=0 
#par Cc=400 
# SOD is between 1 and 10 
par SOD=10 
par GPX=5.8 
# CO2 is between 1000 and 25000 
par CO2=1000 
par Km=50 
par k4NO=6700 
par k5NO=2400 
par k6NO=0.00135 
par k7NO=2 
par k8NO=0.058 
par k9NO=0.025 
par k10NO=0.0006 
par k11NO=66 
par k12aNO=0.000006 
par k13NO=1600 
par Vm=320 
par k12bNOp=1100 
par k12bNOm=81000 
par k14NO=0.0002 
par k15NO=100 
 231 
init CcOx=0.1 
par k16NO=1.21 
init FeL=0.0 
#the same value as k11NO is used for k17NO as a first guess 
par k17NO=66 
par k17NOb=0.0002 
init GSH=100 
##### figure17-GSH10000.ode FINISH ##### 
##### coupling START ##### 
# REACTIONS 
# ONOOm + MPTPcl -> MPTP                k18NO 
# N2O3 + c8a -> c8aNO + products k19NO 
# FeLNO + c8a -> c8aNO + FeL      k20NO 
# FeLNO + c9a -> c9aNO + FeL     k21NO 
# FeLNO + c3a -> c3aNO + FeL     k22NO 
# REACTION RATES 
r18NO=k18NO*ONOOm*MPTPcl 
r19NO=k19NO*N2O3*c8a 
r20NO=k20NO*FeLNO(FeL)*c8a 
r21NO=k21NO*FeLNO(FeL)*c9a 
r22NO=k22NO*FeLNO(FeL)*c3a 
# ODE 
MPTPcl'=-r18NO 
MPTP(MPTPcl)=0.0001-MPTPcl 
init MPTPcl=0.0001 
# assume black box 
par k18NO=1 
par k19NO=10 
#the same value as k11NO is used for k20NO,k21NO,k22NO as a first guess 
par k20NO=66 
par k21NO=66 
par k22NO=66 
##### coupling FINISH ##### 
@ xhi=10000,ylo=0,yhi=0.001 
@ meth=cvode,atol=1e-8,tol=1e-9,total=60000,dt=5,bounds=1000000000 
@ nplot=2,yp=c3a,yp2=gsh 
done 
 
 232 
BIBLIOGRAPHY 
Acehan, D., Jiang, X. J., Morgan, D. G., Heuser, J. E., Wang, X. D., and Akey, C. W. (2002). 
Three-dimensional structure of the apoptosome: Implications for assembly, procaspase-9 
binding, and activation. Mol. Cell. 9, 423-432. 
Afshar, R. K., Patra, A. K., Olmstead, M. M., and Mascharak, P. K. (2004). Syntheses, 
structures, and reactivities of {Fe-NO}(6) nitrosyls derived from polypyridine-
carboxamide ligands: Photoactive NO-donors and reagents for S-nitrosylation of alkyl 
thiols. Inorg. Chem. 43, 5736-5743. 
Albina, J. E., Cui, S., Mateo, R. B., and Reichner, J. S. (1993). Nitric oxide-mediated apoptosis 
in murine peritoneal macrophages. J. Immunol. 150, 5080-5085. 
Aldridge, B. B., Haller, G., Sorger, P. K., and Lauffenburger, D. A. (2006). Direct Lyapunov 
exponent analysis enables parametric study of transient signalling governing cell 
behaviour. Syst. Biol. (Stevenage) 153, 425-432. 
Angeli, D., Ferrell, J. E., and Sontag, E. D. (2004). Detection of multistability, bifurcations, and 
hysteresis in a large class of biological positive-feed back systems. Proc. Natl. Acad. Sci. 
U S A. 101, 1822-1827. 
Antonsson, B., Conti, F., Ciavatta, A., Montessuit, S., Lewis, S., Martinou, I., Bernasconi, L., 
Bernard, A., Mermod, J. J., Mazzei, G., Maundrell, K., Gambale, F., Sadoul, R., and 
Martinou, J.C. (1997). Inhibition of Bax channel-forming activity by Bcl-2. Science 277, 
370-372. 
Antunes, F., Salvador, A., Marinho, H. S., Alves, R., and Pinto, R. E. (1996). Lipid peroxidation 
in mitochondrial inner membranes. 1. An integrative kinetic model. Free Radic. Biol. and 
Med. 21, 917-943. 
Asthagiri, A. R. and Lauffenburger, D. A. (2001). A computational study of feedback effects on 
signal dynamics in a mitogen-activated protein kinase (MAPK) pathway model. 
Biotechnol. Prog. 17, 227-239. 
Bagci, E. Z., Vodovotz, Y., Billiar, T. R., Ermentrout, G. B., and Bahar, I. (2006). Bistability in 
apoptosis: Roles of Bax, Bcl-2, and Mitochondrial Permeability Transition Pores. 
Biophys. J. 90, 1546-1559. 
 233 
Bagci, E. Z., Vodovotz, Y., Billiar, T. R., Ermentrout, G. B., and Bahar, I. (2007). Competing 
effects of nitric oxide in regulating apoptosis: Insights from computational modeling. 
(submitted) 
Beckman, J. S. and Koppenol, W. H. (1996). Nitric oxide, superoxide, and peroxynitrite: The 
good, the bad, and the ugly. Am. J. Physiol., Cell Physiol. 40, C1424-C1437. 
Benhar, M. and Stamler, J. S. (2005). A central role for S-nitrosylation in apoptosis. Nat. Cell 
Biol. 7, 645-646. 
Bentele, M., Lavrik, I., Ulrich, M., Stosser, S., Heermann, D. W., Kalthoff, H., Krammer, P. H., 
and Eils, R. (2004). Mathematical modeling reveals threshold mechanism in CD95-
induced apoptosis. J. Cell Biol. 166, 839-851. 
Bouillet, P., Cory, S., Zhang, L. C., Strasser, A., and Adams, J. M. (2001). Degenerative 
disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. 
Dev. Cell 1, 645-653. 
Buerk, D. G. (2001). Can we model nitric oxide biotransport? A survey of mathematical models 
for a simple diatomic molecule with surprisingly complex biological activities. Annu. 
Rev. Biomed. Eng. 3, 109-143. 
Bulotta, S., Barsacchi, R., Rotiroti, D., Borgese, N., and Clementi, E. (2001). Activation of the 
endothelial nitric-oxide synthase by tumor necrosis factor-alpha. A novel feedback 
mechanism regulating cell death. J. Biol. Chem. 276, 6529-6536. 
Cary, S. P. L., Winger, J. A., and Marletta, M. A. (2005). Tonic and acute nitric oxide signaling 
through soluble guanylate cyclase is mediated by nonheme nitric oxide, ATP, and GTP. 
Proc. Natl. Acad. Sci. U S A. 102, 13064-13069. 
Ceneviva, G. D., Tzeng, E., Hoyt, D. G., Yee, E., Gallagher, A., Engelhardt, J. F., Kim, Y. M., 
Billiar, T. R., Watkins, S. A., and Pitt, B. R. (1998). Nitric oxide inhibits 
lipopolysaccharide-induced apoptosis in pulmonary artery endothelial cells. Am. J. 
Physiol 275, L717-L728. 
Chawla-Sarkar, M., Bae, S. I., Reu, F. J., Jacobs, B. S., Lindner, D. J., and Borden, E. C. (2004). 
Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes 
resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Differ. 11, 
915-923. 
Chen, K. C., Csikasz-Nagy, A., Gyorffy, B., Val, J., Novak, B., and Tyson, J. J. (2000). Kinetic 
analysis of a molecular model of the budding yeast cell cycle. Mol. Biol. Cell. 11, 369-
391. 
Cherry, J. L. and Adler, F. R. (2000). How to make a Biological Switch. J. Theor. Biol. 203, 117-
133. 
 234 
Craciun, G., Tang, Y., and Feinberg, M. (2006). Understanding bistability in complex enzyme-
driven reaction networks. Proc. Natl. Acad. Sci. U S A. 103, 8697-8702. 
Czapski, G. and Goldstein, S. (1995). The role of the reactions of NO with superoxide and 
oxygen in biological systems – A kinetic approach. Free Radic. Biol. Med. 19, 785-794. 
Danial, N. N. and Korsmeyer, S. J. (2004). Cell death: Critical control points. Cell 116, 205-219. 
De Visscher, G., Rooker, S., Jorens, P., Verlooy, J., Borgers, M., Reneman, R. S., Van Rossem, 
K., and Flameng, W. (2005). Pentobarbital fails to reduce cerebral oxygen consumption 
early after non-hemorrhagic closed head injury in rats. J. Neurotrauma 22, 793-806. 
Denicola, A., Freeman, B. A., Trujillo, M., and Radi, R. (1996). Peroxynitrite reaction with 
carbon dioxide/bicarbonate: Kinetics and influence on peroxynitrite-mediated oxidations. 
Arch. Biochem. Biophys. 333, 49-58. 
Deveraux, Q. L., Takahashi, R., Salvesen, G. S., and Reed, J. C. (1997). X-linked IAP is a direct 
inhibitor of cell-death proteases. Nature 388, 300-304. 
Dimmeler, S., Haendeler, J., Nehls, M., and Zeiher, A. M. (1997a). Suppression of apoptosis by 
nitric oxide via inhibition of interleukin- 1beta-converting enzyme (ICE)-like and 
cysteine protease protein (CPP)- 32-like proteases. J. Exp. Med. 185, 601-607. 
Dimmeler, S., Rippmann, V., Weiland, U., Haendeler, J., and Zeiher, A. M. (1997b). 
Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric 
oxide. Circ. Res. 81, 970-976. 
Eissing, T., Allgower, F., and Bullinger, E. (2005). Robustness properties of apoptosis models 
with respect to parameter variations and stochastic influences. Syst. Biol. 152, 221-228. 
Eissing, T., Conzelmann, H., Gilles, E. D., Allgower, F., Bullinger, E., and Scheurich, P. (2004). 
Bistability analyses of a caspase activation model for receptor-induced apoptosis. J. Biol. 
Chem. 279, 36892-36897. 
Eissing, T., Waldherr, S., Allgower, F., Scheurich, P., Bullinger, E. (2007). Response to 
Bistability in apoptosis: Roles of Bax, Bcl-2, and mitochondrial permeability transition 
pores. Biophys. J. in press. 
Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., and Nagata, S. (1998). A 
caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. 
Nature 391, 43-50. 
Ermentrout, B. (2002). Simulating, analyzing, and animating dynamical systems. A guide to 
XPPAUT for researchers and students., J.J.Dongarra, ed. (Philedelphia: SIAM). 
Fadeel, B., Orrenius, S., and Zhivotovsky, B. (1999). Apoptosis in human disease: A new skin 
for the old ceremony? Biochem. Biophys. Res. Commun. 266, 699-717. 
 235 
Ferrell, J. E. (2002). Self-perpetuating states in signal transduction: positive feedback, double-
negative feedback and bistability. Curr. Opin. Cell Biol. 14, 140-148. 
Ferrell, J. E. and Xiong, W. (2001). Bistability in cell signaling: How to make continuous 
processes discontinuous, and reversible processes irreversible. Chaos 11, 227-236. 
Fersht, A. (2002). Structure and mechanism in protein science. A guide to enzyme catalysis and 
protein folding. (New York: W. H. Freeman and Company). 
Fielden, E. M., Roberts, P. B., Bray, R. C., Lowe, D. J., Mautner, G. N., Rotilio, G., and 
Calabrese, L. (1974). The mechanism of action of superdismutase from pulse radiolysis 
and electron paramagnetic resonance. Biochem. J. 139, 49-60. 
Fussenegger, M., Bailey, J. E., and Varner, J. (2000). A mathematical model of caspase function 
in apoptosis. Nature Biotechnol. 18, 768-774. 
Ghafourifar, P., Asbury, M. L., Joshi, S. S., and Kincaid, E. D. (2005). Determination of 
mitochondrial nitric oxide synthase activity. Meth. Enzymol. 396, 424-444. 
Gorren, A. C. F., Schrammel, A., Schmidt, K., and Mayer, B. (1996). Decomposition of S-
nitrosoglutathione in the presence of copper ions and glutathione. Arch. Biochem. 
Biophys. 330, 219-228. 
Green, D. R. and Kroemer, G. (2004). The pathophysiology of mitochondrial cell death. Science 
305, 626-629. 
Grisham, M. B., Jourd'heuil, D., and Wink, D.A. (1999). Nitric oxide. I. Physiological chemistry 
of nitric oxide and its metabolites:implications in inflammation. Am. J. Physiol 276, 
G315-G321. 
Halestrap, A. P. and Brenner, C. (2003). The Adenine Nucleotide Translocase: A central 
component of the mitochondrial permeability transition pore and key player in cell death. 
Curr. Med. Chem. 10, 1507-1525. 
Hill, T. L. (1985). Cooperativity Theory in Biochemistry. Steady-State and Equilibrium Systems. 
(New York, N.Y.: Springer-Verlag). 
Hofseth, L. J., Saito, S., Hussain, S. P., Espey, M. G., Miranda, K. M., Araki, Y., Jhappan, C., 
Higashimoto, Y., He, P. J., Linke, S. P., Quezado, M. M., Zurer, I., Rotter, V., Wink, D. 
A., Appella, E., and Harris, C. C. (2003). Nitric oxide-induced cellular stress and p53 
activation in chronic inflammation. Proc. Natl. Acad. Sci. U S A. 100, 143-148. 
Hon, W. M., Lee, K. H., and Khoo, H. E. (2002). Nitric oxide in liver diseases: friend, foe, or 
just passerby? Ann. N. Y. Acad. Sci. 962, 275-295. 
Hu, T. M., Hayton, W. L., and Mallary (2006). Kinetic modeling of nitric-oxide-associated 
reaction network. Pharm. Res. 23, 1702-1711. 
 236 
Huie, R. E. and Padmaja, A, S. (1993). The reaction of NO with superoxide. Free Radic. Res. 
Commun. 18, 195-199. 
Jiang, X. and Wang, X. (2004). Cytochrome c- mediated apoptosis. Annu. Rev. Biochem. 73, 87-
106. 
Joers, A., Jaks, V., Kase, J., and Maimets, T. (2004). p53-dependent transcription can exhibit 
both on/off and graded response after genotoxic stress. Oncogene 23, 6175-6185. 
Jones, C. M., Lawrence, A., Wardman, P., and Burkitt, M.J. (2002). Electron paramagnetic 
resonance spin trapping investigation into the kinetics of glutathione oxidation by the 
superoxide radical: Re-evaluation of the rate constant. Free Radic. Biol. Med. 32, 982-
990. 
Jourd'Heuil, D., Mai, C. T., Laroux, F. S., Wink, D. A., and Grisham, M. B. (1998). The reaction 
of S-nitrosoglutathione with superoxide. Biochem. Biophys. Res. Commun. 244, 525-
530. 
Karpinich, N. O., Tafani, M., Rothman, R. J., Russo, M. A., and Farber, J. L. (2002). The course 
of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial 
release of cytochrome c. J. Biol. Chem. 277, 16547-16552. 
Katiyar, S. K., Roy, A. M., and Baliga, M. S. (2005). Silymarin induces apoptosis primarily 
through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release, and 
caspase activation. Mol. Cancer Ther. 4 , 207-216. 
Keshive, M., Singh, S., Wishnok, J. S., Tannenbaum, S. R., and Deen, W. M. (1996). Kinetics of 
S-nitrosation of thiols in nitric oxide solutions. Chem. Res. Toxicol. 9, 988-993. 
Kholodenko, B. N. (2006). Cell-signalling dynamics in time and space. Nat. Rev. Mol. Cell Biol. 
7, 165-176. 
Kim, P. K., Zamora, R., Petrosko, P., and Billiar, T. R. (2001). The regulatory role of nitric oxide 
in apoptosis. Int. Immunopharmacol. 1, 1421-1441. 
Kim, P. K. M.,  Zuckerbraun, B. S., Otterbein, L. E., Vodovotz, Y., and Billiar, T. R. (2004). 'Til 
death do us part: nitric oxide and mechanisms of hepatotoxicity. Biol. Chem. 365, 11-15. 
Kim, Y. M., Chung, H. T., Kim, S. S., Han, J. A., Yoo, Y. M., Kim, K. M., Lee, G. H., Yun, H. 
Y., Green, A., Li, J., Simmons, R. L., and Billiar, T. R. (1999). Nitric oxide protects 
PC12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of 
caspase signaling. J. Neurosci. 19, 6740-6747. 
Kim, Y. M., Chung, H. T., Simmons, R. L., and Billiar, T. R. (2000). Cellular non-heme iron 
content is a determinant of nitric oxide- mediated apoptosis, necrosis, and caspase 
inhibition. J. Biol. Chem. 275, 10954-10961. 
 237 
Kim, Y. M., Kim, T. H., Seol, D. W., Talanian, R. V., and Billiar, T. R. (1998). Nitric Oxide 
suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and 
cytochrome c release. J. Biol. Chem. 273, 31437-31441. 
Kim, Y. M., Talanian, R. V., and Billiar, T. R. (1997). Nitric oxide inhibits apoptosis by 
preventing increases in caspase-3-like activity via two distinct mechanisms. J. Biol. 
Chem. 272, 31138-31148. 
King, J. R. B. (2000). Cancer Biology. (Harlow, UK: Pearson Education). 
Kitano, H. (2002). Systems biology: A brief overview. Science 295, 1662-1664. 
Kitano, H. (2006). Computational cellular dynamics: a network-physics integral. Nat. Rev. Mol. 
Cell Biol. 7, 163. 
Kitano, H., Funahashi, A., Matsuoka, Y., and Oda, K. (2005). Using process diagrams for the 
graphical representation of biological networks. Nat. Biotechnol. 23, 961-966. 
Koppenol, W.H., Moreno, J. J., Pryor, W. A., Ischiropoulos, H., and Beckman, J.S. (1992). 
Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem. Res. 
Toxicol. 5, 834-842. 
Lancaster, J. R. (1994). Simulation of the diffusion and reaction of endogenously produced nitric 
oxide. Proc. Natl. Acad. Sci. U S A. 91, 8137-8141. 
Lancaster, J. R. (1997). A tutorial on the diffusibility and reactivity of free nitric oxide. Nitric 
Oxide 1, 18-30. 
Legewie, S., Bluthgen, N., and Herzel, H. (2006). Mathematical modeling identifies inhibitors of 
apoptosis as mediators of positive feedback and bistability. PLoS Comput. Biol. 2, 1061-
1073. 
Li, B. and Dou, Q. P. (2000). Bax degradation by the ubiquitin/proteasome-dependent pathway: 
involvement in tumor survival and progression. Proc. Natl. Acad. Sci. U S A. 97, 3850-
3855. 
Li, J., Billiar, T. R., Talanian, R. V., and Kim, Y. M. (1997). Nitric oxide reversibly inhibits 
seven members of the caspase family via S-nitrosylation. Biochem. Biophys. Res. 
Commun. 240, 419-424. 
Licht, W. R., Tannenbaum, S. R., and Deen, W. M. (1988). Use of ascorbic acid to inhibit 
nitrosation: kinetic and mass transfer coefficients for an in vitro system. Carcinogenesis 
9, 365-372. 
 238 
Luo, X., Budihardjo, I., Zou, H., Slaughter, C., and Wang, X. D. (1998). Bid, a Bcl2 interacting 
protein, mediates cytochrome c release from mitochondria in response to activation of 
cell surface death receptors. Cell 94, 481-490. 
Lutter, M., Perkins, G. A., and Wang, X. D. (2001). The pro-apoptotic Bcl-2 family member tBid 
localizes to mitochondrial contact sites. BMC Cell Biol. 2, 22-30. 
Ma, L., and Iglesias, P. A. (2002). Quantifying robustness of biochemical network models. BMC 
Bioinformatics. 3, 38. 
Mannick, J. B., Hausladen, A., Liu, L. M., Hess, D. T., Zeng, M., Miao, Q. X., Kane, L.S., Gow, 
A. J., and Stamler, J. S. (1999). Fas-induced caspase denitrosylation. Science 284, 651-
654. 
Manoharan, A., Kiefer, T., Leist, S., Schrader, K., Urban, C., Walter, D., Maurer, U., Borner, C. 
(2006). Identification of a ‘genuine’ mammalian homolog of nematodal CED-4: Is the 
hunt over or do we need better guns? Cell Death Differ. 13, 1310-1317. 
Messmer, U. K. and Brune, B. (1996). Nitric oxide-induced apoptosis: p53-dependent and p53-
independent signalling pathways. Biochem. J. 319 ( Pt 1), 299-305. 
Messmer, U. K., Lapetina, E. G., and Brune, B. (1995). Nitric oxide-induced apoptosis in RAW 
264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating 
compounds. Mol. Pharmacol. 47, 757-765. 
Nagata, S. (1997). Apoptosis by death factor. Cell 88, 355-365. 
Nair, V. D., Yuen, T., Olanow, C. W., and Sealfon, S. C. (2004). Early single cell bifurcation of 
pro- and antiapoptotic states during oxidative stress. J. Biol. Chem 279, 27494-27501. 
Nakagawa, T., Shimizu, S., Watanabe, T., Yamaguchi, O., Otsu, K., Yamagata, H., Inohara, H., 
Kubo, T., and Tsujimoto, Y. (2005). Cyclophilin D-dependent mitochondrial 
permeability transition regulates some necrotic but not apoptotic cell death. Nature 434, 
652-658. 
Newmeyer, D. D. and Ferguson-Miller, S. (2003). Mitochondria: Releasing power for life and 
unleashing the machineries of death. Cell 112, 481-490. 
Oltvai, Z. N., Milliman, C. L., and Korsmeyer, S. J. (1993). Bcl-2 heterodimerizes in vivo with a 
conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619. 
Ozbudak, E. M., Thattai, M., Lim, H. N., Shraiman, B. I., and van Oudenaarden, A. (2004). 
Multistability in the lactose utilization network of Escherichia coli. Nature 427, 737-740. 
Pou, S., Tsai, P., Porasuphatana, S., Halpern, H. J., Chandramouli, G. V. R., Barth, E. D., and 
Rosen, G. M. (1999). Spin trapping of nitric oxide by ferro-chelates: kinetic and in vivo 
pharmacokinetic studies. Biochim Biophys Acta 1427, 216-226. 
 239 
Pourzand, C., Watkin, R. D., Brown, J. E., and Tyrrell, R. M. (1999). Ultraviolet A radiation 
induces immediate release of iron in human primary skin fibroblasts: The role of ferritin. 
Proc. Natl. Acad. Sci. U S A. 96, 6751-6756. 
Radi, R., Cassina, A., and Hodara, R. (2002). Nitric oxide and peroxynitrite interactions with 
mitochondria. Biol. Chem. 383, 401-409. 
Radi, R., Denicola, A., Ferrer-Sueta, G., and Rubbo, H. (2000). The biological chemistry of 
peroxynitrite. In Nitric Oxide: Biology and Pathobiology, L.J.Ignarro, ed. (San Diego: 
Academic), pp. 57-82. 
Reed, J. C. (1999). Dysregulation of apoptosis in cancer. J. Clin. Oncol. 17, 2941-2953. 
Reed, J. C. (2002). Apoptosis-based therapies. Nat. Rev. Drug Discov. 1, 111-121. 
Rehm, M., Dussmann, H., Janicke, R. U., Tavare, J. M., Kogel, D., and Prehn, J. H. M. (2002). 
Single-cell fluorescence resonance energy transfer analysis demonstrates that caspase 
activation during apoptosis is a rapid process - Role of caspase-3. J. Biol. Chem. 277, 
24506-24514. 
Rehm, M., Huber, H. J., Dussmann, H., and Prehn, J. H. M. (2006). Systems analysis of effector 
caspase activation and its control by X-linked inhibitor of apoptosis protein. EMBO J. 25, 
4338-4349. 
Riedl, S. J., Li, W., Chao, Y., Schwarzenbacher, R., and Shi, Y. (2005). Structure of the 
apoptotic protease-activating factor 1 bound to ADP. Nature 434, 926-933. 
Rodriguez, J. and Lazebnik, Y. (1999). Caspase-9 and Apaf-1 form an active enzyme. Genes 
Dev. 13, 3179-3184. 
Rossig, L., Fichtlscherer, B., Breitschopf, K., Haendeler, J., Zeiher, A. M., Mulsch, A., and 
Dimmeler, S. (1999). Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J. Biol. 
Chem. 274, 6823-6826. 
Salvesen, G. S. (2002). Caspases and apoptosis. In Proteases in Biology and Medicine Assays in 
Biochemistry, pp. 9-19. 
Salvesen, G. S. and Dixit, V. M. (1999). Caspase activation: The induced-proximity model. Proc. 
Natl. Acad. Sci. U S A. 96, 10964-10967. 
Sanfilippo, C. M. and Blaho, J. A. (2003). The facts of death. Int. Rev. Immunol. 22, 327-340. 
Sarih, M., Souvannavong, V., and Adam, A. (1993). Nitric oxide synthase induces macrophage 
death by apoptosis. Biochem. Biophys. Res. Commun. 191, 503-508. 
 240 
Sarti, P., Arese, M., Bacchi, A., Barone, M.C., Forte, E., Mastronicola, D., Brunori, M., and 
Giuffre, A. (2003). Nitric oxide and mitochondrial complex IV. IUBMB Life 55, 605-
611. 
Schorr, K., Li, M., Krajewski, S., Reed, J. C., and Furth, P. A. (1999). Bcl-2 gene family and 
related proteins in mammary gland involution and breast cancer. J. Mammary Gland 
Biol. 4, 153-164. 
Shiozaki, E. N., Chai, J. J., Rigotti, D. J., Riedl, S. J., Li, P. W., Srinivasula, S. M., Alnemri, E. 
S., Fairman, R., and Shi, Y. G. (2003). Mechanism of XIAP-mediated inhibition of 
caspase-9. Mol. Cell. 11, 519-527. 
Siehs, C., Oberbauer, R., Mayer, G., Lukas, A., and Mayer, B. (2002). Discrete simulation of 
regulatory homo- and heterodimerization in the apoptosis effector phase. Bioinformatics 
18, 67-76. 
Sies, H., Sharov, V. S., Klotz, L. O., and Briviba, K. (1997). Glutathione peroxidase protects 
against peroxynitrite-mediated oxidations - A new function for selenoproteins as 
peroxynitrite reductase. J. Biol. Chem. 272, 27812-27817. 
Slee, E. A., Keogh, S. A., and Martin, S. J. (2000). Cleavage of Bid during cytotoxic drug and 
UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is 
catalysed by caspase-3: a potential feedback loop for amplification of apoptosis-
associated mitochondrial cytochrome c release. Cell Death Differ. 7, 556-565. 
Spencer, J. P. E., Wong, J., Jenner, A., Aruoma, O. I., Cross, C. E., and Halliwell, B. (1996). 
Base modification and strand breakage in isolated calf thymus DNA and in DNA from 
human skin epidermal keratinocytes exposed to peroxynitrite or 3-
morpholinosydnonimine. Chem. Res. Toxicol. 9, 1152-1158. 
Squadrito, G. L. and Pryor, W. A. (1998). Oxidative chemistry of nitric oxide: The roles of 
superoxide, peroxynitrite, and carbon dioxide. Free Radic. Biol. Med. 25, 392-403. 
Stamler,J.S. (1994). Redox signaling – nitrosylation and related target interactions of nitric 
oxide. Cell 78, 931-936. 
Stucki, J. W. and Simon, H. U. (2005). Mathematical modeling of caspase-3 activation and 
degradation. J. Theor. Biol. 234, 123-131. 
Thomson, L., Trujillo,M., Telleri, R., and Radi, R. (1995). Kinetics of cytochrome c(2+) 
oxidation by peroxynitrite – Implications for superoxide measurements in nitric oxide-
producing biological systems. Arch. Biochem. Biophys. 319, 491-497. 
Tyas, L., Brophy, V. A., Pope, A., Rivett, A. J., and Tavare, J. M. (2000). Rapid caspase-3 
activation during apoptosis revealed using fluorescence-resonance energy transfer. 
EMBO Rep. 1, 266-270. 
 241 
Tzeng, E., Kim, Y. M., Pitt, B. R., Lizonova, A., Kovesdi, I., and Billiar, T. R. (1997). 
Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell 
apoptosis. Surgery 122, 255-263. 
Vieira, H. L. A., Belzacq, A. S., Haouzi, D., Bernassola, F., Cohen, I., Jacotot, E., Ferri, K. F., El 
Hamel, C., Bartle, L. M., Melino, G., Brenner, C., Goldmacher, V., and Kroemer, G. 
(2001). The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-
hydroxynonenal. Oncogene 20, 4305-4316. 
Vieira, H. L. A., Haouzi, D., El Hamel, C., Jacotot, E., Belzacq, A. S., Brenner, C., and Kroemer, 
G. (2000). Permeabilization of the mitochondrial inner membrane during apoptosis: 
impact of the adenine nucleotide translocator. Cell Death Differ. 7, 1146-1154. 
Vodovotz, Y., Kim, P. K. M., Bagci, E. Z., Ermentrout, G. B., Chow, C. C., Bahar, I., and 
Billiar, T. R. (2004). Inflammatory modulation of hepatocyte apoptosis by nitric oxide: In 
vivo, in vitro and in silico studies. Curr. Mol. Med. 4, 753-762. Ann. N. Y. Acad. Sci. 
Wang, Y. N., Vodovotz, Y., Kim, P. K. M., Zamora, R., and Billiar,T.R. (2002). Mechanisms of 
hepatoprotection by nitric oxide. Ann. N. Y. ACAD. SCI. 962, 415-422. 
Wei, M. C., Zong, W. X., Cheng, E. H. Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., 
Roth, K. A., MacCregor, G. R., Thompson, C. B., and Korsmeyer, S. J. (2001). 
Proapoptotic Bax and Bak: A requisite gateway to mitochondrial dysfunction and death. 
Science 292, 727-730. 
Weinberg, R. A. (2006). The Biology of Cancer. (New York: Garland Science, Taylor & Francis 
Group). 
Weller, M. (1998). Predicting response to cancer chemotherapy: the role of p53. Cell Tissue Res. 
292, 435-445. 
Weller, R., Schwentker, A., Billiar, T. R., and Vodovotz, Y. (2003). Autologous nitric oxide 
protects mouse and human keratinocytes from ultraviolet B radiation-induced apoptosis. 
Am. J. Physiol. 284, C1140-C1148. 
Wink, D. A., Feelisch, M., Vodovotz, Y., Fukuto, J., and Grisham, M. B. (1999). The Chemical 
Biology of Nitric Oxide. In Reactive Oxygen Species in Biological Systems: An 
Interdisciplinary approach, C.A.Colton and D.L.Gilbert, eds. (New York: Kluwer 
Academic / Plenum Publishing), pp. 245-291. 
Wink, D.A., Nims, R. W., Darbyshire, J. F., Christodoulou, D., Hanbauer, I., Cox, G. W., Laval, 
F., Laval, J., Cook, J. A., Krishna, M. C., Degraff, W. G., and Mitchell, J. B. (1994). 
Reaction kinetics for nitrosation of cysteine and glutathione in aerobic nitric oxide 
solutions at neutral pH – Insights into the fate and physiological effects of intermediates 
generated in the NO/O2- reaction. Chem. Res. Toxicol. 7, 519-525. 
 242 
Wolter, K. G., Hsu, Y. T., Smith, C. L., Nechushtan, A., Xi, X. G., and Youle, R. J. (1997). 
Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139, 
1281-1292. 
Xiong, W. and Ferrell, J. E. (2003). A positive-feedback-based bistable 'memory module' that 
governs a cell fate decision. Nature 426, 460-465. 
Yang, Y. L. and Yu, X. D. (2003). Regulation of apoptosis: the ubiquitous way. FASEB J. 17, 
790-799. 
Yi, X. L., Yin, X. M., and Dong, Z. (2003). Inhibition of Bid-induced apoptosis by Bcl-2 - tBid 
insertion, Bax translocation, and Bax/Bak oligomerization suppressed. J. Biol. Chem. 
278, 16992-16999. 
Yin, X. M., Wang, K., Gross, A., Zhao, Y., Zinkel, S., Klocke, B., Roth, K. A., and Korsmeyer, 
S. J. (1999). Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. 
Nature 400, 886-891. 
Zangemeister-Wittke, U., Leech, S. H., Olie, R. A., Simoes-Wust, A. P., Gautschi, O., Luedke, 
G. H., Natt, F., Haner, R., Martin, P., Hall, J., Nalin, C.M., and Stahel, R. A. (2000). A 
novel bispecific antisense oligonucleotide inhibiting both Bcl-2 and Bcl-xL expression 
efficiently induces apoptosis in tumor cells. Clin. Cancer Res. 6, 2547-2555. 
Zhang, W. and Edwards, A. (2006). A model of nitric oxide tubulo-vascular cross-talk in a renal 
outer medullary cross-section. Am. J. Physiol. Renal. Physiol. in press. 
 243 
